<!DOCTYPE html>
<html lang="en">
<head>
    <title>The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway | Nature Communications</title>
    
        <link rel="dns-prefetch" href="//nexus.ensighten.com"/>
<link rel="dns-prefetch" href="//ajax.googleapis.com"/>
<link rel="dns-prefetch" href="//fonts.googleapis.com"/>
<link rel="dns-prefetch" href="//fonts.gstatic.com"/>

<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=2.5,user-scalable=yes"/>


<script>
    (function(e){var t=e.documentElement,n=e.implementation;t.className='js';if(n&&n.hasFeature('http://www.w3.org/TR/SVG11/feature#Image','1.1')){t.className+=' svg'}})(document)
</script>


    <link rel="apple-touch-icon" sizes="114x114" href="/static/images/favicon-114x114.14310470.png"/>
    <link rel="apple-touch-icon" sizes="144x144" href="/static/images/favicon-144x144.3e61d1f7.png"/>
    <link rel="apple-touch-icon" sizes="180x180" href="/static/images/favicon-180x180.5789768d.png"/>
    <link rel="icon" type="image/png" href="/static/images/favicon-16x16.bfd0e25c.png" sizes="16x16"/>
    <link rel="icon" type="image/png" href="/static/images/favicon-32x32.1c4a0334.png" sizes="32x32"/>
    <link rel="icon" type="image/png" href="/static/images/favicon-96x96.14ff9c7f.png" sizes="96x96"/>
    <link rel="icon" type="image/png" href="/static/images/favicon-194x194.5789768d.png" sizes="194x194"/>
    <link rel="shortcut icon" href="/static/images/favicon.14515a9f.ico"/>
    <meta name="msapplication-TileColor" content="#940720"/>
    <meta name="msapplication-TileImage" content="/static/images/favicon-144x144.3e61d1f7.png">
    <meta name="theme-color" content="#940720">


    <link href="/static/css/mosaic-grade-c.7633a43a.css" rel="stylesheet"/>
    <link href="/static/css/journal-mosaic.748ef760.css" rel="stylesheet"  media="only screen and (-webkit-min-device-pixel-ratio:0), (min-color-index:0), (-ms-high-contrast: none)" />


  <style>
        .background-brand-primary {
            background-color: #f2f7fa;
            color: #222;
        }

        .background-brand-secondary {
            background-color: #dee6e8;
            color: #222;
        }

        .background-brand-tertiary {
            background-color: #e7eff1;
            color: #222;
        }

        .background-gradient-brand-primary {
            background-color: -webkit-gradient(left top, right top, color-stop(50%, #f2f7fa), color-stop(50%, transparent)); /* for Android 4.3- */
            background: url("data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns=%22http:%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20preserveAspectRatio=%22none%22%20version=%221.0%22%20width=%22100%25%22%20height=%22100%25%22%20xmlns:xlink=%22http:%2F%2Fwww.w3.org%2F1999%2Fxlink%22%3E%3Cdefs%3E%3ClinearGradient%20id=%22myLinearGradient%22%20x1=%220%25%22%20y1=%220%25%22%20x2=%22100%25%22%20y2=%220%25%22%20spreadMethod=%22pad%22%3E%3Cstop%20offset=%220%25%22%20stop-color=%22%23f2f7fa%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%2250%25%22%20stop-color=%22%23f2f7fa%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%2250%25%22%20stop-color=%22%23f2f7fa%22%20stop-opacity=%220%22%2F%3E%3Cstop%20offset=%22100%25%22%20stop-color=%22%23f2f7fa%22%20stop-opacity=%220%22%2F%3E%3C%2FlinearGradient%3E%3C%2Fdefs%3E%3Crect%20width=%22100%25%22%20height=%22100%25%22%20style=%22fill:url(%23myLinearGradient);%22%20%2F%3E%3C%2Fsvg%3E") repeat-y;
        }

        .background-gradient-brand-secondary-tertiary {
            background-color: -webkit-gradient(left top, right top, color-stop(50%, #dee6e8), color-stop(50%, #e7eff1)); /* for Android 4.3- */
            background: url("data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns=%22http:%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20preserveAspectRatio=%22none%22%20version=%221.0%22%20width=%22100%25%22%20height=%22100%25%22%20xmlns:xlink=%22http:%2F%2Fwww.w3.org%2F1999%2Fxlink%22%3E%3Cdefs%3E%3ClinearGradient%20id=%22myLinearGradient%22%20x1=%220%25%22%20y1=%220%25%22%20x2=%22100%25%22%20y2=%220%25%22%20spreadMethod=%22pad%22%3E%3Cstop%20offset=%220%25%22%20stop-color=%22%23dee6e8%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%2250%25%22%20stop-color=%22%23dee6e8%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%2250%25%22%20stop-color=%22%23e7eff1%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%22100%25%22%20stop-color=%22%23e7eff1%22%20stop-opacity=%221%22%2F%3E%3C%2FlinearGradient%3E%3C%2Fdefs%3E%3Crect%20width=%22100%25%22%20height=%22100%25%22%20style=%22fill:url(%23myLinearGradient);%22%20%2F%3E%3C%2Fsvg%3E") repeat-y;
        }

        .background-gradient-brand-gray {
            background-color: -webkit-gradient(left top, right top, color-stop(50%, #dadada), color-stop(50%, transparent)); /* for Android 4.3- */
            background: url("data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns=%22http:%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20preserveAspectRatio=%22none%22%20version=%221.0%22%20width=%22100%25%22%20height=%22100%25%22%20xmlns:xlink=%22http:%2F%2Fwww.w3.org%2F1999%2Fxlink%22%3E%3Cdefs%3E%3ClinearGradient%20id=%22myLinearGradient%22%20x1=%220%25%22%20y1=%220%25%22%20x2=%22100%25%22%20y2=%220%25%22%20spreadMethod=%22pad%22%3E%3Cstop%20offset=%220%25%22%20stop-color=%22%23dadada%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%2250%25%22%20stop-color=%22%23dadada%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%2250%25%22%20stop-color=%22%23dadada%22%20stop-opacity=%220%22%2F%3E%3Cstop%20offset=%22100%25%22%20stop-color=%22%23dadada%22%20stop-opacity=%220%22%2F%3E%3C%2FlinearGradient%3E%3C%2Fdefs%3E%3Crect%20width=%22100%25%22%20height=%22100%25%22%20style=%22fill:url(%23myLinearGradient);%22%20%2F%3E%3C%2Fsvg%3E") repeat-y;
        }

        .background-gradient-brand-gray-light {
            background: -webkit-gradient(left top, right top, color-stop(50%, #eee), color-stop(50%, transparent)); /* for Android 4.3- */
            background: url("data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns=%22http:%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20preserveAspectRatio=%22none%22%20version=%221.0%22%20width=%22100%25%22%20height=%22100%25%22%20xmlns:xlink=%22http:%2F%2Fwww.w3.org%2F1999%2Fxlink%22%3E%3Cdefs%3E%3ClinearGradient%20id=%22myLinearGradient%22%20x1=%220%25%22%20y1=%220%25%22%20x2=%22100%25%22%20y2=%220%25%22%20spreadMethod=%22pad%22%3E%3Cstop%20offset=%220%25%22%20stop-color=%22%23eee%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%2250%25%22%20stop-color=%22%23eee%22%20stop-opacity=%221%22%2F%3E%3Cstop%20offset=%2250%25%22%20stop-color=%22%23eee%22%20stop-opacity=%220%22%2F%3E%3Cstop%20offset=%22100%25%22%20stop-color=%22%23eee%22%20stop-opacity=%220%22%2F%3E%3C%2FlinearGradient%3E%3C%2Fdefs%3E%3Crect%20width=%22100%25%22%20height=%22100%25%22%20style=%22fill:url(%23myLinearGradient);%22%20%2F%3E%3C%2Fsvg%3E") repeat-y;
        }


        

        

        


        .nav-border {
            border-bottom: 4px solid #dee6e8;
        }

        /* less than or equal to 875px */
        @media only screen and (max-width: 54.688em) {
            .banner {
                background-color: #f2f7fa;
            }

            .nav-border .menu-cell li {
                border-bottom: 1px solid #dee6e8;
            }
        }

        .ie7 .small-header-main,
        .ie8 .small-header-main {
            background-color: #f2f7fa;
        }

        .sticky-header .inner-banner,
        .header-primary-color {
            background-color: #f2f7fa;
        }

        
            .nature-research-logo {
                background-image: url("/static/images/nature-research-logo-dark.2dec4e54.svg"), none;
            }
        

    </style>


<script>
    dataLayer = [{"content":{"category":{"contentType":"article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"cancer-metabolism;cns-cancer;energy-metabolism;tor-signalling","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Nature Communications","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Article"}},"article":{"doi":"10.1038/ncomms12700"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"legacy":{"webtrendsLicenceType":"http://creativecommons.org/licenses/by/3.0/"}}},"contentInfo":{"authors":["Mélissa Carbonneau","Laurence M. Gagné","Marie-Eve Lalonde","Marie-Anne Germain","Alena Motorina","Marie-Christine Guiot","Blandine Secco","Emma E. Vincent","Anthony Tumber","Laura Hulea","Jonathan Bergeman","Udo Oppermann","Russell G. Jones","Mathieu Laplante","Ivan Topisirovic","Kevin Petrecca","Marc-Étienne Huot","Frédérick A. Mallette"],"publishedAt":1473811200,"publishedAtString":"2016-09-14","title":"The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway","legacy":null,"publishedAtTime":null},"journal":{"title":"nature communications","volume":"7","issue":null},"authorization":{"status":true}},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[]}},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null}];
</script>
<script src="//nexus.ensighten.com/npg/Bootstrap.js" async="async"></script>


    <meta name="description" content="Article"/>

<meta name="robots" content="noarchive">
<meta name="access" content="Yes">
<meta name="WT.cg_s" content="Article"/>
<meta name="WT.z_bandiera_abtest" content="a"/>
<meta name="WT.page_categorisation" content="Article_HTML"/>

    <meta name="WT.template" content="oscar"/>
    <meta name="WT.z_cg_type" content="Nature Research Journals"/>
    <meta name="WT.cg_n" content="Nature Communications"/>
    <meta name="dc.rights" content="©2017 Macmillan Publishers Limited. All Rights Reserved."/>
    <meta name="prism.issn" content="2041-1723"/>


<link rel="search" href="http://www.nature.com/search">
<link rel="search" href="http://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="http://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">


    
    
    
    <meta name="twitter:card" content="summary"/>
    
    <meta name="twitter:title" content="The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pa"/>
    
    <meta name="twitter:site" content="@NatureComms"/>
    
    <meta name="twitter:description" content="Oncogenic mutations of isocitrate dehydrogenases 1 and 2 result in the production of the oncometabolite R-2-hydroxyglutarate. Here the authors show that the oncometabolite promotes mTOR activation in "/>
    
    <meta name="twitter:image" content="https://media.springernature.com/m685/nature-static/assets/v1/image-assets/ncomms12700-f1.jpg"/>
    
    <meta name="WT.z_cc_license_type" content="cc_by"/>
    
    <meta name="WT.z_primary_atype" content="Research"/>
    
    <meta name="WT.z_subject_term" content="Cancer metabolism;CNS cancer;Energy metabolism;TOR signalling"/>
    
    <meta name="WT.z_subject_term_id" content="cancer-metabolism;cns-cancer;energy-metabolism;tor-signalling"/>
    
    <meta name="dc.identifier" content="doi:10.1038/ncomms12700"/>
    
    <meta name="DOI" content="10.1038/ncomms12700"/>
    
    <meta name="prism.doi" content="doi:10.1038/ncomms12700"/>
    
    <meta name="citation_doi" content="doi:10.1038/ncomms12700"/>
    
    <meta name="journal_id" content="41467"/>
    
    <meta name="dc.title" content="The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway"/>
    
    <meta name="dc.description" content="&lt;p&gt;
Oncogenic mutations of isocitrate dehydrogenases 1 and 2 result in the production of the oncometabolite R-2-hydroxyglutarate. Here the authors show that the oncometabolite promotes mTOR activation in a PTEN/PI3K-independent manner by regulating DEPTOR stability via inhib&amp;hellip;&lt;/p&gt;"/>
    
    <meta name="dc.source" content="Nature Communications 2016 7:null"/>
    
    <meta name="dc.format" content="text/html"/>
    
    <meta name="dc.publisher" content="Nature Publishing Group"/>
    
    <meta name="dc.date" content="2016-09-14"/>
    
    <meta name="dc.type" content="Research"/>
    
    <meta name="dc.language" content="en"/>
    
    <meta name="dc.copyright" content="2016 Nature Publishing Group"/>
    
    <meta name="dc.rightsAgent" content="permissions@nature.com"/>
    
    <meta name="prism.issn" content="2041-1723"/>
    
    <meta name="prism.publicationName" content="Nature Communications"/>
    
    <meta name="prism.publicationDate" content="2016-09-14"/>
    
    <meta name="prism.volume" content="7"/>
    
    <meta name="prism.section" content="Research"/>
    
    <meta name="prism.startingPage" content="ncomms12700"/>
    
    <meta name="prism.copyright" content="2016 Nature Publishing Group"/>
    
    <meta name="prism.rightsAgent" content="permissions@nature.com"/>
    
    <meta name="prism.url" content="http://www.nature.com/articles/ncomms12700"/>
    
    <meta name="citation_pdf_url" content="http://www.nature.com/articles/ncomms12700.pdf"/>
    
    <meta name="citation_abstract_html_url" content="http://www.nature.com/articles/ncomms12700"/>
    
    <meta name="citation_fulltext_html_url" content="http://www.nature.com/articles/ncomms12700"/>
    
    <meta name="citation_journal_title" content="Nature Communications"/>
    
    <meta name="citation_publisher" content="Nature Publishing Group"/>
    
    <meta name="citation_issn" content="2041-1723"/>
    
    <meta name="citation_title" content="The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway"/>
    
    <meta name="citation_volume" content="7"/>
    
    <meta name="citation_date" content="2016/09/14"/>
    
    <meta name="citation_publication_date" content="2016/09/14"/>
    
    <meta name="citation_firstpage" content="ncomms12700"/>
    
    <meta name="citation_article_type" content="Article"/>
    
    <meta name="citation_fulltext_world_readable" content=""/>
    
    <meta name="dc.creator" content="M&#233;lissa Carbonneau"/>
    
    <meta name="dc.creator" content="Laurence M. Gagn&#233;"/>
    
    <meta name="dc.creator" content="Marie-Eve Lalonde"/>
    
    <meta name="dc.creator" content="Marie-Anne Germain"/>
    
    <meta name="dc.creator" content="Alena Motorina"/>
    
    <meta name="dc.creator" content="Marie-Christine Guiot"/>
    
    <meta name="dc.creator" content="Blandine Secco"/>
    
    <meta name="dc.creator" content="Emma E. Vincent"/>
    
    <meta name="dc.creator" content="Anthony Tumber"/>
    
    <meta name="dc.creator" content="Laura Hulea"/>
    
    <meta name="dc.creator" content="Jonathan Bergeman"/>
    
    <meta name="dc.creator" content="Udo Oppermann"/>
    
    <meta name="dc.creator" content="Russell G. Jones"/>
    
    <meta name="dc.creator" content="Mathieu Laplante"/>
    
    <meta name="dc.creator" content="Ivan Topisirovic"/>
    
    <meta name="dc.creator" content="Kevin Petrecca"/>
    
    <meta name="dc.creator" content="Marc-&#201;tienne Huot"/>
    
    <meta name="dc.creator" content="Fr&#233;d&#233;rick A. Mallette"/>
    
    <meta name="dc.subject" content="Cancer metabolism"/>
    
    <meta name="dc.subject" content="CNS cancer"/>
    
    <meta name="dc.subject" content="Energy metabolism"/>
    
    <meta name="dc.subject" content="TOR signalling"/>
    
    <meta name="citation_author" content="M&#233;lissa Carbonneau"/>
    
    <meta name="citation_author" content="Laurence M. Gagn&#233;"/>
    
    <meta name="citation_author" content="Marie-Eve Lalonde"/>
    
    <meta name="citation_author" content="Marie-Anne Germain"/>
    
    <meta name="citation_author" content="Alena Motorina"/>
    
    <meta name="citation_author" content="Marie-Christine Guiot"/>
    
    <meta name="citation_author" content="Blandine Secco"/>
    
    <meta name="citation_author" content="Emma E. Vincent"/>
    
    <meta name="citation_author" content="Anthony Tumber"/>
    
    <meta name="citation_author" content="Laura Hulea"/>
    
    <meta name="citation_author" content="Jonathan Bergeman"/>
    
    <meta name="citation_author" content="Udo Oppermann"/>
    
    <meta name="citation_author" content="Russell G. Jones"/>
    
    <meta name="citation_author" content="Mathieu Laplante"/>
    
    <meta name="citation_author" content="Ivan Topisirovic"/>
    
    <meta name="citation_author" content="Kevin Petrecca"/>
    
    <meta name="citation_author" content="Marc-&#201;tienne Huot"/>
    
    <meta name="citation_author" content="Fr&#233;d&#233;rick A. Mallette"/>
    
    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access">

    
    <meta property="og:url" content="https://www.nature.com/articles/ncomms12700"/>
    <meta property="og:type" content="article"/>
    <meta property="og:site_name" content="Nature Communications"/>
    <meta property="og:title" content="The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway"/>
    <meta property="og:description" content="&lt;p&gt;
Oncogenic mutations of isocitrate dehydrogenases 1 and 2 result in the production of the oncometabolite R-2-hydroxyglutarate. Here the authors show that the oncometabolite promotes mTOR activation in a PTEN/PI3K-independent manner by regulating DEPTOR stability via inhib&amp;hellip;&lt;/p&gt;"/>
    <meta property="og:image" content="https://media.springernature.com/m685/nature-static/assets/v1/image-assets/ncomms12700-f1.jpg"/>

</head>
<!--[if IE 9]><body class="ie9 article-page"><![endif]-->
<!--[if gt IE 9]><!--><body class="article-page"><!--<![endif]-->
<div role="banner" class="position-relative cleared z-index-50" data-test="top-containers">
    <div class="hide-print container background-gray-dark">
    <div class="content mq1200-padded">
        <a href="#content" id="skiplink" class="skiplink contrast-text js-no-scroll" data-track="click"
           data-track-source="skip-link" data-track-dest="anchor:Skip to main content">Skip to main content</a>
    </div>
</div>


<div class="container cleared container-type-cookies-usage" data-container-type="cookies-usage">
    <div class="cookie-banner hide-print position-relative z-index-100">
        <div class="content cleared mq1200-padded">
            <form class="suppress-bottom-margin text-center mb10 mt10" action="/platform/accept-cookies" method="post">
                <p class="contrast-text text13 hide-overflow"><span class="icon">We use cookies to improve your experience with our site.</span>
                    <button type="submit" name="cookies" value="accepted" class="accept-btn contrast-text text13 ml10">
                        Accept and close
                    </button>
                    <span class="pl6 pr6"> | </span><a href="/info/cookies.html" class="contrast-text text13">More
                        info.</a></p>
            </form>
        </div>
    </div>
</div>



<div class="container cleared container-type-banner-advert" data-container-type="banner-advert">
    <div class="hide-print pt10 pb10 mq875-pa0 position-relative z-index-100 clear-float cleared leaderboard-container">
        <div class="leaderboard-inner">
            
                
    <div id="div-gpt-ad-top-1"
         class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide hide-overflow"
         data-gpt-unitpath="/285/nature_communications/article"
         data-gpt-sizes="728x90"
         data-gpt-targeting="template=mosaic;pos=top;abr=!webtv;tile=1;artid=ncomms12700">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/nature_communications/article&amp;sz=728x90&amp;tile=1&amp;c=-2074163080&amp;t=template%3Dmosaic%26pos%3Dtop%26abr%3D%21webtv%26tile%3D1%26artid%3Dncomms12700">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/nature_communications/article&amp;sz=728x90&amp;tile=1&amp;c=-2074163080&amp;t=template%3Dmosaic%26pos%3Dtop%26abr%3D%21webtv%26tile%3D1%26artid%3Dncomms12700"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>

            
        </div>
    </div>
</div>

<div class="text-orange content grade-c-show"><p>Thank you for visiting nature.com. You are using a browser version with
    limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off
    compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site
    without styles and JavaScript.</p></div>

    <div class="hide-print container background-bluegray contrast-text text14 strong lower mq640-hide position-relative z-index-100"
     data-test="header-breadcrumbs">
     <div class="content cleared mq1200-padded">
         <div class="breadcrumbs pin-left">
             <ol class="ma0 cleared clean-list inline-list"><li id="breadcrumb0" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                             itemref="breadcrumb1"><a href="/" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15"
                                data-track="click" data-track-source="breadcrumb" data-track-dest="link:nature.com"><span itemprop="title">nature.com</span></a></li><li id="breadcrumb1" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                             itemref="breadcrumb2" class="ml6"><a href="/ncomms" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15"
                                data-track="click" data-track-source="breadcrumb" data-track-dest="link:nature communications"><span itemprop="title">nature communications</span></a></li><li id="breadcrumb2" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"
                             itemref="breadcrumb3" class="ml6"><a href="/ncomms/articles?type&#x3D;article" itemprop="url" class="icon icon-right icon-arrow-right-6x10-white pr15"
                                data-track="click" data-track-source="breadcrumb" data-track-dest="link:articles"><span itemprop="title">articles</span></a></li><li id="breadcrumb3" itemscope="itemscope" itemtype="http://data-vocabulary.org/Breadcrumb"><a href="/articles/ncomms12700" itemprop="url" data-track="click" data-track-source="breadcrumb"
                                data-track-dest="link:article" class="ml6"><span itemprop="title">article</span></a></li></ol>
             
        </div>
         
        <p class="pin-right box-sizing header-primary-color nature-research-logo ma0 pa6 hide-text grade-c-hide">A Nature Research Journal</p>
        
     </div>
</div>

    
    <div class="container js-header-container mb20 position-relative z-index-50" data-ui="header-container"
         data-container-type="header">
        <div class="cleared clear hide-print position-relative background-gradient-brand-primary js-header default-header z-index-100 composite-layer tighten-line-height">
            <div class="banner js-banner content mq1200-padded position-relative">
                <div class="inner-banner cleared">
                    <div class="main-column small-header-main pin-left">
                        <div class="header-logo-container header-primary-color">
                            <a href="#menu" id="menu-button" class="js-header-menu-button menu-button js-no-scroll"
                               data-test="menu-button">
										<span class="menu-button-icon icon-rotate">
											<span class="menu-button-label">Menu</span>
										</span>
                            </a>
                            <h1 class="visually-hidden" data-test="product-title">Nature Communications</h1>
                            
                                <a href="/ncomms" class="header-logo inline-block equalize-line-height"
                                   data-track="click"
                                   data-track-source="logo"
                                   data-track-dest=""><img alt=""
                                                           src="//media.springernature.com/full/nature-cms/uploads/product/ncomms/header-aa7f836a57fbef4ef15c560ab4ce386f.svg"
                                                           class="grade-c-invisible header-logo-primary js-svg"
                                                           data-png="//media.springernature.com/full/nature-cms/uploads/product/ncomms/header-ad455ad76a3630f410bf4c569e7f3aaa.png"><img
                                        alt="" src="//media.springernature.com/full/nature-cms/uploads/product/ncomms/header-aa6f7c33d1ba82f8cce520a556a024c0.svg"
                                        class="grade-c-invisible header-logo-secondary js-svg"
                                        data-png="//media.springernature.com/full/nature-cms/uploads/product/ncomms/header-8390435b3a84674c7a7895bc7a60eef0.png"></a>
                        </div>
                    </div>
                    <div class="position-absolute position-right small-header-side">
                        <div class="pin-right">
                            <a href="#search-menu" data-component="tray-button"
                               class="pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray-translucent text11 contrast-text mr1"
                               data-test="search-link" data-track="click" data-track-source="search-menu"
                               data-track-dest="open" data-track-dl="51">
										<span class="icon icon-above icon-search-25x25-white icon-search-25x25-gray block text-center">
											<span class="block mt6 mq875-hide small-header-hide">Search</span>
										</span>
                            </a>
                            
                                <a href="http://www.nature.com/nams/svc/myaccount/save/alert?list_id&#x3D;264"
                                   class="mq640-hide pin-left inline-group-top pa10 small-header-icons background-bluegray-translucent text11 contrast-text mr1"
                                   data-test="ealert-link" data-track="click" data-track-source="ealert-menu"
                                   data-track-dest="link:E-alert">
										<span class="icon icon-above icon-ealert-25x25-white icon-ealert-25x25-gray block text-center">
											<span class="block mt6 mq875-hide small-header-hide">E-alert</span>
										</span>
                                </a>
                            
                            
                                <a href="http://mts-ncomms.nature.com/"
                                   class="mq640-hide inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray-translucent text11 contrast-text mr1"
                                   data-test="submit-link" data-track="click" data-track-source="submit-menu"
                                   data-track-dest="link:Submit">
										<span class="icon icon-above icon-submit-25x25-white icon-submit-25x25-gray block text-center">
											<span class="block mt6 mq875-hide small-header-hide">Submit</span>
										</span>
                                </a>
                            
                              <a href="/nams/svc/myaccount"
       id="my-account"
       class="placeholder inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray-translucent text11 contrast-text"
       data-test="login-link" data-track="click" data-track-source="user-menu"
       data-track-dest="link:My Account">
            <span class="icon icon-above icon-login-25x25-white icon-login-25x25-gray block text-center">
                <span class="block mt6 mq875-hide small-header-hide">My Account</span>
            </span>
    </a>
    <a href="https://idp.nature.com/authorize/natureuser?client_id&#x3D;grover&amp;redirect_uri&#x3D;http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700"
       id="login-button"
       style="display: none;"
       class="placeholder inline-block pin-left inline-group-top pa10 pr15 pl15 small-header-icons background-bluegray-translucent text11 contrast-text"
       data-test="login-link" data-track="click"
       data-track-source="user-menu"
       data-track-dest="link:Login">
            <span class="icon icon-above icon-login-25x25-white icon-login-25x25-gray block text-center">
                <span class="block mt6 mq875-hide small-header-hide">Login</span>
            </span>
    </a>

                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    
    

</div>

<div role="main" id="content" class="position-relative z-index-1">
    <div class="container cleared container-type-article" data-container-type="article">
        <div class="content position-relative cleared clear mq1200-padded" data-component="article-container">
            <article itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle">
                <div class="full-width-print main-column pin-left js-main-column highlighter" role="main">
                    <header>
                        <div class="grid grid-12 last pb20">
                            
    <ul class="grade-c-hide hide-print mq875-metrics-summary mq480-metrics-summary background-steelblue-light clean-list tighten-line-height standard-space-below cleared clear text14">
        
            
                <li class="pa10 pin-left"><!--[if lte IE 8]><img
                        src="https://badges.altmetric.com/?size&#x3D;100&amp;score&#x3D;69&amp;types&#x3D;mmmbttt1&amp;style&#x3D;bar"
                        class=altmetric-summary-bar alt=""><![endif]--><!--[if gt IE 8]><!--><img
                        src="https://badges.altmetric.com/?size&#x3D;100&amp;score&#x3D;69&amp;types&#x3D;mmmbttt1&amp;style&#x3D;bar"
                        class="altmetric-summary-bar" alt=""><!--<![endif]--></li>
            
            
                <li data-test="altmetric-score" class="pa10 pin-left">Altmetric: 69</li>
            
        

        
            <li data-test="citation-count" class="pa10 pin-left">Citations: 7</li>
        

        
            
                <li class="pa10 pin-right">
                    <a data-test="metrics-link" href="/articles/ncomms12700/metrics"
                       class="strong icon icon-right icon-double-chevron-right-10x10-blue pr15 inline-block"
                       data-track="click" data-track-source="metrics" data-track-dest="link:metrics">More detail</a>
                </li>
        
    </ul>

                            <p class="text13 text-gray-light tiny-space-below" data-test="article-identifier">
                                Article
                                
                                    |
                                    <abbr title="Open Access" class="text-orange upper">Open</abbr>
                                
                            </p>

                            <h1 class="tighten-line-height small-space-below" data-article-title="" itemprop="name headline">The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway</h1>
                            <ul class="grid grid-12 last clean-list inline-list js-list-authors text14" data-etal=25 data-etal-small=3><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator></span><a href=#auth-1><span itemprop=name>Mélissa Carbonneau</span></a><sup class=js-hide><a href=#a1>1</a>, <a href=#a2>2</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Département de Biochimie et Médecine Moléculaire, Université de Montréal"><meta itemprop=address content="Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Quebec, Canada H3C 3J7"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre"><meta itemprop=address content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, Quebec, Canada H1T 2M4"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-2><span itemprop=name>Laurence M. Gagné</span></a><sup class=js-hide><a href=#a3>3</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Centre de Recherche sur le Cancer de l’Université Laval; Départements de Biologie moléculaire, biochimie médicale et pathologie, Université Laval"><meta itemprop=address content="Centre de Recherche sur le Cancer de l’Université Laval; Départements de Biologie moléculaire, biochimie médicale et pathologie, Université Laval, Québec City, Quebec, Canada G1V 0A6"></span></sup><sup class=js-hide> <a href=#n1>n1</a></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-3><span itemprop=name>Marie-Eve Lalonde</span></a><sup class=js-hide><a href=#a2>2</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre"><meta itemprop=address content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, Quebec, Canada H1T 2M4"></span></sup><sup class=js-hide> <a href=#n1>n1</a></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-4><span itemprop=name>Marie-Anne Germain</span></a><sup class=js-hide><a href=#a2>2</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre"><meta itemprop=address content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, Quebec, Canada H1T 2M4"></span></sup><sup class=js-hide> <a href=#n1>n1</a></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-5><span itemprop=name>Alena Motorina</span></a><sup class=js-hide><a href=#a1>1</a>, <a href=#a2>2</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Département de Biochimie et Médecine Moléculaire, Université de Montréal"><meta itemprop=address content="Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Quebec, Canada H3C 3J7"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre"><meta itemprop=address content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, Quebec, Canada H1T 2M4"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-6><span itemprop=name>Marie-Christine Guiot</span></a><sup class=js-hide><a href=#a4>4</a>, <a href=#a5>5</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Brain Tumour Research Centre, Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University"><meta itemprop=address content="Brain Tumour Research Centre, Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, 3801 University Street, Montreal, Quebec, Canada H3A 2B4"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Division of Neuropathology, Department of Pathology, McGill University"><meta itemprop=address content="Division of Neuropathology, Department of Pathology, McGill University, Montreal, Quebec, Canada H3A 2B4"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-7><span itemprop=name>Blandine Secco</span></a><sup class=js-hide><a href=#a6>6</a>, <a href=#a7>7</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Institut universitaire de cardiologie et de pneumologie de Québec"><meta itemprop=address content="Institut universitaire de cardiologie et de pneumologie de Québec, 2725 chemin Sainte-Foy, Québec City, Quebec, Canada G1V 4G5"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Département de Médecine, Faculté de Médecine, Université Laval"><meta itemprop=address content="Département de Médecine, Faculté de Médecine, Université Laval, Québec City, Quebec, Canada G1V 0A6"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-8><span itemprop=name>Emma E. Vincent</span></a><sup class=js-hide><a href=#a8>8</a>, <a href=#a9>9</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Goodman Cancer Research Centre, McGill University"><meta itemprop=address content="Goodman Cancer Research Centre, McGill University, Montréal, Quebec, Canada H3G 1Y6"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Department of Physiology, McGill University"><meta itemprop=address content="Department of Physiology, McGill University, Montréal, Quebec, Canada H3G 1Y6"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-9><span itemprop=name>Anthony Tumber</span></a><sup class=js-hide><a href=#a10>10</a>, <a href=#a11>11</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Structural Genomics Consortium, University of Oxford"><meta itemprop=address content="Structural Genomics Consortium, University of Oxford, Old Road Campus, Roosevelt Drive, Headington OX3 7DQ, UK"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Target Discovery Institute, University of Oxford"><meta itemprop=address content="Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7LD, UK"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-10><span itemprop=name>Laura Hulea</span></a><sup class=js-hide><a href=#a12>12</a>, <a href=#a13>13</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Lady Davis Institute for Medical Research, Jewish General Hospital"><meta itemprop=address content="Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte-Ste-Catherine Road, Montréal, Quebec, Canada H3T 1E2"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Department of Oncology, McGill University"><meta itemprop=address content="Department of Oncology, McGill University, 546 Pine Avenue West, Montréal, Quebec, Canada H2W 1S6"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-11><span itemprop=name>Jonathan Bergeman</span></a><sup class=js-hide><a href=#a3>3</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Centre de Recherche sur le Cancer de l’Université Laval; Départements de Biologie moléculaire, biochimie médicale et pathologie, Université Laval"><meta itemprop=address content="Centre de Recherche sur le Cancer de l’Université Laval; Départements de Biologie moléculaire, biochimie médicale et pathologie, Université Laval, Québec City, Quebec, Canada G1V 0A6"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-12><span itemprop=name>Udo Oppermann</span></a><sup class=js-hide><a href=#a10>10</a>, <a href=#a14>14</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Structural Genomics Consortium, University of Oxford"><meta itemprop=address content="Structural Genomics Consortium, University of Oxford, Old Road Campus, Roosevelt Drive, Headington OX3 7DQ, UK"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Botnar Research Center, NIHR Oxford Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology &amp; Musculoskeletal Sciences"><meta itemprop=address content="Botnar Research Center, NIHR Oxford Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology &amp; Musculoskeletal Sciences, Oxford OX3 7LD, UK"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-13><span itemprop=name>Russell G. Jones</span></a><sup class=js-hide><a href=#a8>8</a>, <a href=#a9>9</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Goodman Cancer Research Centre, McGill University"><meta itemprop=address content="Goodman Cancer Research Centre, McGill University, Montréal, Quebec, Canada H3G 1Y6"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Department of Physiology, McGill University"><meta itemprop=address content="Department of Physiology, McGill University, Montréal, Quebec, Canada H3G 1Y6"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-14><span itemprop=name>Mathieu Laplante</span></a><sup class=js-hide><a href=#a6>6</a>, <a href=#a7>7</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Institut universitaire de cardiologie et de pneumologie de Québec"><meta itemprop=address content="Institut universitaire de cardiologie et de pneumologie de Québec, 2725 chemin Sainte-Foy, Québec City, Quebec, Canada G1V 4G5"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Département de Médecine, Faculté de Médecine, Université Laval"><meta itemprop=address content="Département de Médecine, Faculté de Médecine, Université Laval, Québec City, Quebec, Canada G1V 0A6"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-15><span itemprop=name>Ivan Topisirovic</span></a><span class=js-hide> <a href=http://orcid.org/0000-0002-5510-9762 class="strong js-orcid" itemprop=url><span class=visually-hidden>ORCID: </span>orcid.org/0000-0002-5510-9762</a></span><sup class=js-hide><a href=#a12>12</a>, <a href=#a13>13</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Lady Davis Institute for Medical Research, Jewish General Hospital"><meta itemprop=address content="Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte-Ste-Catherine Road, Montréal, Quebec, Canada H3T 1E2"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Department of Oncology, McGill University"><meta itemprop=address content="Department of Oncology, McGill University, 546 Pine Avenue West, Montréal, Quebec, Canada H2W 1S6"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-16><span itemprop=name>Kevin Petrecca</span></a><sup class=js-hide><a href=#a4>4</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Brain Tumour Research Centre, Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University"><meta itemprop=address content="Brain Tumour Research Centre, Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, 3801 University Street, Montreal, Quebec, Canada H3A 2B4"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>, </span><a href=#auth-17 class="icon icon-right-top icon-mail-12x9-blue pr15" data-corresp-id=c17><span itemprop=name>Marc-Étienne Huot</span></a><sup class=js-hide><a href=#a3>3</a>, <a href=#a15>15</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Centre de Recherche sur le Cancer de l’Université Laval; Départements de Biologie moléculaire, biochimie médicale et pathologie, Université Laval"><meta itemprop=address content="Centre de Recherche sur le Cancer de l’Université Laval; Départements de Biologie moléculaire, biochimie médicale et pathologie, Université Laval, Québec City, Quebec, Canada G1V 0A6"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="CHU de Québec–Axe Oncologie (Hôtel-Dieu de Québec)"><meta itemprop=address content="CHU de Québec–Axe Oncologie (Hôtel-Dieu de Québec), Québec City, Quebec Canada G1R 3S3"></span></sup><li itemprop=author itemscope itemtype=http://schema.org/Person><span class=js-separator>&nbsp;&amp; </span><a href=#auth-18 class="icon icon-right-top icon-mail-12x9-blue pr15" data-corresp-id=c18><span itemprop=name>Frédérick A. Mallette</span></a><sup class=js-hide><a href=#a1>1</a>, <a href=#a2>2</a>, <a href=#a16>16</a><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Département de Biochimie et Médecine Moléculaire, Université de Montréal"><meta itemprop=address content="Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Quebec, Canada H3C 3J7"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre"><meta itemprop=address content="Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, Quebec, Canada H1T 2M4"></span><span itemprop=affiliation itemscope itemtype=http://schema.org/Organization class=hide><meta itemprop=name content="Département de Médecine, Université de Montréal"><meta itemprop=address content="Département de Médecine, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Quebec, Canada H3C 3J7"></span></sup></ul>
                            
                            
                            <div class="flex-box grid-12 mq480-kill-flex standard-space-below cleared" data-container-section=info><div class="flex-box grid grid-6 mq480-grid-12"><ul class="flex-box-item none border-gray-medium border-left-1 text14 ma0 pa0 pl10" data-component=article-info-list><li><i>Nature Communications</i> <b>7</b>, Article&nbsp;number:&nbsp;12700 (2016)<li><abbr title="Digital Object Identifier">doi</abbr>:10.1038/ncomms12700<li><a href=/articles/ncomms12700.ris data-track=click data-track-source=citation-download data-track-dest="link:Download Citation">Download Citation</a></ul></div><div class="flex-box grid grid-6 last mq480-grid-12"><div class="flex-box-item border-gray-medium border-left-1 text14 pl10 mq480-pt10" data-component=article-history-list><dl><dt class="pin-left clear-left text-gray-light pr6">Received:<dd><time datetime=2015-11-27>27 November 2015</time><dt class="pin-left clear-left text-gray-light pr6">Accepted:<dd><time datetime=2016-07-25>25 July 2016</time><dt class="pin-left clear-left text-gray-light pr6">Published online:<dd><time datetime=2016-09-14 itemprop=datePublished>14 September 2016</time></dl></div></div></div>
                            
                        </div>
                    </header>
                    
    <ul class="mb0 pa0 tiny-space-above inline-list text14 js-hide" data-component="article-subject-links">
        <li><a href="/subjects/cancer-metabolism" class="subject-tag-link mr2 mb2" data-track="click" data-track-source="subject-name" data-track-dest="link:Cancer metabolism">Cancer metabolism</a></li><li><a href="/subjects/cns-cancer" class="subject-tag-link mr2 mb2" data-track="click" data-track-source="subject-name" data-track-dest="link:CNS cancer">CNS cancer</a></li><li><a href="/subjects/energy-metabolism" class="subject-tag-link mr2 mb2" data-track="click" data-track-source="subject-name" data-track-dest="link:Energy metabolism">Energy metabolism</a></li><li><a href="/subjects/tor-signalling" class="subject-tag-link mr2 mb2" data-track="click" data-track-source="subject-name" data-track-dest="link:TOR signalling">TOR signalling</a></li>
    </ul>

                    
    <ul class="clean-list mb0 tiny-space-above js-hide" data-component="article-relations">
        
    </ul>


                    <div data-article-body="true" class="article-body clear">
                        <section aria-labelledby=abstract><div class="serif article-section js-article-section cleared clear" id=abstract-section><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left" id=abstract>Abstract</h2><div class="pl20 mq875-pl0 js-collapsible-section" id=abstract-content itemprop=description><p>The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis. IDH1/2 normally catalyse the oxidative decarboxylation of isocitrate into α-ketoglutarate (αKG). In gliomas and acute myeloid leukaemias, IDH1/2 mutations confer gain-of-function leading to production of the oncometabolite <i>R</i>-2-hydroxyglutarate (2HG) from αKG. Here we show that generation of 2HG by mutated IDH1/2 leads to the activation of mTOR by inhibiting KDM4A, an αKG-dependent enzyme of the Jumonji family of lysine demethylases. Furthermore, KDM4A associates with the DEP domain-containing mTOR-interacting protein (DEPTOR), a negative regulator of mTORC1/2. Depletion of KDM4A decreases DEPTOR protein stability. Our results provide an additional molecular mechanism for the oncogenic activity of mutant IDH1/2 by revealing an unprecedented link between TCA cycle defects and positive modulation of mTOR function downstream of the canonical PI3K/AKT/TSC1-2 pathway.</p></div></div></section>

                        
                            <section aria-labelledby="introduction"><div class="serif article-section js-article-section cleared clear" id="introduction-section"><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id="introduction">Introduction</h2><div class="pl20 mq875-pl0 js-collapsible-section" id="introduction-content"><p>It is now evident that aberration of normal metabolic function represents a hallmark of tumorigenesis<sup><a id="ref-link-section-1" title="Hanahan, D. &amp; Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)." href="/articles/ncomms12700#ref1">1</a></sup>. For example, mutation, deletion or silencing of genes encoding tricarboxylic acid cycle (TCA cycle) proteins, including isocitrate dehydrogenases 1 and 2 (IDH1/2), are frequent in acute myeloid leukaemias and brain cancers (WHO grade 2 and 3 astrocytomas, oligodendrogliomas and secondary glioblastomas)<sup><a id="ref-link-section-2" title="Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009)." href="/articles/ncomms12700#ref2">2</a>,<a id="ref-link-section-3" title="Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009)." href="/articles/ncomms12700#ref3">3</a></sup>. IDH1/2 mutations occur predominantly at arginine 132 for IDH1, and arginine 140 or 172 for IDH2 (refs <a id="ref-link-section-4" title="Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009)." href="/articles/ncomms12700#ref2">2</a>, <a id="ref-link-section-5" title="Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009)." href="/articles/ncomms12700#ref3">3</a>), in each case resulting in a gain of function that promotes conversion of αKG to 2HG (refs <a id="ref-link-section-6" title="Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744 (2009)." href="/articles/ncomms12700#ref4">4</a>, <a id="ref-link-section-7" title="Ward, P. S. et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225–234 (2010)." href="/articles/ncomms12700#ref5">5</a>). These latter metabolites share high structural similarity, allowing 2HG to bind and inhibit αKG-dependent enzyme activity including that of the Jumonji lysine demethylases family and the Ten-eleven translocation (TET) family of 5-methylcytosine hydroxylases<sup><a id="ref-link-section-8" title="Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17–30 (2011)." href="/articles/ncomms12700#ref6">6</a>,<a id="ref-link-section-9" title="Chowdhury, R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12, 463–469 (2011)." href="/articles/ncomms12700#ref7">7</a></sup>.</p><p>Jumonji family members require αKG as co-substrate to catalyse the removal of methyl moieties on lysine. Conversely, 2HG has been shown to effectively inhibit this family of enzymes<sup><a id="ref-link-section-10" title="Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17–30 (2011)." href="/articles/ncomms12700#ref6">6</a>,<a id="ref-link-section-11" title="Chowdhury, R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12, 463–469 (2011)." href="/articles/ncomms12700#ref7">7</a></sup>. Jumonji proteins are oxygenases catalysing demethylation of mono-, di- or tri-methylated lysines<sup><a id="ref-link-section-12" title="Tsukada, Y. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811–816 (2006)." href="/articles/ncomms12700#ref8">8</a>,<a id="ref-link-section-13" title="Whetstine, J. R. et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467–481 (2006)." href="/articles/ncomms12700#ref9">9</a></sup>. To date, more than 30 Jumonji proteins have been identified, which carry different secondary domains in addition to their common JmjC catalytic domain. These enzymes are classified into numerous sub-families according to sequence homology and substrate specificity. The KDM4 sub-family comprises four members (KDM4A-D) which are Fe(II)- and α-ketoglutarate-dependent enzymes possessing a JmjC catalytic domain<sup><a id="ref-link-section-14" title="Tsukada, Y. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811–816 (2006)." href="/articles/ncomms12700#ref8">8</a>,<a id="ref-link-section-15" title="Whetstine, J. R. et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467–481 (2006)." href="/articles/ncomms12700#ref9">9</a></sup>. KDM4A-C display similar structures including JmjN-, tandem PHD-, and tandem Tudor-domains and each catalyses demethylation of di- and tri-methylated H3K9 and H3K36. On the other hand, KDM4D lacks the PHD and tandem Tudor domains and is specific for H3K9(me2/3) (refs <a id="ref-link-section-16" title="Katoh, M. &amp; Katoh, M. Identification and characterization of JMJD2 family genes in silico. Int. J. Oncol. 24, 1623–1628 (2004)." href="/articles/ncomms12700#ref10">10</a>, <a id="ref-link-section-17" title="Kim, J. et al. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 7, 397–403 (2006)." href="/articles/ncomms12700#ref11">11</a>). KDM4A is involved in the regulation of many cellular processes including cell cycle progression, DNA damage signalling and Ras-induced senescence<sup><a id="ref-link-section-18" title="Black, J. C. et al. Conserved antagonism between JMJD2A/KDM4A and HP1gamma during cell cycle progression. Mol. Cell 40, 736–748 (2010)." href="/articles/ncomms12700#ref12">12</a>,<a id="ref-link-section-19" title="Mallette, F. A. et al. RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J. 31, 1865–1878 (2012)." href="/articles/ncomms12700#ref13">13</a>,<a id="ref-link-section-20" title="Mallette, F. A. &amp; Richard, S. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep. 2, 1233–1243 (2012)." href="/articles/ncomms12700#ref14">14</a></sup>.</p><p>The mammalian (mechanistic) Target Of Rapamycin (mTOR) is a serine/threonine kinase belonging to the phosphoinositide 3-kinase (PI3K)-related kinase (PIKK) family. mTOR associates with either Raptor or Rictor to form distinct complexes, that is, mTORC1 and mTORC2, respectively, both of which are regulated by growth factors, amino acids and energy levels<sup><a id="ref-link-section-21" title="Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177–189 (2002)." href="/articles/ncomms12700#ref15">15</a>,<a id="ref-link-section-22" title="Kim, D. H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163–175 (2002)." href="/articles/ncomms12700#ref16">16</a>,<a id="ref-link-section-23" title="Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122–1128 (2004)." href="/articles/ncomms12700#ref17">17</a>,<a id="ref-link-section-24" title="Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296–1302 (2004)." href="/articles/ncomms12700#ref18">18</a></sup>. PRAS40 is recovered within the mTORC1 complex, while mSin1 and Protor1/2 are present in the mTORC2 complex<sup><a id="ref-link-section-25" title="Sancak, Y. et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903–915 (2007)." href="/articles/ncomms12700#ref19">19</a>,<a id="ref-link-section-26" title="Vander Haar, E., Lee, S. I., Bandhakavi, S., Griffin, T. J. &amp; Kim, D. H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9, 316–323 (2007)." href="/articles/ncomms12700#ref20">20</a>,<a id="ref-link-section-27" title="Frias, M. A. et al. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 16, 1865–1870 (2006)." href="/articles/ncomms12700#ref21">21</a>,<a id="ref-link-section-28" title="Pearce, L. R. et al. Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem. J. 405, 513–522 (2007)." href="/articles/ncomms12700#ref22">22</a></sup>. mLST8 and DEPTOR, an inhibitor of mTOR, are common to both mTORC1 and mTORC2 (refs <a id="ref-link-section-29" title="Kim, D. H. et al. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 11, 895–904 (2003)." href="/articles/ncomms12700#ref23">23</a>, <a id="ref-link-section-30" title="Peterson, T. R. et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873–886 (2009)." href="/articles/ncomms12700#ref24">24</a>). Among the cellular processes regulated by mTORC1 are cell growth and autophagy, while mTORC2 regulates cell survival and cytoskeleton organisation (for a review, see ref. <a id="ref-link-section-31" title="Laplante, M. &amp; Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274–293 (2012)." href="/articles/ncomms12700#ref25">25</a>). mTORC1/2 are frequently activated in human cancers via mutation of upstream negative regulators such as <i>PTEN</i> or <i>TSC2.</i> Following mTOR activation, DEPTOR is phosphorylated by mTOR, which in turn leads to phosphorylation of DEPTOR by CK1 (refs <a id="ref-link-section-32" title="Gao, D. et al. mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. Mol. Cell 44, 290–303 (2011)." href="/articles/ncomms12700#ref26">26</a>, <a id="ref-link-section-33" title="Duan, S. et al. mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR. Mol. Cell 44, 317–324 (2011)." href="/articles/ncomms12700#ref27">27</a>). These phosphorylation events are recognized by SCF<sup>β-TrCP</sup> ubiquitin ligase, resulting in DEPTOR polyubiquitination and proteolytic degradation<sup><a id="ref-link-section-34" title="Gao, D. et al. mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. Mol. Cell 44, 290–303 (2011)." href="/articles/ncomms12700#ref26">26</a>,<a id="ref-link-section-35" title="Duan, S. et al. mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR. Mol. Cell 44, 317–324 (2011)." href="/articles/ncomms12700#ref27">27</a>,<a id="ref-link-section-36" title="Zhao, Y., Xiong, X. &amp; Sun, Y. DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy. Mol. Cell 44, 304–316 (2011)." href="/articles/ncomms12700#ref28">28</a></sup>. Following its activation by mTORC1, p70S6K can also phosphorylate DEPTOR, thus facilitating β-TrCP binding<sup><a id="ref-link-section-37" title="Zhao, Y., Xiong, X. &amp; Sun, Y. DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy. Mol. Cell 44, 304–316 (2011)." href="/articles/ncomms12700#ref28">28</a></sup>.</p><p>Herein we provide intriguing evidence for a novel oncogenic mechanism regulated by mutations of IDH1/2, whereby 2HG-induced KDM4A inhibition promotes mTOR activation. We show that KDM4A specifically interacts with DEPTOR, a negative regulator of both mTORC1 and mTORC2. KDM4A depletion/inactivation results in drastic reduction of DEPTOR levels, while KDM4A overexpression reduces DEPTOR ubiquitination by β-TrCP1. We also show that 2HG-mediated inhibition of KDM4A directly affects the stability of DEPTOR, leading to mTOR activation independently of the PI3K/AKT/TSC1-2 pathway. This newly revealed PTEN-independent mode of mTORC1/2 activation via the mutated IDH/2HG/KDM4A/DEPTOR pathway may provide an additional molecular mechanism to explain the oncogenic activity of IDH1/2 mutations in glioma and other cancers.</p></div></div></section><section aria-labelledby="results"><div class="serif article-section js-article-section cleared clear" id="results-section"><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id="results">Results</h2><div class="pl20 mq875-pl0 js-collapsible-section" id="results-content"><h2 class="h3 strong mb4"><i>IDH1/2</i> and <i>PTEN</i> mutations are mutually exclusive</h2><p>Towards elucidating the oncogenic properties of mutated <i>IDH1/2</i>, we analysed <i>The Cancer Genome Atlas</i> (TCGA) and deduced that mutations in <i>IDH1/2</i> and <i>PTEN</i> (Phosphatase and TENsin homologue), an important tumour suppressor frequently disrupted in many cancers, display mutual exclusivity in low-grade glioma (<i>P</i>&lt;0.00001; Fisher’s exact test) and glioblastoma multiforme (<i>P</i>=0.005; Fisher's exact test; <a href="#f1">Fig. 1a</a>). On the other hand, as previously reported<sup><a id="ref-link-section-38" title="Ohgaki, H. &amp; Kleihues, P. Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathol. 28, 177–183 (2011)." href="/articles/ncomms12700#ref29">29</a>,<a id="ref-link-section-39" title="Liu, X. Y. et al. Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathol. 124, 615–625 (2012)." href="/articles/ncomms12700#ref30">30</a></sup>, mutations in the tumour suppressor <i>tp53</i> often co-occur with <i>IDH1/2</i> mutations in low-grade glioma (<i>P</i>&lt;0.0001; Fisher's exact test) and glioblastoma multiforme (<i>P</i>&lt;0.00001; Fisher's exact test) (<a href="#f1">Fig. 1a</a>). Thus it appears that major cancer networks can be strongly influenced by <i>IDH1/2</i> gene status. The mutual exclusivity between <i>IDH1/2</i> and <i>PTEN</i> mutations suggests that abrogation of <i>PTEN</i> function might not confer a growth advantage to tumours carrying <i>IDH1/2</i> mutations, allowing speculation that <i>IDH1/2</i> mutations mimic <i>PTEN</i> loss or inactivation. PTEN governs multiple cellular functions such as survival, growth and energy metabolism by suppressing the phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway. Oncogenic activation of mTOR stimulates critical processes required for cancer cell survival, proliferation, angiogenesis and metastasis<sup><a id="ref-link-section-40" title="Laplante, M. &amp; Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274–293 (2012)." href="/articles/ncomms12700#ref25">25</a></sup>. Importantly, even though no <i>PTEN</i> mutations were observed in <i>IDH1/2</i>-mutated gliomas, the mTOR pathway is nonetheless frequently activated in these tumours<sup><a id="ref-link-section-41" title="Pollack, I. F. et al. IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group. Childs Nerv. Syst. 27, 87–94 (2011)." href="/articles/ncomms12700#ref31">31</a></sup>.</p><div class="border-gray-medium border-all-5 standard-space-below pl10 pr10 pt20 pb20 clear" data-container-section="figure"><figure id="Fig1"><figcaption><b id="f1" class="block tiny-space-below">Figure 1: Activation of mTOR signalling by 2HG-producing IDH1/2 gain-of-function mutations.</b></figcaption><div class="small-space-below"><a href="/articles/ncomms12700/figures/1" class="block small-space-below" data-track="click" data-track-source="image" data-track-dest="link:Figure1"><img src="https://images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f1.jpg" alt="Figure 1" class="block max-width" itemprop="image"></a><div class="suppress-bottom-margin add-top-margin text14 sans-serif"><p>(<b>a</b>) <i>IDH1/2</i> and <i>PTEN</i> mutations are mutually exclusive in low-grade gliomas and glioblastomas. Data were obtained from The Cancer Genome Atlas (TCGA). Each vertical lane represents one patient; green lines depict the presence of a mutation. Statistical analysis was performed using the Fisher's exact test. (<b>b</b>) mTOR pathway activation in MEFs p53<sup>−/−</sup> cells expressing wt versus mutant IDH. Flag-tagged IDH was retrovirally transduced into MEFs p53<sup>−/−</sup> cells, and whole-cell lysates were harvested at 9 days post selection. Asterisk denotes a nonspecific band recognized by the antibody. (<b>c</b>) Intracellular accumulation of 2HG on IDH1/2 mutant expression as in <b>b</b>. 2HG levels were normalized against glutamate levels. Asterisks denote a statistical difference between IDH1/2 mutated cells and empty vector cells, two-sided <i>t</i>-test <i>P</i>&lt;0.0001 (graph represents three independent experiments). Error bars represent standard deviation. (<b>d</b>) Increased cell size associated with mutated <i>IDH1/2</i> expression. FSC measurement in FACS analysis demonstrates the shift in cell size in MEFs p53<sup>−/−</sup> cells expressing IDH1<sup>R123H</sup> (green line) or IDH2<sup>R172K</sup> (blue line) compared with empty vector-infected cells (black line). A total 250,000 cells were counted for each condition and graph is representative of four independent experiments. (<b>e</b>) Inhibition of mTORC1 rescues the increased cell size in IDH2<sup>R172K</sup> mutant cells. MEFs p53<sup>−/−</sup> cells expressing IDH2<sup>R172K</sup> or empty vector were treated with 25 nM rapamycin for 16 h before FACS analysis. A total 250,000 cells were counted for each condition. (<b>f</b>) Rapamycin or Torin1 treatment prevents mTORC1 activation in cells expressing IDH1/2 mutants. MEFs p53<sup>−/−</sup> cells expressing IDH1/2 mutants were treated with 100 nM rapamycin or 250 nM Torin1 for 24 h and whole-cell lysates blotted for markers of mTORC1 activation. (<b>g</b>) 2HG stimulates the mTOR pathway. MEFs p53<sup>−/−</sup> were treated with 2 mM of octyl-2HG for 4 h, and whole-cell extracts analysed by western blot. (<b>h</b>) Octyl-2HG treatment increases cell size. MEFs p53<sup>−/−</sup> cells were treated with 1 mM octyl-2HG for 8 h before FCS analysis by FACS. A total 25,000 cells were counted for each condition and graph is representative of two independent experiments.</p></div></div><div class="text-right hide-print"><a href="/articles/ncomms12700/figures/1" class=" ml10 sans-serif pill-button inline-block" data-track="click" data-track-source="button" data-track-dest="link:Figure1 Full size image"><span>Full size image</span></a></div></figure></div><h2 class="h3 strong mb4">IDH1/2 mutations and 2HG activate mTOR signalling</h2><p>The above considerations prompted us to postulate the existence of a PTEN-independent mode of mTOR pathway activation by oncogenic <i>IDH1/2</i>, which might constitute an important determinant in glioma development. We first evaluated the possibility that the mTOR pathway is actually regulated by oncogenic <i>IDH1/2</i>. Murine embryonic fibroblasts (MEFs) retrovirally transduced with cancer-associated IDH1<sup>R132H</sup> or IDH2<sup>R172K</sup>, but not with wild-type counterparts, exhibited increased mTORC1 and mTORC2 signalling as highlighted by enhanced phosphorylation of p70S6K, S6 and Rictor, and AKT, respectively (<a href="#f1">Fig. 1b</a> and <a href="/articles/ncomms12700#s1">Supplementary Fig. 1a</a>). The extent of mTORC1 stimulation correlated with intracellular levels of the oncometabolite <i>R</i>-2-hydroxyglutarate (2HG) produced by mutant IDH1 and IDH2 (<a href="#f1">Fig. 1c</a>). Intracellular accumulation of 2HG in mutated IDH1/2-expressing cells is not associated with decreased levels of αKG levels (<a href="/articles/ncomms12700#s1">Supplementary Fig. 1b</a>), which has been shown, in different studies, to either inhibit<sup><a id="ref-link-section-42" title="Chin, R. M. et al. The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 510, 397–401 (2014)." href="/articles/ncomms12700#ref32">32</a></sup> or stimulate<sup><a id="ref-link-section-43" title="Duran, R. V. et al. Glutaminolysis activates Rag-mTORC1 signaling. Mol. Cell 47, 349–358 (2012)." href="/articles/ncomms12700#ref33">33</a>,<a id="ref-link-section-44" title="Lorin, S. et al. Glutamate dehydrogenase contributes to leucine sensing in the regulation of autophagy. Autophagy 9, 850–860 (2013)." href="/articles/ncomms12700#ref34">34</a>,<a id="ref-link-section-45" title="Marino, G. et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol. Cell 53, 710–725 (2014)." href="/articles/ncomms12700#ref35">35</a></sup> mTOR activity.</p><p>It has been shown that mTOR activity is a major determinant of cell size<sup><a id="ref-link-section-46" title="Fingar, D. C., Salama, S., Tsou, C., Harlow, E. &amp; Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16, 1472–1487 (2002)." href="/articles/ncomms12700#ref36">36</a></sup>. Therefore, to probe the physiological response to mutant IDH1/2-mediated activation of mTOR signalling, we compared the effects of IDH1<sup>WT</sup>, IDH1<sup>R132H</sup>, IDH2<sup>WT</sup> and IDH2<sup>R172K</sup> expression in MEFs on cell size using flow cytometry. Cells expressing mutated IDH1/2 were larger than control counterparts (<a href="#f1">Fig. 1d</a> and <a href="/articles/ncomms12700#s1">Supplementary Fig. 1c,d</a>), and this increase correlated with intracellular levels of 2HG (<a href="#f1">Fig. 1c</a>). Moreover, treatment of IDH2<sup>R172K</sup>-expressing cells with the mTORC1 inhibitor rapamycin mitigated the effect on cell size (<a href="#f1">Fig. 1e</a>). In addition, treatment with rapamycin or the mTORC1/2 inhibitor Torin1 abrogated S6 phosphorylation on serines 240 and 244 in IDH1/2 mutant-expressing cells, confirming the activation of mTORC1-dependent p70S6K by 2HG-producing mutants (<a href="#f1">Fig. 1f</a>). Expression of IDH1<sup>R132H</sup> in cells treated with AGI-5198, an inhibitor of mutated IDH1 (ref. <a id="ref-link-section-47" title="Rohle, D. et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 340, 626–630 (2013)." href="/articles/ncomms12700#ref37">37</a>), failed to activate mTORC1 (<a href="/articles/ncomms12700#s1">Supplementary Fig. 1e</a>), suggesting that oncogenic IDH1-mediated production of 2HG is responsible for mTOR stimulation.</p><p>To directly evaluate whether 2HG is responsible for activation of mTORC1/2, we synthesized cell permeable 1-octyl-D-2-hydroxyglutarate (octyl-2HG) (<a href="/articles/ncomms12700#s1">Supplementary Fig. 1f</a>)<sup><a id="ref-link-section-48" title="Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474–478 (2012)." href="/articles/ncomms12700#ref38">38</a></sup>. Treatment of cells with octyl-2HG led to activation of mTORC1/2, as illustrated by increased phosphorylation of p70S6K, S6, Rictor and AKT in both MEFs and HeLa cells (<a href="#f1">Fig. 1g</a> and <a href="/articles/ncomms12700#s1">Supplementary Fig. 1g</a>) in a time- and dose-dependent fashion (<a href="/articles/ncomms12700#s1">Supplementary Fig. 1h,i</a>) compared with the control. Furthermore, treatment with octyl-2HG caused a relative increase in cell size (<a href="#f1">Fig. 1h</a>), consistent with activation of mTOR by 2HG. 2HG-mediated effects on phosphorylation of mTORC1 substrates and cell size were attenuated by rapamycin (<a href="/articles/ncomms12700#s1">Supplementary Fig. 1j,k</a>), and effect on mTORC2 activity inhibited by Torin1 (<a href="/articles/ncomms12700#s1">Supplementary Fig. 1l</a>). Taken together, our results demonstrate that IDH1/2 mutations engender an increase in 2HG levels that stimulate mTOR signalling via both mTORC1 and mTORC2.</p><h2 class="h3 strong mb4">KDM4A modulates mTOR activity</h2><p>Previous studies showed that mutated IDH1/2-stimulated 2HG production inhibits the activity of αKG-dependent enzymes including (i) the Jumonji family of Fe(II)-dependent oxygenases comprising lysine demethylases and (ii) the TET family of 5-methylcytosine hydroxylases<sup><a id="ref-link-section-49" title="Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17–30 (2011)." href="/articles/ncomms12700#ref6">6</a>,<a id="ref-link-section-50" title="Chowdhury, R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12, 463–469 (2011)." href="/articles/ncomms12700#ref7">7</a></sup>. To evaluate the possibility that one or more enzymes among these families is/are responsible for regulation of mTORC1 activity, we performed a targeted short interfering RNA (siRNA) screen in HeLa cells using S6 phosphorylation on serines 240 and 244 as a readout of mTOR activity. Among the αKG-dependent enzymes tested, depletion of KDM4A showed the most potent increase in S6 phosphorylation (<a href="#f2">Fig. 2a</a>). KDM4A is an Fe(II)- and αKG-dependent enzyme possessing a JmjC catalytic domain<sup><a id="ref-link-section-51" title="Tsukada, Y. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811–816 (2006)." href="/articles/ncomms12700#ref8">8</a>,<a id="ref-link-section-52" title="Whetstine, J. R. et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467–481 (2006)." href="/articles/ncomms12700#ref9">9</a></sup>, as well as tandem PHD- and tandem Tudor- domains which are thought to associate with methylated chromatin residues. KDM4A catalyses demethylation of di- and tri-methylated H3K9 and H3K36 (refs <a id="ref-link-section-53" title="Whetstine, J. R. et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467–481 (2006)." href="/articles/ncomms12700#ref9">9</a>, <a id="ref-link-section-54" title="Cloos, P. A. et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442, 307–311 (2006)." href="/articles/ncomms12700#ref39">39</a>, <a id="ref-link-section-55" title="Klose, R. J. et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442, 312–316 (2006)." href="/articles/ncomms12700#ref40">40</a>, <a id="ref-link-section-56" title="Shin, S. &amp; Janknecht, R. Diversity within the JMJD2 histone demethylase family. Biochem. Biophys. Res. Commun. 353, 973–977 (2007)." href="/articles/ncomms12700#ref41">41</a>), and modulates multiple cellular processes including the DNA damage response<sup><a id="ref-link-section-57" title="Mallette, F. A. et al. RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J. 31, 1865–1878 (2012)." href="/articles/ncomms12700#ref13">13</a></sup>, cellular senescence<sup><a id="ref-link-section-58" title="Mallette, F. A. &amp; Richard, S. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep. 2, 1233–1243 (2012)." href="/articles/ncomms12700#ref14">14</a>,<a id="ref-link-section-59" title="Johmura, Y. et al. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence. Nat. Commun. 7, 10574 (2016)." href="/articles/ncomms12700#ref42">42</a>,<a id="ref-link-section-60" title="Neault, M., Mallette, F. A. &amp; Richard, S. miR-137 modulates a tumor suppressor network-inducing senescence in pancreatic cancer cells. Cell Rep. 14, 1966–1978 (2016)." href="/articles/ncomms12700#ref43">43</a></sup>, transcription<sup><a id="ref-link-section-61" title="Klose, R. J. et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442, 312–316 (2006)." href="/articles/ncomms12700#ref40">40</a>,<a id="ref-link-section-62" title="Zhang, D., Yoon, H. G. &amp; Wong, J. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol. Cell. Biol. 25, 6404–6414 (2005)." href="/articles/ncomms12700#ref44">44</a></sup>, DNA replication<sup><a id="ref-link-section-63" title="Black, J. C. et al. Conserved antagonism between JMJD2A/KDM4A and HP1gamma during cell cycle progression. Mol. Cell 40, 736–748 (2010)." href="/articles/ncomms12700#ref12">12</a>,<a id="ref-link-section-64" title="Black, J. C. et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 154, 541–555 (2013)." href="/articles/ncomms12700#ref45">45</a></sup> and innate immunity<sup><a id="ref-link-section-65" title="Jin, J. et al. Noncanonical NF-kappaB pathway controls the production of type I interferons in antiviral innate immunity. Immunity 40, 342–354 (2014)." href="/articles/ncomms12700#ref46">46</a></sup>. Knockdown of KDM4A using three different short hairpin RNAs (shRNAs) led to increased phosphorylation of the mTORC1 substrates p70S6K<sup>T389</sup> and 4E-BP1<sup>S65</sup>, and of the mTORC2 substrate AKT<sup>S473</sup> (<a href="#f2">Fig. 2b</a>), thus validating our siRNA screening approach. As AKT modulates cell survival and depletion of KDM4A leads to AKT activation (<a href="#f2">Fig. 2b</a>), we determined the function of KDM4A in cell survival on metabolic stress. KDM4A knockdown prevented cleavage of caspase-3 and PARP, two indicators of apoptosis, following serum withdrawal (<a href="#f2">Fig. 2c</a>). Moreover KDM4A-depleted cells were larger than cells treated with siGFP, and treatment with the mTORC1 inhibitor rapamycin abrogated this phenotype (<a href="#f2">Fig. 2d</a>). We emphasize that the entire KDM4 family shares common substrates; nonetheless KDM4A was the sole family member to influence mTORC1 activity, as depletion of KDM4B-D had no impact on phosphorylation of 4E-BP1, S6 and Rictor (<a href="/articles/ncomms12700#s1">Supplementary Fig. 2a,b</a>). KDM4A is profoundly inhibited by 2HG, exhibiting an IC<sub>50</sub> of 2.1 μM (<a href="#f2">Fig. 2e</a>) as determined by RapidFire mass spectrometry. 2HG failed to further increase mTORC1 activity in KDM4A-depleted cells (<a href="#f2">Fig. 2f</a>), suggesting that inhibition of KDM4A by 2HG-producing mutated IDH1/2 is responsible for mTORC1/2 activation.</p><div class="border-gray-medium border-all-5 standard-space-below pl10 pr10 pt20 pb20 clear" data-container-section="figure"><figure id="Fig2"><figcaption><b id="f2" class="block tiny-space-below">Figure 2: Targeted-siRNA screen reveals KDM4A as an α-KG-dependent enzyme modulating mTOR activity.</b></figcaption><div class="small-space-below"><a href="/articles/ncomms12700/figures/2" class="block small-space-below" data-track="click" data-track-source="image" data-track-dest="link:Figure2"><img src="https://images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f2.jpg" alt="Figure 2" class="block max-width"></a><div class="suppress-bottom-margin add-top-margin text14 sans-serif"><p>(<b>a</b>) siRNA screen of αKG-dependent enzymes for the involvement in mTOR signalling in HeLa cells. The experiments were performed in triplicate and the results of all experiments were plotted. The levels of phosphorylated S6 on serines 240/244 were normalized to total S6 protein. (<b>b</b>) KDM4A knockdown increases mTORC1/2 signalling. Depletion of KDM4A by lentiviral infection in HeLa cells using three different shRNAs. Whole-cell lysates were blotted for mTORC1/2 activation. (<b>c</b>) Depletion of KDM4A protects against apoptosis induced by serum deprivation. HeLa cells expressing a control shRNA or shRNAs targeting KDM4A were grown in media containing the indicated concentrations of serum for 24 h. Cell lysates were then analysed by western blotting. (<b>d</b>) KDM4A depletion increases cell size in an mTORC1-dependent manner. MEFs p53<sup>−/−</sup> were treated with siKDM4A and, where indicated, with DMSO or 25 nM rapamycin, for 16 h before FSC measurements by FACS. A total 200,000 cells were counted for each condition. (<b>e</b>) Dose-dependent inhibition of KDM4A by <i>R</i>-2HG in <i>in vitro</i> demethylation assay (graph represents two independent experiments). (<b>f</b>) 2HG does not further stimulate mTORC1 in KDM4A-depleted HeLa cells. HeLa cells transfected with siGFP or siKDM4A were serum starved for 16 h before stimulation with 2 mM octyl-2HG for 4 h.</p></div></div><div class="text-right hide-print"><a href="/articles/ncomms12700/figures/2" class=" ml10 sans-serif pill-button inline-block" data-track="click" data-track-source="button" data-track-dest="link:Figure2 Full size image"><span>Full size image</span></a></div></figure></div><h2 class="h3 strong mb4">KDM4A interacts with mTORC1/2</h2><p>To elucidate the molecular mechanism involved in the regulation of mTOR kinase activity by KDM4A, we evaluated whether the latter transcriptionally modulates either PTEN/AKT/mTOR pathway regulators or mTORC1/2 complex components. Depletion of KDM4A in HeLa cells revealed minor or no significant changes in mRNA levels for either PTEN or tuberous sclerosis 1/2 (TSC1/2) (<a href="#f3">Fig. 3a</a>). TSC1/2 is a GTPase-activating protein complex that maintains Rheb (Ras homologue enriched in brain) in an inactive form, thereby causing mTOR inhibition<sup><a id="ref-link-section-66" title="Garami, A. et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11, 1457–1466 (2003)." href="/articles/ncomms12700#ref47">47</a>,<a id="ref-link-section-67" title="Inoki, K., Li, Y., Xu, T. &amp; Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829–1834 (2003)." href="/articles/ncomms12700#ref48">48</a>,<a id="ref-link-section-68" title="Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. &amp; Blenis, J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259–1268 (2003)." href="/articles/ncomms12700#ref49">49</a></sup>. In addition, mRNA levels of RHEB, mTOR, DEPTOR or the upstream activating kinase PDK1 were at most very modestly changed following KDM4A depletion (<a href="#f3">Fig. 3a</a>). Similar observations were made at the protein level for KDM4A-depleted cells, where expression of PTEN, TSC2, mTOR, Rictor and components of the amino acid signalling arm (that is, Rag and LAMTOR) remained essentially unaltered (<a href="/articles/ncomms12700#s1">Supplementary Fig. 2c,d</a>). Interestingly, KDM4A knockdown had no impact on phosphorylation of AKT at threonine 308, a site phosphorylated by PDK1 after PI3K activation, suggesting that activation of mTORC1 occurs downstream PDK1/AKT (<a href="/articles/ncomms12700#s1">Supplementary Fig. 2c</a>). This was further confirmed by our result showing that pharmacological PI3K inhibition using CAL-101 did not block activation of mTORC2 upon depletion of KDM4A, as revealed by increased phosphorylation of AKT<sup>S473</sup> (<a href="/articles/ncomms12700#s1">Supplementary Fig. 2e</a>). Furthermore, knockdown of KDM4A in rapamycin-treated cells still caused activation of mTORC2, implying mTORC1-independent modulation of mTORC2 by KDM4A (<a href="/articles/ncomms12700#s1">Supplementary Fig. 2e</a>).</p><div class="border-gray-medium border-all-5 standard-space-below pl10 pr10 pt20 pb20 clear" data-container-section="figure"><figure id="Fig3"><figcaption><b id="f3" class="block tiny-space-below">Figure 3: KDM4A interacts with the mTORC1/2 complex.</b></figcaption><div class="small-space-below"><a href="/articles/ncomms12700/figures/3" class="block small-space-below" data-track="click" data-track-source="image" data-track-dest="link:Figure3"><img src="https://images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f3.jpg" alt="Figure 3" class="block max-width"></a><div class="suppress-bottom-margin add-top-margin text14 sans-serif"><p>(<b>a</b>) Relative mRNA levels of negative and positive regulators of the PTEN/AKT/mTOR pathway following KDM4A depletion. Quantifications of mRNAs by RT–qPCR were normalized against β-actin (<i>ActB</i>) mRNA. Asterisks denote a statistical difference between siKDM4A-treated cells and siGFP control cells, two-sided <i>t</i>-test <i>P</i>&lt;0.05 (graph represents two independent experiences). Error bars represent standard deviation. (<b>b</b>) Co-immunoprecipitation of endogenous mTORC1/2 complex members with Flag-KDM4A in 293T transfected cells. (<b>c</b>) Comparison of mTORC1/2-associated proteins with Flag-tagged mTOR or KDM4A. The 293T cells were transfected with either Flag-eYFP, Flag-KDM4A or Flag-mTOR, and protein lysates were subjected to anti-Flag immunoprecipitation. (<b>d</b>) Co-immunoprecipitation of Flag-KDM4A and HA-DEPTOR in 293T cells. (<b>e</b>) Endogenous KDM4A co-immunoprecipitates with Flag-DEPTOR. (<b>f</b>) DEPTOR PDZ domain associates with endogenous KDM4A. Flag immunoprecipitation of flag-tagged full length or fragments of DEPTOR. The samples were not sonicated in this experiment to confirm that the interaction is independent of nucleus disruption. (<b>g</b>) Endogenous KDM4A and DEPTOR associate in 293E cells. (<b>h</b>) Endogenous KDM4A and DEPTOR co-immunoprecipitate in NHA-hTERT cells.</p></div></div><div class="text-right hide-print"><a href="/articles/ncomms12700/figures/3" class=" ml10 sans-serif pill-button inline-block" data-track="click" data-track-source="button" data-track-dest="link:Figure3 Full size image"><span>Full size image</span></a></div></figure></div><p>Since the control exerted by KDM4A on mTOR activity seems to occur downstream of PTEN–PDK1–AKT–TSC1/2, we investigated whether KDM4A might physically interact with the mTORC1/2 complexes. Consistent with this possibility, KDM4A co-immunoprecipitated numerous members of mTORC1 and mTORC2 including mTOR, Raptor, Rictor, mSin1 and DEPTOR (<a href="#f3">Fig. 3b</a> and <a href="/articles/ncomms12700#s1">Supplementary Fig. 3a–c</a>). We then qualitatively compared the amount of mTORC1/2 components interacting with mTOR or KDM4A. Flag-tagged KDM4A modestly interacted with mSin1 and Raptor when compared with the amount co-immunoprecipitated with mTOR. On the other hand, both KDM4A and mTOR immunoprecipitated similar amounts of DEPTOR (<a href="#f3">Fig. 3c</a> and <a href="/articles/ncomms12700#s1">Supplementary Fig. 3d</a>), suggesting that DEPTOR might represent the major mTORC1/2 component interacting with KDM4A. We confirmed the interaction between DEPTOR and KDM4A in cells co-expressing the exogenous tagged proteins (<a href="#f3">Fig. 3d</a>). Moreover, ectopic Flag-tagged DEPTOR co-immunoprecipitated endogenous KDM4A (<a href="#f3">Fig. 3e</a>) and this interaction appeared to be mediated by the DEPTOR PDZ domain (<a href="#f3">Fig. 3f</a>). Individual depletion of mTOR or mSin1 did not alter the binding of KDM4A and DEPTOR (<a href="/articles/ncomms12700#s1">Supplementary Fig. 3e,f</a>), supporting our hypothesis that DEPTOR is the major mTORC1/2 component interacting with KDM4A. Endogenous KDM4A and DEPTOR are also associated in 293E (<a href="#f3">Fig. 3g</a>), HeLa (<a href="/articles/ncomms12700#s1">Supplementary Fig. 3g</a>), as well as in glioma-related central nervous system-derived cells, that is, immortalized normal human astrocytes (NHAs; <a href="#f3">Fig. 3h</a>). Surprisingly, endogenous KDM4B also interacted with DEPTOR (<a href="/articles/ncomms12700#s1">Supplementary Fig. 3h</a>), but was unable to modulate mTOR activity (<a href="/articles/ncomms12700#s1">Supplementary Fig. 2a</a>). Recombinant KDM4A and DEPTOR proteins purified from <i>E.coli</i> failed to interact (<a href="/articles/ncomms12700#s1">Supplementary Fig. 3i</a>), suggesting that KDM4A–DEPTOR interaction might be indirect, or requires either post-translational modifications absent in bacteria or conformational changes in DEPTOR occuring during its association with mTORC1 or mTORC2. We performed a fractionation assay to confirm that KDM4A and DEPTOR localize to the same sub-cellular compartments. While DEPTOR is mostly cytoplasmic, KDM4A was present in both the nucleus and cytoplasm (<a href="/articles/ncomms12700#s1">Supplementary Fig. 4a,b</a>).</p><h2 class="h3 strong mb4">KDM4A stabilizes DEPTOR</h2><p>The stability of DEPTOR, an endogenous negative regulator of mTOR activity<sup><a id="ref-link-section-69" title="Peterson, T. R. et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873–886 (2009)." href="/articles/ncomms12700#ref24">24</a></sup>, is tightly regulated in response to growth signals via mTOR in conjunction with the SCF(βTrCP) E3 ubiquitin ligase complex<sup><a id="ref-link-section-70" title="Gao, D. et al. mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. Mol. Cell 44, 290–303 (2011)." href="/articles/ncomms12700#ref26">26</a>,<a id="ref-link-section-71" title="Duan, S. et al. mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR. Mol. Cell 44, 317–324 (2011)." href="/articles/ncomms12700#ref27">27</a>,<a id="ref-link-section-72" title="Zhao, Y., Xiong, X. &amp; Sun, Y. DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy. Mol. Cell 44, 304–316 (2011)." href="/articles/ncomms12700#ref28">28</a></sup>. We sought to determine the impact of KDM4A on DEPTOR protein levels. KDM4A knockdown led to a significant decrease in both DEPTOR protein levels (<a href="#f4">Fig. 4a</a>) and half-life after serum stimulation (<a href="/articles/ncomms12700#s1">Supplementary Fig. 5a-b</a>). Transient expression of wild-type KDM4A or tandem Tudor-disrupted KDM4A<sup>D939R</sup>, but not of catalytically inactive KDM4A<sup>H188A</sup>, in KDM4A-depleted cells partially restored DEPTOR levels (<a href="/articles/ncomms12700#s1">Supplementary Fig. 5c,d</a>). This partial rescue might reflect reduced transfection efficiency (40–50%) of lentiviral-transduced cells under our experimental conditions. It is also possible that the transient nature of KDM4A re-introduction may not allow enough time for complete restoration of DEPTOR levels. We cannot exclude, however, that a portion of the effects we observed on DEPTOR levels are independent of KDM4A and maybe due to shRNA off-targeting effects. In addition, overexpression of wild-type KDM4A significantly abrogated <i>in vivo</i> ubiquitination of DEPTOR by β−TrCP1 (<a href="#f4">Fig. 4b,c</a>); moreover, this reduction was dependent on the catalytic activity of the demethylase, but not on its chromatin-binding ability, since overexpression of the KDM4A<sup>D939R</sup> Tudor domain mutant, but not of the KDM4A<sup>H188A</sup> catalytic dead mutant, decreased DEPTOR poly-ubiquitination (<a href="#f4">Fig. 4b,c</a>). In addition, KDM4A interacted with β-TrCP ubiquitin ligases (<a href="/articles/ncomms12700#s1">Supplementary Fig. 5e</a>). Consistent with our finding that inhibition of KDM4A decreased DEPTOR protein levels, expression of the 2HG-producing IDH1<sup>R132H</sup> mutant also caused such a reduction (<a href="#f4">Fig. 4d</a>). Treatment of human fibrosarcoma HT1080 cells bearing a heterozygous IDH1<sup>R132C</sup> mutation with the mutated-IDH1-specific inhibitor AGI-5198 (ref. <a id="ref-link-section-73" title="Rohle, D. et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 340, 626–630 (2013)." href="/articles/ncomms12700#ref37">37</a>) caused a marked decrease in mTORC1/2 activity. Moreover this was rescued upon KDM4A depletion (<a href="#f4">Fig. 4e</a> and <a href="/articles/ncomms12700#s1">Supplementary Fig. 5f,g</a>), showing that 2HG-mediated inhibition of KDM4A is indeed responsible for activation of mTOR. Our data raise the intriguing possibility that cancer therapeutic regimens designed to inhibit mutated IDH1/2 would be expected to reduce oncogenic mTOR activity.</p><div class="border-gray-medium border-all-5 standard-space-below pl10 pr10 pt20 pb20 clear" data-container-section="figure"><figure id="Fig4"><figcaption><b id="f4" class="block tiny-space-below">Figure 4: Functional implication of IDH1/2 mutations in central neuron system-derived cells.</b></figcaption><div class="small-space-below"><a href="/articles/ncomms12700/figures/4" class="block small-space-below" data-track="click" data-track-source="image" data-track-dest="link:Figure4"><img src="https://images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f4.jpg" alt="Figure 4" class="block max-width"></a><div class="suppress-bottom-margin add-top-margin text14 sans-serif"><p>(<b>a</b>) KDM4A depletion reduces DEPTOR levels. HeLa cells were transduced with lentivirus expressing sh_KDM4A.3, sh_KDM4A.5, sh_KDM4A.7 or sh_Control and whole-cell lysates were blotted to determine DEPTOR levels. (<b>b</b>) The demethylase activity of KDM4A is required to block β-TrCP1-dependent ubiquitination of DEPTOR <i>in vivo</i>. HA IP was performed on 293E cells transfected with the indicated plasmids. (<b>c</b>) Quantification of DEPTOR ubiquitination by β-TrCP1 in the presence or absence of wild-type KDM4A or mutants. DEPTOR ubiquitination was quantified in three independent experiments using ImageJ. Asterisks denote a statistical difference, two-sided <i>t</i>-test, *<i>P</i>&lt;0.05; **<i>P</i>&lt;0.01. Error bars represent standard deviation. NS, not significant, <i>P</i>&gt;0.05. (<b>d</b>) IDH1<sup>R132H</sup> expression diminishes DEPTOR levels. Flag-IDH1<sup>R132H</sup> was introduced in p53<sup>−/−</sup> MEFs by retroviral transduction and whole-cell lysates immunoblotted. (<b>e</b>) Inhibition of endogenous mutated IDH1<sup>R132C</sup> decreases mTOR activity in a KDM4A-dependent manner. HT1080 cells were transduced with lentivirus expressing sh_KDM4A.3 or sh_Control. The cells were treated with 3 μM AGI-5198 twice every day for 5 days and whole-cell lysates blotted for markers of mTOR activation. (<b>f</b>) Expression of mutant IDH1 in NHA-hTERT increases mTOR signalling. IDH1<sup>WT</sup>-Flag or IDH1<sup>R132H</sup> genes were introduced in astrocytes through retroviral infection and cell lysates were blotted for mTORC2 activation. (<b>g</b>) IDH1<sup>R132H</sup> overexpression increases 2HG production in astrocytes. Intracellular 2HG levels were normalized to glutamate. Asterisk denotes a statistical difference between IDH1<sup>R132H</sup> and empty vector cells, two-sided <i>t</i>-test <i>P</i>&lt;0.0001 (graph represents three independent experiments). Error bars represent standard deviation. (<b>h</b>) Treatment of NHA-hTERT with octyl-2HG activates mTOR signalling. The cells were treated for 8 h with 1 mM octyl-2HG. The experiment shown is a representative of triplicates. (<b>i</b>) Non-canonical mTOR activation in IDH1/2<sup>WT</sup> and IDH1<sup>R132H</sup> human astrocytomas. Scale bar, 50 μm. Representative samples from IDH1/2<sup>WT</sup> (<i>n</i>=3) and IDH1<sup>R132H</sup> (<i>n</i>=3) human astrocytomas are shown.</p></div></div><div class="text-right hide-print"><a href="/articles/ncomms12700/figures/4" class=" ml10 sans-serif pill-button inline-block" data-track="click" data-track-source="button" data-track-dest="link:Figure4 Full size image"><span>Full size image</span></a></div></figure></div><h2 class="h3 strong mb4">IDH1 mutation and 2HG regulate mTOR in human astrocytes</h2><p>To evaluate the impact of IDH mutations on mTOR activation in a more physiological setting, we first retrovirally transduced immortalized NHAs with empty vector, wild-type IDH1 or IDH1<sup>R132H</sup>. NHAs expressing mutant IDH1 displayed higher levels of p-AKT<sup>S473</sup> (<a href="#f4">Fig. 4f</a>) associated with increased accumulation of intracellular 2HG (<a href="#f4">Fig. 4g</a>), but did not manifest decreased αKG (<a href="/articles/ncomms12700#s1">Supplementary Fig. 5h</a>). In addition, treatment of NHAs with octyl-2HG led to activation of mTORC1 and mTORC2, as indicated by increased p-S6<sup>S240/244</sup> and p-AKT<sup>S473</sup>, respectively (<a href="#f4">Fig. 4h</a>). Finally, octyl-2HG decreased DEPTOR levels in NHA, as compared with control (<a href="/articles/ncomms12700#s1">Supplementary Fig. 5i</a>).</p><p>We then asked whether oncogenic IDH1 might be associated with markers of mTOR activation in human brain tumours. Immunohistochemistry analysis of IDH1<sup>R132H</sup>-mutated human-grade 2/3 astrocytoma samples revealed an increase in S6 phosphorylation on serines 240/244 (<a href="#f4">Fig. 4i</a>). However, while 20 to 40% of the tumour cells from wild-type IDH1/2 astrocytomas showed strong staining for p-AKT<sup>T308</sup>, the upstream activator of mTORC1, less than 2% of IDH1<sup>R132H</sup>-mutated astrocytomas stained positively for p-AKT<sup>T308</sup> (<a href="#f4">Fig. 4i</a>). This suggests that activation of mTORC1 occurs downstream of the PI3K–PDK1–AKT cascade in tumours harbouring IDH1 mutations, supporting the notion that 2HG-mediated inhibition of KDM4A affects the stability of DEPTOR leading to mTOR activation independently of the PI3K/AKT/TSC1-2 pathway (<a href="#f5">Fig. 5</a>).</p><div class="border-gray-medium border-all-5 standard-space-below pl10 pr10 pt20 pb20 clear" data-container-section="figure"><figure id="Fig5"><figcaption><b id="f5" class="block tiny-space-below">Figure 5: Non-canonical regulation of mTOR activity by 2HG-mediated inhibition of KDM4A.</b></figcaption><div class="small-space-below"><a href="/articles/ncomms12700/figures/5" class="block small-space-below" data-track="click" data-track-source="image" data-track-dest="link:Figure5"><img src="https://images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f5.jpg" alt="Figure 5" class="block max-width"></a><div class="suppress-bottom-margin add-top-margin text14 sans-serif"><p>Simplified schematic model for mTOR activation following KDM4A inhibition by <i>IDH1/2</i> gain-of-function mutations.</p></div></div><div class="text-right hide-print"><a href="/articles/ncomms12700/figures/5" class=" ml10 sans-serif pill-button inline-block" data-track="click" data-track-source="button" data-track-dest="link:Figure5 Full size image"><span>Full size image</span></a></div></figure></div></div></div></section><section aria-labelledby="discussion"><div class="serif article-section js-article-section cleared clear" id="discussion-section"><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id="discussion">Discussion</h2><div class="pl20 mq875-pl0 js-collapsible-section" id="discussion-content"><p>IDH mutations, frequently observed in brain tumours and leukaemia, lead to production of the oncometabolite 2HG, which in turn causes cell differentiation defects by impairing histone demethylation<sup><a id="ref-link-section-74" title="Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474–478 (2012)." href="/articles/ncomms12700#ref38">38</a></sup>. In addition, reversible inhibition of the 5′-methylcytosine hydroxylase TET2 by 2HG causes profound epigenetic changes contributing to transformation<sup><a id="ref-link-section-75" title="Figueroa, M. E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18, 553–567 (2010)." href="/articles/ncomms12700#ref50">50</a>,<a id="ref-link-section-76" title="Losman, J. A. et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339, 1621–1625 (2013)." href="/articles/ncomms12700#ref51">51</a></sup>. Herein we describe for the first time that oncogenic IDH and subsequent production of 2HG activate mTOR signalling. Either expression of mutated IDH1/2 or treatment with 2HG engendered activation of both mTORC1 and mTORC2 and, as a consequence, cell size increase. We note that the mTORC1 inhibitor rapamycin significantly, but only partially, decreased cell size of IDH2<sup>R172K</sup>-expressing cells. In mammalian systems, control of cell size by mTOR is mediated by both p70S6K and 4E-BP/eIF4E<sup><a id="ref-link-section-77" title="Fingar, D. C., Salama, S., Tsou, C., Harlow, E. &amp; Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16, 1472–1487 (2002)." href="/articles/ncomms12700#ref36">36</a></sup>. As these latter factors display differential sensitivity to rapamycin<sup><a id="ref-link-section-78" title="Choo, A. Y., Yoon, S. O., Kim, S. G., Roux, P. P. &amp; Blenis, J. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc. Natl Acad. Sci. USA 105, 17414–17419 (2008)." href="/articles/ncomms12700#ref52">52</a></sup>, recovery of 4E-BP1 phosphorylation in rapamycin-treated IDH2<sup>R172K</sup> cells might explain the observed partial rescue of cell size (<a href="#f1">Fig. 1e</a>).</p><p>Since 2HG constitutes an inhibitor of α-ketoglutarate-dependent enzymes, we used a targeted siRNA screen against these enzymes to identify KDM4A as a novel regulator of mTOR. Furthermore, our data indicate that KDM4A controls mTOR through modulation of DEPTOR stability. Indeed, KDM4A catalytic activity is essential for decreasing β-TrCP1-dependent poly-ubiquitination of DEPTOR (<a href="#f4">Fig. 4b,c</a>) thereby promoting DEPTOR protein stability (<a href="/articles/ncomms12700#s1">Supplementary Fig. 5c</a>). Further investigation will be required to identify the substrate(s) of KDM4A-mediated demethylation involved in controlling DEPTOR stability.</p><p>Amplification of <i>KDM4A</i> gene copy number, or of its mRNA expression, has been observed in various cancers. Such upregulation of KDM4A has been reported to promote site-specific genomic amplification<sup><a id="ref-link-section-79" title="Black, J. C. et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 154, 541–555 (2013)." href="/articles/ncomms12700#ref45">45</a></sup> or hinder p53 activation and senescence<sup><a id="ref-link-section-80" title="Mallette, F. A. &amp; Richard, S. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep. 2, 1233–1243 (2012)." href="/articles/ncomms12700#ref14">14</a></sup>. Conversely, genomic loss of <i>KMD4A</i> and concomitant decrease in mRNA levels has also been reported in multiple tumour types (<a href="/articles/ncomms12700#s1">Supplementary Fig. 6a–j</a>)<sup><a id="ref-link-section-81" title="Black, J. C. et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 154, 541–555 (2013)." href="/articles/ncomms12700#ref45">45</a></sup>, particularly bladder cancer where KDM4A downregulation correlates with tumour progression<sup><a id="ref-link-section-82" title="Kauffman, E. C. et al. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol. Carcinog. 50, 931–944 (2011)." href="/articles/ncomms12700#ref53">53</a></sup>. Our own results suggest that decreased KDM4A expression could contribute to mTOR activation during cancer development, suggesting that this demethylase could act as a context-dependent oncogene.</p><p>Recent evidence demonstrates that mTORC1 controls mitochondrial activity<sup><a id="ref-link-section-83" title="Morita, M. et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab. 18, 698–711 (2013)." href="/articles/ncomms12700#ref54">54</a></sup> and stimulates metabolism of glutamine<sup><a id="ref-link-section-84" title="Csibi, A. et al. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell 153, 840–854 (2013)." href="/articles/ncomms12700#ref55">55</a></sup>, an amino acid catabolized into αKG, suggesting that mTOR modulates the TCA cycle. Here we provide evidence that TCA cycle defects can lead to aberrant activation of mTOR kinase. Indeed our data show that KDM4A associates with DEPTOR, and that 2HG-mediated inhibition of KDM4A in IDH1/2-mutated cells impacts DEPTOR protein stability leading to mTOR activation (<a href="#f5">Fig. 5</a>). On the other hand, it has been reported that 2HG inhibits ATP synthase and mTOR activity in cell lines wherein mTOR is chronically hyperactivated due to the loss of PTEN activity or other causes<sup><a id="ref-link-section-85" title="Fu, X. et al. 2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling. Cell Metab. 22, 508–515 (2015)." href="/articles/ncomms12700#ref56">56</a></sup>. Under such conditions, 2HG-mediated inhibition of ATP synthase might alter the ATP/ADP ratio leading to a decrease in mTOR activity. As a possible explanation for this controversy, we emphasize that our genomic analysis of human gliomas and glioblastomas revealed that <i>IDH</i> and <i>PTEN</i> mutations are mutually exclusive. In addition, our data show that 2HG stimulates mTORC1/2 activity in numerous cell lines where mTOR is not hyperactivated by abrogation of PTEN. Furthermore, mTOR signalling is readily observed in clinical samples of IDH1-mutated gliomas. This clearly suggests that the effects of 2HG on mTOR signalling rely on the integrity of upstream signalling pathways.</p><p>The novel PTEN-independent mode of mTORC1/2 activation via mutated IDH/2HG/KDM4A/DEPTOR revealed here may provide an additional molecular explanation for the oncogenic activity of IDH1/2 mutation in brain cancer. This would indicate a potential therapeutic strategy to target oncogenic mTOR signalling in cancers harbouring IDH1/2 mutations.</p></div></div></section><section aria-labelledby="methods"><div class="serif article-section js-article-section cleared clear" id="methods-section"><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id="methods">Methods</h2><div class="pl20 mq875-pl0 js-collapsible-section" id="methods-content"><h2 class="h3 strong mb4">Cell culture</h2><p>HEK293T, HeLa, HT1080 and 293E were obtained from the American Type Culture Collection (ATCC), p53<sup>−/−</sup> MEFs were obtained from Dr Gerardo Ferbeyre and previously described<sup><a id="ref-link-section-86" title="Mallette, F. A. et al. Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence. Ann. N. Y. Acad. Sci. 1197, 142–151 (2010)." href="/articles/ncomms12700#ref57">57</a></sup>, and normal human astrocytes immortalized by hTERT (NHA-hTERT) were kindly provided by Dr Nada Jabado. All the cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Hyclone), 1% sodium pyruvate (Gibco) and 1% penicillin/streptomycin (Gibco). Mycoplasma contamination check has been carried out for all cancer cell lines.</p><h2 class="h3 strong mb4">Plasmids and transfections</h2><p>Cells were transfected with 10 μg of DNA using 30 μg of linear polyethylenimine. The following vectors were used: pcDNA3.1 Flag-eYFP, pLPC Flag-KDM4A, pCMV-Sport6-Flag-mTOR, pMSCV HA-DEPTOR, pDEST myc-KDM4A wild type or mutants (H188A and D939R), pcDNA3 Myc-β-TrCP1 (Addgene plasmid #20718; gift from Dr Yue Xiong) and pcDNA3 HA-Ub. The following plasmids, pRK5 Myc-mTOR (Addgene plasmid #1861), pRK5 Myc-Raptor (Addgene plasmid #1859), pRK5 Myc-Rictor (Addgene plasmid #11367), pRK5 Flag-DEPTOR (Addgene plasmid #21334), pRK5 Flag-DEPTOR DEP domains (Addgene plasmid #21700) and pRK5 Flag-DEPTOR PDZ domain (Addgene plasmid #21701) were gifts from Dr David Sabatini.</p><h2 class="h3 strong mb4">Lentiviral and retroviral infections</h2><p>Lentiviral particles were generated by transfecting 293T cells using 5 μg of shRNA plasmid, 3.75 μg of psPAX2 packaging plasmid and 1.25 μg pMD2.G envelope plasmid. Media was changed 24 h after transfection and lentiviral particles were harvested 24 h later. Viral supernatant was filtered through 0.45 μm filters and supplemented with 8 μg ml<sup>−1</sup> polybrene and 10% FBS. Viruses were titrated using limiting dilution in HeLa cells and the same MOI was used for each condition. The following plasmids were used: pLKO.1-sh_Control, pLKO.1-sh_KDM4A#3 (RHS3979-201745071, Dharmacon), pLKO.1-sh_KDM4A#5 (RHS3979-201745073, Dharmacon), pLKO.1-sh_KDM4A#7 (RHS3979-201745075, Dharmacon), pLKO.1-sh_mTOR#53 (TRCN0000195453, Sigma), pLKO.1-sh_mTOR#84 (TRCN0000039784, Sigma), pLKO.1-sh_mSin1#1 (13483, Addgene) and pLKO.1-sh_mSin1#2 (13484, Addgene).</p><p>Retroviruses were produced by transfecting packaging cells (Phoenix) with 10 μg of DNA using 30 μg of polyethylenimine. Media was changed 24 h later and viral supernatant harvested at 48 and 56 h post-transfection. Viral supernatants were filtered through 0.45 μm filters and supplemented with 8 μg ml<sup>−1</sup> polybrene and 10% FBS. Media were changed 16 h after infection. Retroviral plasmids pLPCX IDH1<sup>WT</sup> Flag, pLPCX IDH1<sup>R132H</sup> Flag, pLPCX IDH2<sup>WT</sup> Flag and pLPCX IDH2<sup>R172K</sup> Flag are described in ref. <a id="ref-link-section-87" title="Li, S. et al. Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. Neuro Oncol. 15, 57–68 (2013)." href="/articles/ncomms12700#ref58">58</a>. The pLXSN IDH1<sup>WT</sup> Flag and pLXSN IDH1<sup>R132H</sup> Flag were generated by PCR of the IDH1 genes (forward primer with EcoR1 site : 5′-TAGAATTCATGTCCAAAAAAATCAGTGG-3′, reverse primer with Xho1 site and Flag tag : 5′-ACCTCGAGTTACTTGTCATCGTCATCCTTGTAATCCATAAGTTTGGCCTG-3′). PCR products were inserted into the EcoRI- and XhoI-linearized pLXSN vector.</p><h2 class="h3 strong mb4">FACS-cell size determination</h2><p>The cells were trypsinized and resuspended in phosphate-buffered saline (PBS) containing 2% FBS. Forward-scatter measurement (FSC) intensity was measured using BD FACSCalibur (BD Biosciences) and analysed with BD CellQuest Pro software (BD Biosciences). For each experiment 1,00,000–2,00,000 cells were analysed, except for cells treated with 2HG where 10,000–25,000 cells were used.</p><h2 class="h3 strong mb4">Immunoblots and antibodies</h2><p>The cells were lysed in 10 mM Tris (pH 7.4), 120 mM NaCl, 0.5% Triton with protease inhibitor mix (cOmplete, Roche) and phosphatase inhibitors (PhosSTOP, Roche) and sonicated for 3 × 10 s. After centrifugation at 15,000<i>g</i> for 10 min, proteins were separated on SDS–PAGE and transferred to nitrocellulose or PVDF membranes (Bio-Rad). Primary antibodies used were anti-Flag (M2, Sigma, 1:5,000), anti-HA.11 (16B12, Covance, 1:1,000), anti-Myc (9E10, Sigma, 1:1,000), anti-α-Tubulin (B-5-1-2, Sigma, 1:10,000), anti-KDM4A (NB110-40585, Novus Biologicals, 1:1,000) and (N154/32, NeuroMab, 1:1,000), anti-mTOR (2972, Cell Signaling, 1:1,000) (7C10, Cell Signaling, 1:1,000), anti-DEPTOR (ABS222, Millipore, 1:1,000), anti-DEPTOR (D9F5, Cell Signaling, 1:500), anti-DEPTOR (NBP1-49674, Novus Biologicals, 1:1,000), anti-GβL (PA5-17442, Thermo Scientific, 1:1,000), anti-Raptor (24C12, Cell Signaling, 1:1,000), anti-phospho-Raptor S792 (2083, Cell Signaling, 1:1,000), anti-PRAS40 (PA5-17184, Thermo Scientific, 1:1,000), anti-Rictor (53A2, Cell Signaling, 1:1,000), anti-phospho-Rictor<sup>T1135</sup> (D30A3, Cell Signaling, 1:1,000), anti-mSin1 (07-2276, Millipore, 1:1,000), anti-Protor2 (D19A5, Cell Signaling, 1:1,000), anti-PTEN (A2B1, Santa Cruz, 1:1,000), anti-TSC2 (T.309-0 Thermo Scientific, 1:1,000), anti-RagA (D8B5, Cell Signaling, 1:1,000), anti-RagB (D18F3, Cell Signaling, 1:1,000), anti-RagC (D31G9, Cell Signaling, 1:1,000), anti-RagD (4470, Cell Signaling, 1:1,000), anti-LAMTOR1 (D11H6, Cell Signaling, 1:1,000), anti-LAMTOR2 (D7C10, Cell Signaling, 1:1,000), anti-LAMTOR3 (D38G5, Cell Signaling, 1:1,000), anti-p70S6K (9202, Cell Signaling, 1:1,000), anti-phospho-p70S6K<sup>T389</sup> (108D2, Cell Signaling, 1:1,000), anti-4E-BP1 (53H11, Cell Signaling, 1:1,000), anti-phospho-4E-BP1<sup>S65</sup> (9451, Cell Signaling, 1:1,000), anti-S6 (54D2, Cell Signaling, 1:1,000), anti-phospho-S6<sup>S240/244</sup> (5364 and 2215, Cell Signaling, 1:1,000), anti-AKT PH domain (05-591, Millipore, 1:1,000), anti-phospho-AKT<sup>S473</sup> (9271, Cell Signaling, 1:1,000) (D9E, Cell Signaling, 1:1,000), anti-phospho-AKT<sup>T308</sup> (C31E5E, Cell Signaling, 1:1,000), anti-PARP (9542, Cell Signaling, 1:1,000), anti-Caspase 3 (9662, Cell Signaling, 1:1,000), anti-actin (D6A8, Cell Signaling, 1:2,000) and anti-GAPDH (D16H11, Cell Signaling, 1:2,000). Scans of ECL and/or X-ray films showing whole membranes are presented in <a href="/articles/ncomms12700#s1">Supplementary Fig. 7</a>.</p><h2 class="h3 strong mb4">Immunoprecipitations</h2><p>The cells were lysed in 1 ml of lysis buffer (0.3% CHAPS, 50 mM Hepes, 120 mM NaCl, 2 mM EDTA with protease inhibitor mix and phosphatase inhibitors (Roche)) and sonicated three times for 10 s each (except for <a href="#f3">Fig. 3f</a>, for which samples were not sonicated to confirm that the interaction between KDM4A and DEPTOR occurred prior sonication). After centrifugation at 15,000<i>g</i> for 10 min, the supernatant was incubated for 2 h at 4 °C with 20 μl of Flag M2 agarose beads (Sigma). Immunoprecipitates were washed three times with lysis buffer containing 150 mM NaCl and twice with TBS before elution in Laemmli buffer.</p><p>For qualitative comparison of IP performed in CHAPS and Triton (<a href="/articles/ncomms12700#s1">Supplementary Fig. 3d</a>), the cells were lysed in lysis buffer (40 mM Hepes pH 7.5, 120 mM NaCl, 1 mM EDTA with protease inhibitor mix Roche) containing either 0.25% CHAPS or 1% triton. The cells were then sonicated three times for 10 s each before centrifugation at 15,000<i>g</i> for 10 min. The supernatants were incubated for 1 h at 4 °C with 20 μl of Flag M2 agarose beads (Sigma). The immunoprecipitates were washed five times with lysis buffer and eluted in Laemmli buffer.</p><p>For HA-Ub IP, the cells were serum starved for 24 h followed by 30 min serum stimulation (10%) before addition of lysis buffer A (20 mM Tris pH 7.5, 1% Triton, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 20 mM <i>N</i>-ethylmaleimide with protease inhibitor mix and phosphatase inhibitors (Roche)). Sample were sonicated three times for 10 s each and immunoprecipitated with 20 μl of HA agarose beads (Sigma) for 2 h at 4 °C. The immunoprecipitates were washed three times with lysis buffer A before elution in Laemmli buffer.</p><p>For endogenous KDM4A IP, <span class="stix"><span class="stix">∼</span></span>2 × 10<sup>8</sup> cells (NHAs, HeLa or 293E) were resuspended in 5 ml of lysis buffer A with 0,5% triton. Extracts were prepared as described above and were pre-cleared for 1 h with 20 μl protA/G beads (Cell Signaling). Immunoprecipitations were performed with 12 μg of NO66 antibody (negative control, SCG consortium, ABC058-F03), KDM4A antibody (p014, SCG consortium) or KDM4B antibody (SCG consortium) overnight at 4 °C. 60 μl of M-280 streptavidin-coated dynabeads (Life Technologies) were added to each sample and incubated for 1 h at 4 °C. The beads were washed three times with lysis buffer A before elution in Laemmli buffer.</p><h2 class="h3 strong mb4">Production of recombinant proteins</h2><p>The GST-DEPTOR (pGEX 5X3), His-KDM4A(aa 1-562) and His-KDM4A(aa 563-1064) (pDest17) were expressed in BL21 bacteria grown in LB. After induction with IPTG (0.2 mM) for 16 h at 20 °C, bacteria were harvested by centrifugation and lysed by sonication. The GST-fusion protein was purified on glutathione agarose beads (Sigma) and the His-fusion protein were purified with Ni-NTA agarose (Qiagen). The His-fusion proteins were eluted off the beads using 200 mM imidazole buffer and dialysed overnight against PBS, followed by concentration on Amicon columns (Millipore).</p><h2 class="h3 strong mb4">GST pull-down assays</h2><p>For GST pull-downs, 1 μg of purified GST-DEPTOR recombinant protein was incubated for 2 h at 4 °C with 500 ng of His-KDM4A (aa 1–562) or (aa 563–1064) recombinant protein in GST pull-down buffer (25 mM HEPES pH7.5, 250 mM KCl, 0,1% NP-40, 10% glycerol, 100 μg ml<sup>−1</sup> BSA). The beads were then washed with GST pull-down buffer four times and eluted in Laemmli buffer 2 × .</p><h2 class="h3 strong mb4">Metabolite extraction and quantification of 2HG</h2><p>Quantification of citric acid cycle (CAC) organic acid intermediates was carried out at the Goodman Cancer Research Center metabolomics core facility (McGill University, Montreal, QC, Canada). Following cellular extraction and either keto-acid reduction or methoximation, GC/MS data were collected and analysed as described in detail<sup><a id="ref-link-section-88" title="Mamer, O. et al. The complete targeted profile of the organic acid intermediates of the citric acid cycle using a single stable isotope dilution analysis, sodium borodeuteride reduction and selected ion monitoring GC/MS. Metabolomics 9, 1019–1030 (2013)." href="/articles/ncomms12700#ref59">59</a>,<a id="ref-link-section-89" title="McGuirk, S. et al. PGC-1alpha supports glutamine metabolism in breast cancer. Cancer Metab. 1, 22 (2013)." href="/articles/ncomms12700#ref60">60</a></sup> except that 4 μl of the deuterated CAC standard mix was added due to the high level of 2-hydroxyglutaric acid in mutant IDH1/2-expressing cells. Resulting levels of CAC intermediates were normalized against cell number.</p><h2 class="h3 strong mb4">Synthesis of 1-octyl-<i>D</i>-2-hydroxyglutarate</h2><p>Synthesis of 1-octyl-D-2-hydroxyglutarate was performed as previously described<sup><a id="ref-link-section-90" title="Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474–478 (2012)." href="/articles/ncomms12700#ref38">38</a></sup>. Briefly, commercial <i>R</i>(-)-tetrahydro-5-oxofuran-2-carboxylic acid (910 mg, 7 mmol) was dissolved in water (1 ml), cooled to 0 °C and treated with 1 N KOH (14.7 ml, 14.7 mmol). After stirring, the solution was dessicated under reduced pressure, co-evaporated with EtOH and dried. The white salt obtained was partially dissolved in trifluoroactic anhydride (50 ml) and the solution evaporated under reduced pressure. Anhydrous tetrahydrofuran (45 ml) was then used to dry and dissolve the residue, and octanol (2.3 ml, 14.7 mmol) was added to the resulting solution. After stirring overnight, water was added to quench the reaction and the mixture extracted with EtOAc. The extracts were combined, dried over MgSO<sub>4</sub>, concentrated and purified by flash chromatography eluting with Hexanes-EtOAc 3:1 to 1:1 giving 1-octyl-D-2-hydroxyglutarate (70 mg, 7 %) as an oil. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 4.19 (m, 1H), 4.15 (m, 2H), 2.51–2.36 (m, 2H), 2.12–2.04 (m, 1H), 1.94–1.85 (m, 1H), 1.70–1.63 (m, 2H), 1.40–1.31 (m, 10H), 0.90 (t, 3H, <i>J</i>=6.8 Hz); MS (APCI neg) 259.05 [M-H]-.</p><h2 class="h3 strong mb4">siRNA screen targeting αKG-dependent oxygenases</h2><p>HeLa cells were transfected using Lipofectamine RNAiMAX (Invitrogen) using reverse transfection protocol supplied by the manufacturer. Briefly, 20 nM siRNA duplexes and 10 μl RNAiMAX lipofectamine (Invitrogen) were diluted in 1 ml OPTI-MEM (Invitrogen) in 6 mm plates and incubated for 15 min before adding 600,000 cells per plate. Three days following the transfection, the cells were lysed in 10 mM Tris-HCl, 100 mM NaCl, 0.5% Triton X-100, pH 7.6 with protease inhibitor mix and phosphatase inhibitors (Roche), sonicated three times for 10 s, then centrifuged for 10 min at 10,000<i>g</i>. The supernatants were then analysed by western blotting for total S6 or phospho-S6<sup>S240/244</sup>, and quantification of band intensity was performed using ImageJ. All siRNAs were purchased from ThermoScientific (Dharmacon). For a complete list of siRNAs, see <a href="/articles/ncomms12700#s1">Supplementary Table 1</a>.</p><h2 class="h3 strong mb4">Immunofluorescence</h2><p>Cells were fixed with 4% paraformaldehyde in PBS for 5 min at room temperature and permeabilized with 1% Triton X-100 in PBS for 5 min at room temperature. Fluorescent visualization of KDM4A was performed using pAb anti-KDM4A antibody (1:100, NB110-40585; Novus Biologicals) coupled with an Alexa Fluor 488 Goat Anti-Rabbit IgG (H+L) secondary antibody (catalogue # 4412, Cell Signaling, 1:1,000). Polymerized actin was visualized using CF™568 phalloidin (catalogue # 00044-300U; Biotium). DNA was stained with 4′,6′-diamidino-2-phenylindole (DAPI). Immunofluorescent images were captured using a × 60 lens (1.42 NA, splan APO), mounted on an FV1000 confocal laser scanning microscope driven by FluoView software (Olympus). Image acquisition was performed at room temperature, the brightness/contrast tool in FluoView software (Olympus) was used to process images and montages were made using Photoshop CS6 (Adobe).</p><h2 class="h3 strong mb4">Cell fractionation</h2><p>The harvested cells were suspended in cold extraction buffer (10 mM Hepes (pH 7,4), 5 mM MgCl<sub>2</sub>, 320 mM sucrose and 1% Triton X-100), agitated for 10 s and incubated on ice for 10 min. The cells were centrifuged at 2,000<i>g</i> and the supernatant (cytoplasmic fraction) collected while the pellet (nuclear fraction) was washed two times with 10 mM Hepes (pH 7,4) containing 5 mM MgCl<sub>2</sub> and 320 mM sucrose.</p><h2 class="h3 strong mb4">Quantitative real-time PCR</h2><p>Total RNA was isolated using Trizol (Invitrogen) according to the manufacturer's protocol. The High Capacity cDNA Reverse Transcription Kit was used with random primers (Applied Biosystems) to reverse transcribe 2 μg of total RNA in a final volume of 20 μl. GAPDH (glyceraldehyde-3-phosphate dehydrogenase), HPRT1 (hypoxanthine guanine phosphoribosyl transferase) and ACTB (Beta-actin) were used as endogenous controls and their gene expression levels determined using pre-validated Taqman Gene Expression Assays (Applied Biosystems). Quantitative PCR (qPCR) reactions were performed in 384-well plates using 1.5 μl of cDNA samples (5–25 ng), 5 μl of the TaqMan Fast Universal PCR Master Mix (Applied Biosystems), 0.5 μl of the TaqMan Gene Expression Assay (20X) and 3 μl of water in a final volume of 10 μl. The assays used to determine target gene expression levels were designed using the Universal Probe Library from Roche (<a href="http://www.universalprobelibrary.com">www.universalprobelibrary.com</a>). qPCR reactions for target genes were performed in 384-well plates using 1.5 μl of cDNA samples (5–25 ng), 5 μl of the TaqMan Fast Universal PCR Master Mix (Applied Biosystems), 2 μM of each primer and 1 μM of UPL probe in a final volume of 10 μl. Amplification levels were detected using the ABI PRISM 7900HT Sequence Detection System (Applied Biosystems) programmed to run at 95 °C for 3 min before starting 40 cycles of 5 s at 95 °C and 30 s at 60 °C. The reactions were run in triplicate and the quantification performed using average Cts values. The ΔΔCT method was used to determine relative quantification of target genes. The primers used for RT–qPCR (qPCR with reverse transcription) are listed in <a href="/articles/ncomms12700#s1">Supplementary Table 2</a>.</p><h2 class="h3 strong mb4">2-Hydroxyglutarate IC<sub>50</sub> determination</h2><p>The potency of 2-hydroxyglutarate for KDM4A inhibition was determined by RapidFire Mass Spectrometry<sup><a id="ref-link-section-91" title="Hutchinson, S. E. et al. Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry. J. Biomol. Screen. 17, 39–48 (2012)." href="/articles/ncomms12700#ref61">61</a></sup> and as previously described<sup><a id="ref-link-section-92" title="Ng, S. S. et al. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448, 87–91 (2007)." href="/articles/ncomms12700#ref62">62</a></sup>. Briefly, 25 μl of recombinant human KDM4A (400 nM) was pre-incubated with 2-hydroxyglutarate during 15 min before starting the reaction by adding 25 μl of substrate mix (200 μM <span class="small-caps">L</span>-ascorbic acid, 20 μM Fe<sup>2+</sup>, 20 μM H3K9(me3) peptide and 20 μM 2-oxoglutarate). The enzymatic reaction was stopped after 50 min with 5 μl of 10% formic acid, then the reaction mixture was transferred to a RapidFire RF360 sampling robot. The samples were applied onto a C4 Solid Phase Extraction (SPE) cartridge by aspiration under vacuum. Non-volatile buffer components were removed from the C4 SPE by an aqueous wash step (0.1% formic acid in water). Then, the peptide was eluted from the C4 SPE onto an Agilent 6530 Q-TOF by an organic wash step (85% acetonitrile in water, 0.1% formic acid). Peak area data for the substrate and the product methyl marks were extracted from ion chromatograms and integrated using RapidFire Integrator software. The percentage of demethylation was calculated using Microsoft Excel software, and IC<sub>50</sub> curves were generated by GraphPad Prism.</p><h2 class="h3 strong mb4">Protein stability assay</h2><p>For half-life measurements, HeLa cells were starved for 24 h and pre-treated with 100 μg ml<sup>−1</sup> cycloheximide and 40 μg ml<sup>−1</sup> chloramphenicol 1 h before serum addition (10%). The cells were harvested at indicated time periods and whole cell lysates blotted. The protein levels were normalized to tubulin and quantified using ImageJ.</p><h2 class="h3 strong mb4">Immunohistochemical stainings of astrocytomas</h2><p>Diffuse astrocytomas with IDH1<sup>R132H</sup> mutation (<i>n</i>=3) or wild-type IDH1/2 (<i>n</i>=3) were processed for immunohistochemistry. IDH1/2 wild-type status was confirmed by Sanger sequencing. Four-micrometre thick sections were cut from the selected formalin paraffin embedded specimens and stained using a Benchmark XT immunostainer (Ventana). The Ventana staining protocol included a pretreatment with Cell Conditioner 1 for 40 min, followed by incubation with the primary antibodies at 37 °C for 60 min. All the antibodies were diluted in the Ventana dilution buffer as followed: p-S6<sup>S240/244</sup> (D68F8, Cell Signaling Technology, 1:1,000); p-AKT1<sup>T308</sup> (Novus Biologicals, 1:30). Incubation was followed by detection using Optiview DAB IHC detection kit (Ventana).</p><h2 class="h3 strong mb4">Reproducibility of experiments</h2><p>Representative figures were repeated as follows. <a href="#f1">Figs 1d,g</a>; <a href="#f2">2b,f</a> and <a href="#f3">3g,h</a> and <a href="/articles/ncomms12700#s1">Supplementary Fig. 3g</a> were reproduced at least four times. <a href="#f1">Figs 1b,c</a>; <a href="#f3">3b,f</a> and <a href="#f4">4a,b,g,i</a> and <a href="/articles/ncomms12700#s1">Supplementary Figs 1b–d,k; 2b,c,e; 3a,c; 4a,b; 5a,c,g,h,i</a> were repeated three times. <a href="#f1">Figs 1h</a> and <a href="#f2">2c,e</a>, <a href="#f3">Figs 3a,c</a> and <a href="#f4">4d–f,h</a> and <a href="/articles/ncomms12700#s1">Supplementary Figs 1a,g–i,l; 2d; 3b,d,i; 5e,f</a> were reproduced twice.</p><h2 class="h3 strong mb4">Data availability</h2><p>The TCGA data referenced in this study are available in a public repository from the TCGA website (<a href="http://cancergenome.nih.gov">http://cancergenome.nih.gov</a>). The authors declare that all the other data supporting the findings of this study are available within the article and its <a href="/articles/ncomms12700#s1">Supplementary Information</a> files, and from the corresponding authors upon reasonable request.</p></div></div></section><section aria-labelledby="additional-information"><div class="serif article-section js-article-section cleared clear" id="additional-information-section"><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id="additional-information">Additional information</h2><div class="pl20 mq875-pl0 js-collapsible-section" id="additional-information-content"><p><b>How to cite this article:</b> Carbonneau, M. <i>et al</i>. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. <i>Nat. Commun.</i> 7:12700 doi: 10.1038/ncomms12700 (2016).</p></div></div></section>
                        
                        <section aria-labelledby=references><div class="serif article-section js-article-section cleared clear" id=references-section><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id=references>References</h2><div class="pl20 mq875-pl0 js-collapsible-section" id=references-content><div data-container-section=references><ol class="clean-list ma0 standard-space-below indented-list" data-component=reading-companion-references><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">1.</span><p id=ref1 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Hanahan, D.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Weinberg, R. A.</span></span> <cite itemprop="name headline">Hallmarks of cancer: the next generation</cite>. <i>Cell</i> <b>144</b>, 646–674 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3MXjsFeqtrk%3D&amp;md5=e000cac6dec2dac95c0efee4716bf6fa" data-track=click data-track-source=link data-track-dest="link:Reference1 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=21376230&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference1 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cell.2011.02.013 data-track=click data-track-source=link data-track-dest="link:Reference1 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">2.</span><p id=ref2 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Yan, H.</span></span> <i>et al.</i> <cite itemprop="name headline">IDH1 and IDH2 mutations in gliomas</cite>. <i>N. Engl. J. Med.</i> <b>360</b>, 765–773 (2009).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD1MXitFWru7o%3D&amp;md5=f191d62c32b7183c305613523ebf1330" data-track=click data-track-source=link data-track-dest="link:Reference2 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=19228619&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference2 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1056/NEJMoa0808710 data-track=click data-track-source=link data-track-dest="link:Reference2 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">3.</span><p id=ref3 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Mardis, E. R.</span></span> <i>et al.</i> <cite itemprop="name headline">Recurring mutations found by sequencing an acute myeloid leukemia genome</cite>. <i>N. Engl. J. Med.</i> <b>361</b>, 1058–1066 (2009).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD1MXhtFaltLvL&amp;md5=1f6dc76c250961c9d223c7cd7fdd15cf" data-track=click data-track-source=link data-track-dest="link:Reference3 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=19657110&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference3 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1056/NEJMoa0903840 data-track=click data-track-source=link data-track-dest="link:Reference3 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">4.</span><p id=ref4 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Dang, L.</span></span> <i>et al.</i> <cite itemprop="name headline">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</cite>. <i>Nature</i> <b>462</b>, 739–744 (2009).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD1MXhsVGlurzE&amp;md5=0a340f50422c7fbaa7a67ab8cdc944c2" data-track=click data-track-source=link data-track-dest="link:Reference4 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=19935646&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference4 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/nature08617 data-track=click data-track-source=link data-track-dest="link:Reference4 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">5.</span><p id=ref5 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Ward, P. S.</span></span> <i>et al.</i> <cite itemprop="name headline">The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate</cite>. <i>Cancer Cell</i> <b>17</b>, 225–234 (2010).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3cXlsVWqtLg%3D&amp;md5=3ac17b6a2571c95c6f403d30ac213abb" data-track=click data-track-source=link data-track-dest="link:Reference5 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=20171147&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference5 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.ccr.2010.01.020 data-track=click data-track-source=link data-track-dest="link:Reference5 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">6.</span><p id=ref6 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Xu, W.</span></span> <i>et al.</i> <cite itemprop="name headline">Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases</cite>. <i>Cancer Cell</i> <b>19</b>, 17–30 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3MXpvValsQ%3D%3D&amp;md5=ba6d560e19642b72488eb4e9fcf85084" data-track=click data-track-source=link data-track-dest="link:Reference6 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=21251613&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference6 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.ccr.2010.12.014 data-track=click data-track-source=link data-track-dest="link:Reference6 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">7.</span><p id=ref7 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Chowdhury, R.</span></span> <i>et al.</i> <cite itemprop="name headline">The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases</cite>. <i>EMBO Rep.</i> <b>12</b>, 463–469 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3MXktFahs74%3D&amp;md5=5142aa7020a393096e4d10a3e38d0343" data-track=click data-track-source=link data-track-dest="link:Reference7 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=21460794&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference7 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/embor.2011.43 data-track=click data-track-source=link data-track-dest="link:Reference7 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">8.</span><p id=ref8 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Tsukada, Y.</span></span> <i>et al.</i> <cite itemprop="name headline">Histone demethylation by a family of JmjC domain-containing proteins</cite>. <i>Nature</i> <b>439</b>, 811–816 (2006).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD28XhsVSkuro%3D&amp;md5=ddb7894f27870abd01d3b5e595b2ea9b" data-track=click data-track-source=link data-track-dest="link:Reference8 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16362057&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference8 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/nature04433 data-track=click data-track-source=link data-track-dest="link:Reference8 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">9.</span><p id=ref9 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Whetstine, J. R.</span></span> <i>et al.</i> <cite itemprop="name headline">Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases</cite>. <i>Cell</i> <b>125</b>, 467–481 (2006).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD28XkslCjtLo%3D&amp;md5=e161a052832d0b9d13449aefcae0c21b" data-track=click data-track-source=link data-track-dest="link:Reference9 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16603238&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference9 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cell.2006.03.028 data-track=click data-track-source=link data-track-dest="link:Reference9 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">10.</span><p id=ref10 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Katoh, M.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Katoh, M.</span></span> <cite itemprop="name headline">Identification and characterization of JMJD2 family genes in silico</cite>. <i>Int. J. Oncol.</i> <b>24</b>, 1623–1628 (2004).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2cXkvFaisbo%3D&amp;md5=23e841ead4b5907f75700ea44ac40b41" data-track=click data-track-source=link data-track-dest="link:Reference10 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=15138608&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference10 PubMed">PubMed</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">11.</span><p id=ref11 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Kim, J.</span></span> <i>et al.</i> <cite itemprop="name headline">Tudor, MBT and chromo domains gauge the degree of lysine methylation</cite>. <i>EMBO Rep.</i> <b>7</b>, 397–403 (2006).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD28XjtV2htLs%3D&amp;md5=8569b2c1c879189c7ec3ea07291e91c4" data-track=click data-track-source=link data-track-dest="link:Reference11 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16415788&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference11 PubMed">PubMed</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">12.</span><p id=ref12 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Black, J. C.</span></span> <i>et al.</i> <cite itemprop="name headline">Conserved antagonism between JMJD2A/KDM4A and HP1gamma during cell cycle progression</cite>. <i>Mol. Cell</i> <b>40</b>, 736–748 (2010).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3cXhsFGhu7vP&amp;md5=98ba3d337839307cd3f48869194d1654" data-track=click data-track-source=link data-track-dest="link:Reference12 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=21145482&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference12 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.molcel.2010.11.008 data-track=click data-track-source=link data-track-dest="link:Reference12 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">13.</span><p id=ref13 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Mallette, F. A.</span></span> <i>et al.</i> <cite itemprop="name headline">RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites</cite>. <i>EMBO J.</i> <b>31</b>, 1865–1878 (2012).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC38Xis1eqsbo%3D&amp;md5=c1a55c0a6cb0afe267e8f86176a8029d" data-track=click data-track-source=link data-track-dest="link:Reference13 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=22373579&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference13 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/emboj.2012.47 data-track=click data-track-source=link data-track-dest="link:Reference13 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">14.</span><p id=ref14 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Mallette, F. A.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Richard, S.</span></span> <cite itemprop="name headline">JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5</cite>. <i>Cell Rep.</i> <b>2</b>, 1233–1243 (2012).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC38XhvVWnsrfM&amp;md5=18f9f64e04c560bc4c2c2060ffed630f" data-track=click data-track-source=link data-track-dest="link:Reference14 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=23168260&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference14 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.celrep.2012.09.033 data-track=click data-track-source=link data-track-dest="link:Reference14 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">15.</span><p id=ref15 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Hara, K.</span></span> <i>et al.</i> <cite itemprop="name headline">Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action</cite>. <i>Cell</i> <b>110</b>, 177–189 (2002).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD38XlvV2htr8%3D&amp;md5=64e06269b0ce609672c48482ef78ae01" data-track=click data-track-source=link data-track-dest="link:Reference15 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12150926&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference15 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/S0092-8674(02)00833-4 data-track=click data-track-source=link data-track-dest="link:Reference15 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">16.</span><p id=ref16 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Kim, D. H.</span></span> <i>et al.</i> <cite itemprop="name headline">mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery</cite>. <i>Cell</i> <b>110</b>, 163–175 (2002).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD38XlvV2htr4%3D&amp;md5=341b1472b6e33842dafe46ec6190c9a7" data-track=click data-track-source=link data-track-dest="link:Reference16 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12150925&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference16 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/S0092-8674(02)00808-5 data-track=click data-track-source=link data-track-dest="link:Reference16 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">17.</span><p id=ref17 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Jacinto, E.</span></span> <i>et al.</i> <cite itemprop="name headline">Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</cite>. <i>Nat. Cell Biol.</i> <b>6</b>, 1122–1128 (2004).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2cXptFentL8%3D&amp;md5=63e8427d5e3aa54c1f643fb1bbc4c48d" data-track=click data-track-source=link data-track-dest="link:Reference17 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=15467718&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference17 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/ncb1183 data-track=click data-track-source=link data-track-dest="link:Reference17 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">18.</span><p id=ref18 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Sarbassov, D. D.</span></span> <i>et al.</i> <cite itemprop="name headline">Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton</cite>. <i>Curr. Biol.</i> <b>14</b>, 1296–1302 (2004).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2cXmtVamsLs%3D&amp;md5=f855a1c18934ddc92ef67767912cd917" data-track=click data-track-source=link data-track-dest="link:Reference18 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=15268862&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference18 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cub.2004.06.054 data-track=click data-track-source=link data-track-dest="link:Reference18 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">19.</span><p id=ref19 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Sancak, Y.</span></span> <i>et al.</i> <cite itemprop="name headline">PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase</cite>. <i>Mol. Cell</i> <b>25</b>, 903–915 (2007).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2sXktFCgsbc%3D&amp;md5=970855e7126aad86d0ab0ed14fdc80bf" data-track=click data-track-source=link data-track-dest="link:Reference19 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=17386266&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference19 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.molcel.2007.03.003 data-track=click data-track-source=link data-track-dest="link:Reference19 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">20.</span><p id=ref20 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Vander Haar, E.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Lee, S. I.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Bandhakavi, S.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Griffin, T. J.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Kim, D. H.</span></span> <cite itemprop="name headline">Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40</cite>. <i>Nat. Cell Biol.</i> <b>9</b>, 316–323 (2007).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2sXit12rsr0%3D&amp;md5=ff9466623f8def7e66274d9806ac77a9" data-track=click data-track-source=link data-track-dest="link:Reference20 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=17277771&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference20 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/ncb1547 data-track=click data-track-source=link data-track-dest="link:Reference20 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">21.</span><p id=ref21 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Frias, M. A.</span></span> <i>et al.</i> <cite itemprop="name headline">mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s</cite>. <i>Curr. Biol.</i> <b>16</b>, 1865–1870 (2006).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD28Xps1Ons7s%3D&amp;md5=9a34b8280b52b53e669e09b185755e3a" data-track=click data-track-source=link data-track-dest="link:Reference21 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16919458&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference21 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cub.2006.08.001 data-track=click data-track-source=link data-track-dest="link:Reference21 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">22.</span><p id=ref22 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Pearce, L. R.</span></span> <i>et al.</i> <cite itemprop="name headline">Identification of Protor as a novel Rictor-binding component of mTOR complex-2</cite>. <i>Biochem. J.</i> <b>405</b>, 513–522 (2007).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2sXns12gs7s%3D&amp;md5=cdb48c3b91e74ae6593f936847cca064" data-track=click data-track-source=link data-track-dest="link:Reference22 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=17461779&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference22 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1042/BJ20070540 data-track=click data-track-source=link data-track-dest="link:Reference22 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">23.</span><p id=ref23 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Kim, D. H.</span></span> <i>et al.</i> <cite itemprop="name headline">GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR</cite>. <i>Mol. Cell</i> <b>11</b>, 895–904 (2003).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD3sXjslGhsLY%3D&amp;md5=d38289a403d3acec976e641d8c0894fe" data-track=click data-track-source=link data-track-dest="link:Reference23 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12718876&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference23 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/S1097-2765(03)00114-X data-track=click data-track-source=link data-track-dest="link:Reference23 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">24.</span><p id=ref24 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Peterson, T. R.</span></span> <i>et al.</i> <cite itemprop="name headline">DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival</cite>. <i>Cell</i> <b>137</b>, 873–886 (2009).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD1MXosVCltb0%3D&amp;md5=af58fee5d899497ca658f78d3a45818d" data-track=click data-track-source=link data-track-dest="link:Reference24 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=19446321&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference24 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cell.2009.03.046 data-track=click data-track-source=link data-track-dest="link:Reference24 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">25.</span><p id=ref25 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Laplante, M.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Sabatini, D. M.</span></span> <cite itemprop="name headline">mTOR signaling in growth control and disease</cite>. <i>Cell</i> <b>149</b>, 274–293 (2012).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC38Xls1eguro%3D&amp;md5=122abe6bcd5c5ba25dc3767f4ed23e79" data-track=click data-track-source=link data-track-dest="link:Reference25 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=22500797&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference25 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cell.2012.03.017 data-track=click data-track-source=link data-track-dest="link:Reference25 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">26.</span><p id=ref26 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Gao, D.</span></span> <i>et al.</i> <cite itemprop="name headline">mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR</cite>. <i>Mol. Cell</i> <b>44</b>, 290–303 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3MXhtlKisb%2FK&amp;md5=9ebe32219f79b792f882cac1aaa3b485" data-track=click data-track-source=link data-track-dest="link:Reference26 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=22017875&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference26 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.molcel.2011.08.030 data-track=click data-track-source=link data-track-dest="link:Reference26 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">27.</span><p id=ref27 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Duan, S.</span></span> <i>et al.</i> <cite itemprop="name headline">mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR</cite>. <i>Mol. Cell</i> <b>44</b>, 317–324 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3MXhtlKisbzI&amp;md5=c8290ec35239dd3dd30aa61727982987" data-track=click data-track-source=link data-track-dest="link:Reference27 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=22017877&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference27 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.molcel.2011.09.005 data-track=click data-track-source=link data-track-dest="link:Reference27 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">28.</span><p id=ref28 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Zhao, Y.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Xiong, X.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Sun, Y.</span></span> <cite itemprop="name headline">DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy</cite>. <i>Mol. Cell</i> <b>44</b>, 304–316 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3MXhtlKisbzN&amp;md5=e4f5744bafaf7d6b130690abeb1ad5b2" data-track=click data-track-source=link data-track-dest="link:Reference28 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=22017876&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference28 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.molcel.2011.08.029 data-track=click data-track-source=link data-track-dest="link:Reference28 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">29.</span><p id=ref29 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Ohgaki, H.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Kleihues, P.</span></span> <cite itemprop="name headline">Genetic profile of astrocytic and oligodendroglial gliomas</cite>. <i>Brain Tumor Pathol.</i> <b>28</b>, 177–183 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3MXpvVOnt7k%3D&amp;md5=413cf2069380a0c0637a682414fe899e" data-track=click data-track-source=link data-track-dest="link:Reference29 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=21442241&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference29 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1007/s10014-011-0029-1 data-track=click data-track-source=link data-track-dest="link:Reference29 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">30.</span><p id=ref30 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Liu, X. Y.</span></span> <i>et al.</i> <cite itemprop="name headline">Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations</cite>. <i>Acta Neuropathol.</i> <b>124</b>, 615–625 (2012).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC38XhsFags7vL&amp;md5=fe3b5a226f869eb9d2b06893abc42b11" data-track=click data-track-source=link data-track-dest="link:Reference30 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=22886134&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference30 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1007/s00401-012-1031-3 data-track=click data-track-source=link data-track-dest="link:Reference30 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">31.</span><p id=ref31 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Pollack, I. F.</span></span> <i>et al.</i> <cite itemprop="name headline">IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group</cite>. <i>Childs Nerv. Syst.</i> <b>27</b>, 87–94 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=20725730&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference31 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1007/s00381-010-1264-1 data-track=click data-track-source=link data-track-dest="link:Reference31 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">32.</span><p id=ref32 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Chin, R. M.</span></span> <i>et al.</i> <cite itemprop="name headline">The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR</cite>. <i>Nature</i> <b>510</b>, 397–401 (2014).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC2cXpslGiurw%3D&amp;md5=4ba15f8737dd27f2c9b7cf122e86115c" data-track=click data-track-source=link data-track-dest="link:Reference32 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=24828042&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference32 PubMed">PubMed</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">33.</span><p id=ref33 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Duran, R. V.</span></span> <i>et al.</i> <cite itemprop="name headline">Glutaminolysis activates Rag-mTORC1 signaling</cite>. <i>Mol. Cell</i> <b>47</b>, 349–358 (2012).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC38XpsVOrtL0%3D&amp;md5=63c6619941e519b1c68cfb85b7f55ea6" data-track=click data-track-source=link data-track-dest="link:Reference33 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=22749528&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference33 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.molcel.2012.05.043 data-track=click data-track-source=link data-track-dest="link:Reference33 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">34.</span><p id=ref34 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Lorin, S.</span></span> <i>et al.</i> <cite itemprop="name headline">Glutamate dehydrogenase contributes to leucine sensing in the regulation of autophagy</cite>. <i>Autophagy</i> <b>9</b>, 850–860 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3sXhvVOnsr7F&amp;md5=3b0060824e7b848038a4474beb6f2866" data-track=click data-track-source=link data-track-dest="link:Reference34 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=23575388&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference34 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.4161/auto.24083 data-track=click data-track-source=link data-track-dest="link:Reference34 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">35.</span><p id=ref35 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Marino, G.</span></span> <i>et al.</i> <cite itemprop="name headline">Regulation of autophagy by cytosolic acetyl-coenzyme A</cite>. <i>Mol. Cell</i> <b>53</b>, 710–725 (2014).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC2cXivFCmtLk%3D&amp;md5=ab46618a00eae86dde40ce754a9ccd74" data-track=click data-track-source=link data-track-dest="link:Reference35 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=24560926&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference35 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.molcel.2014.01.016 data-track=click data-track-source=link data-track-dest="link:Reference35 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">36.</span><p id=ref36 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Fingar, D. C.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Salama, S.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Tsou, C.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Harlow, E.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Blenis, J.</span></span> <cite itemprop="name headline">Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E</cite>. <i>Genes Dev.</i> <b>16</b>, 1472–1487 (2002).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD38XltVGmtL0%3D&amp;md5=6f69d6f50ce51fce5d871ed5fa33c026" data-track=click data-track-source=link data-track-dest="link:Reference36 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12080086&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference36 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1101/GAD.995802 data-track=click data-track-source=link data-track-dest="link:Reference36 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">37.</span><p id=ref37 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Rohle, D.</span></span> <i>et al.</i> <cite itemprop="name headline">An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells</cite>. <i>Science</i> <b>340</b>, 626–630 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3sXmslWksbg%3D&amp;md5=286b326bf6974a134a4512acc726f7b4" data-track=click data-track-source=link data-track-dest="link:Reference37 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=23558169&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference37 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1126/science.1236062 data-track=click data-track-source=link data-track-dest="link:Reference37 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">38.</span><p id=ref38 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Lu, C.</span></span> <i>et al.</i> <cite itemprop="name headline">IDH mutation impairs histone demethylation and results in a block to cell differentiation</cite>. <i>Nature</i> <b>483</b>, 474–478 (2012).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC38XisVKks74%3D&amp;md5=e0d6a558a94322638d79628b4a0c22dc" data-track=click data-track-source=link data-track-dest="link:Reference38 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=22343901&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference38 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/nature10860 data-track=click data-track-source=link data-track-dest="link:Reference38 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">39.</span><p id=ref39 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Cloos, P. A.</span></span> <i>et al.</i> <cite itemprop="name headline">The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3</cite>. <i>Nature</i> <b>442</b>, 307–311 (2006).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD28XmvF2jsr4%3D&amp;md5=caec15a73943b5944e7ec87d0eeeda0a" data-track=click data-track-source=link data-track-dest="link:Reference39 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16732293&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference39 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/nature04837 data-track=click data-track-source=link data-track-dest="link:Reference39 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">40.</span><p id=ref40 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Klose, R. J.</span></span> <i>et al.</i> <cite itemprop="name headline">The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36</cite>. <i>Nature</i> <b>442</b>, 312–316 (2006).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD28XmvF2jsr0%3D&amp;md5=7766db28454f539ce29c215c0285f759" data-track=click data-track-source=link data-track-dest="link:Reference40 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16732292&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference40 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/nature04853 data-track=click data-track-source=link data-track-dest="link:Reference40 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">41.</span><p id=ref41 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Shin, S.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Janknecht, R.</span></span> <cite itemprop="name headline">Diversity within the JMJD2 histone demethylase family</cite>. <i>Biochem. Biophys. Res. Commun.</i> <b>353</b>, 973–977 (2007).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2sXmtVaqtg%3D%3D&amp;md5=261594860fc7ebc8771efe2ced22d3f7" data-track=click data-track-source=link data-track-dest="link:Reference41 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=17207460&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference41 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.bbrc.2006.12.147 data-track=click data-track-source=link data-track-dest="link:Reference41 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">42.</span><p id=ref42 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Johmura, Y.</span></span> <i>et al.</i> <cite itemprop="name headline">SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence</cite>. <i>Nat. Commun.</i> <b>7</b>, 10574 (2016).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC28XisFWitrs%3D&amp;md5=56c534ee7f4d1a49c1b0d9daacecf5db" data-track=click data-track-source=link data-track-dest="link:Reference42 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=26868148&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference42 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/ncomms10574 data-track=click data-track-source=link data-track-dest="link:Reference42 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">43.</span><p id=ref43 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Neault, M.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Mallette, F. A.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Richard, S.</span></span> <cite itemprop="name headline">miR-137 modulates a tumor suppressor network-inducing senescence in pancreatic cancer cells</cite>. <i>Cell Rep.</i> <b>14</b>, 1966–1978 (2016).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC28XivFOqtLw%3D&amp;md5=16866c92b80e515ff8fd71c7cac4a47c" data-track=click data-track-source=link data-track-dest="link:Reference43 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=26904954&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference43 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.celrep.2016.01.068 data-track=click data-track-source=link data-track-dest="link:Reference43 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">44.</span><p id=ref44 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Zhang, D.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Yoon, H. G.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Wong, J.</span></span> <cite itemprop="name headline">JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2)</cite>. <i>Mol. Cell. Biol.</i> <b>25</b>, 6404–6414 (2005).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2MXntVShtbc%3D&amp;md5=52a2e23a0c6bbab99a634a7858c0c8b1" data-track=click data-track-source=link data-track-dest="link:Reference44 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=16024779&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference44 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1128/MCB.25.15.6404-6414.2005 data-track=click data-track-source=link data-track-dest="link:Reference44 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">45.</span><p id=ref45 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Black, J. C.</span></span> <i>et al.</i> <cite itemprop="name headline">KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors</cite>. <i>Cell</i> <b>154</b>, 541–555 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3sXhtFCgtrzE&amp;md5=5301f7d8a97c4f90e11cf9e86838e451" data-track=click data-track-source=link data-track-dest="link:Reference45 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=23871696&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference45 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cell.2013.06.051 data-track=click data-track-source=link data-track-dest="link:Reference45 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">46.</span><p id=ref46 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Jin, J.</span></span> <i>et al.</i> <cite itemprop="name headline">Noncanonical NF-kappaB pathway controls the production of type I interferons in antiviral innate immunity</cite>. <i>Immunity</i> <b>40</b>, 342–354 (2014).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC2cXkvF2qtrk%3D&amp;md5=2ca7683f7605068fd8aca8adba3471a7" data-track=click data-track-source=link data-track-dest="link:Reference46 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=24656046&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference46 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.immuni.2014.02.006 data-track=click data-track-source=link data-track-dest="link:Reference46 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">47.</span><p id=ref47 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Garami, A.</span></span> <i>et al.</i> <cite itemprop="name headline">Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2</cite>. <i>Mol. Cell</i> <b>11</b>, 1457–1466 (2003).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD3sXltlSkurg%3D&amp;md5=9d6023c7bd431116d8720f3632fe9d07" data-track=click data-track-source=link data-track-dest="link:Reference47 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12820960&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference47 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/S1097-2765(03)00220-X data-track=click data-track-source=link data-track-dest="link:Reference47 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">48.</span><p id=ref48 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Inoki, K.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Li, Y.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Xu, T.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Guan, K. L.</span></span> <cite itemprop="name headline">Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling</cite>. <i>Genes Dev.</i> <b>17</b>, 1829–1834 (2003).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD3sXmt1Sjtrk%3D&amp;md5=c521a987cc785addd1bf92df2db648e6" data-track=click data-track-source=link data-track-dest="link:Reference48 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12869586&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference48 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1101/gad.1110003 data-track=click data-track-source=link data-track-dest="link:Reference48 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">49.</span><p id=ref49 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Tee, A. R.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Manning, B. D.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Roux, P. P.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Cantley, L. C.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Blenis, J.</span></span> <cite itemprop="name headline">Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb</cite>. <i>Curr. Biol.</i> <b>13</b>, 1259–1268 (2003).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD3sXmt1Kitr0%3D&amp;md5=c742830fe5f5d06fd53900a638950eb1" data-track=click data-track-source=link data-track-dest="link:Reference49 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=12906785&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference49 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/S0960-9822(03)00506-2 data-track=click data-track-source=link data-track-dest="link:Reference49 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">50.</span><p id=ref50 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Figueroa, M. E.</span></span> <i>et al.</i> <cite itemprop="name headline">Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</cite>. <i>Cancer Cell</i> <b>18</b>, 553–567 (2010).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3cXhsFGhsbvJ&amp;md5=1a0a6f2e0f4071e5ae869e54348e189b" data-track=click data-track-source=link data-track-dest="link:Reference50 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=21130701&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference50 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.ccr.2010.11.015 data-track=click data-track-source=link data-track-dest="link:Reference50 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">51.</span><p id=ref51 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Losman, J. A.</span></span> <i>et al.</i> <cite itemprop="name headline">(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible</cite>. <i>Science</i> <b>339</b>, 1621–1625 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3sXksFOhsLc%3D&amp;md5=63cf51b7712b769ae32c386973e0dad1" data-track=click data-track-source=link data-track-dest="link:Reference51 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=23393090&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference51 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1126/science.1231677 data-track=click data-track-source=link data-track-dest="link:Reference51 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">52.</span><p id=ref52 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Choo, A. Y.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Yoon, S. O.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Kim, S. G.</span></span>, <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Roux, P. P.</span></span> &amp; <span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Blenis, J.</span></span> <cite itemprop="name headline">Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation</cite>. <i>Proc. Natl Acad. Sci. USA</i> <b>105</b>, 17414–17419 (2008).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=18955708&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference52 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1073/pnas.0809136105 data-track=click data-track-source=link data-track-dest="link:Reference52 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">53.</span><p id=ref53 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Kauffman, E. C.</span></span> <i>et al.</i> <cite itemprop="name headline">Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer</cite>. <i>Mol. Carcinog.</i> <b>50</b>, 931–944 (2011).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3MXhtlyqu7bP&amp;md5=bb89d0358601cbd8d3ca6e211ca407d4" data-track=click data-track-source=link data-track-dest="link:Reference53 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=21400613&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference53 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1002/mc.20758 data-track=click data-track-source=link data-track-dest="link:Reference53 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">54.</span><p id=ref54 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Morita, M.</span></span> <i>et al.</i> <cite itemprop="name headline">mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation</cite>. <i>Cell Metab.</i> <b>18</b>, 698–711 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3sXhslertLfE&amp;md5=63bc62ed6f948d06b71500b6e87b36fd" data-track=click data-track-source=link data-track-dest="link:Reference54 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=24206664&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference54 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cmet.2013.10.001 data-track=click data-track-source=link data-track-dest="link:Reference54 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">55.</span><p id=ref55 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Csibi, A.</span></span> <i>et al.</i> <cite itemprop="name headline">The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4</cite>. <i>Cell</i> <b>153</b>, 840–854 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3sXnsFWis7w%3D&amp;md5=2f766d096fa7e471fab5495100ef07fb" data-track=click data-track-source=link data-track-dest="link:Reference55 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=23663782&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference55 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cell.2013.04.023 data-track=click data-track-source=link data-track-dest="link:Reference55 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">56.</span><p id=ref56 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Fu, X.</span></span> <i>et al.</i> <cite itemprop="name headline">2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling</cite>. <i>Cell Metab.</i> <b>22</b>, 508–515 (2015).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC2MXhtF2ksLvJ&amp;md5=8a3a132c114cf0ae7182998f48c67c8f" data-track=click data-track-source=link data-track-dest="link:Reference56 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=26190651&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference56 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1016/j.cmet.2015.06.009 data-track=click data-track-source=link data-track-dest="link:Reference56 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">57.</span><p id=ref57 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Mallette, F. A.</span></span> <i>et al.</i> <cite itemprop="name headline">Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence</cite>. <i>Ann. N. Y. Acad. Sci.</i> <b>1197</b>, 142–151 (2010).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3cXptFOgt7w%3D&amp;md5=b06c9256e0e4ee4958c44611948da164" data-track=click data-track-source=link data-track-dest="link:Reference57 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=20536843&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference57 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1111/j.1749-6632.2010.05192.x data-track=click data-track-source=link data-track-dest="link:Reference57 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">58.</span><p id=ref58 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Li, S.</span></span> <i>et al.</i> <cite itemprop="name headline">Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation</cite>. <i>Neuro Oncol.</i> <b>15</b>, 57–68 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3sXns1Gguw%3D%3D&amp;md5=425889433f9f0997ddf5107f26b20ac2" data-track=click data-track-source=link data-track-dest="link:Reference58 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=23115158&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference58 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1093/neuonc/nos261 data-track=click data-track-source=link data-track-dest="link:Reference58 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">59.</span><p id=ref59 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Mamer, O.</span></span> <i>et al.</i> <cite itemprop="name headline">The complete targeted profile of the organic acid intermediates of the citric acid cycle using a single stable isotope dilution analysis, sodium borodeuteride reduction and selected ion monitoring GC/MS</cite>. <i>Metabolomics</i> <b>9</b>, 1019–1030 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC3sXhsVWqs7rO&amp;md5=7b04bdad894fc72a5632c64104439179" data-track=click data-track-source=link data-track-dest="link:Reference59 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=24348278&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference59 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1007/s11306-013-0521-1 data-track=click data-track-source=link data-track-dest="link:Reference59 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">60.</span><p id=ref60 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>McGuirk, S.</span></span> <i>et al.</i> <cite itemprop="name headline">PGC-1alpha supports glutamine metabolism in breast cancer</cite>. <i>Cancer Metab.</i> <b>1</b>, 22 (2013).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=24304688&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference60 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1186/2049-3002-1-22 data-track=click data-track-source=link data-track-dest="link:Reference60 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">61.</span><p id=ref61 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Hutchinson, S. E.</span></span> <i>et al.</i> <cite itemprop="name headline">Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry</cite>. <i>J. Biomol. Screen.</i> <b>17</b>, 39–48 (2012).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BC38Xit1Olt74%3D&amp;md5=6e1ea200c2769c1dc576f3231fdae87f" data-track=click data-track-source=link data-track-dest="link:Reference61 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=21859681&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference61 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1177/1087057111416660 data-track=click data-track-source=link data-track-dest="link:Reference61 Article" itemprop=url>Article</a></ul></ul><li class="small-space-below border-gray-medium border-bottom-1 position-relative js-ref-item" itemprop=citation itemscope itemtype=http://schema.org/Article><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">62.</span><p id=ref62 class=tiny-space-below><span itemprop=author itemscope itemtype=http://schema.org/Person><span itemprop=name>Ng, S. S.</span></span> <i>et al.</i> <cite itemprop="name headline">Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity</cite>. <i>Nature</i> <b>448</b>, 87–91 (2007).</p><ul class="js-ref-links clean-list cleared strong sans-serif text13 hide-print"><li class=pin-right><ul class="clean-list ma0"><li class="pin-left pl20"><a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&amp;action=reflink&amp;origin=npg&amp;version=1.0&amp;coi=1:CAS:528:DC%2BD2sXnt1ent7c%3D&amp;md5=69863d2026ff5ba4aeabc9f36c95a4f7" data-track=click data-track-source=link data-track-dest="link:Reference62 CAS">CAS</a><li class="pin-left pl20"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&amp;cmd=Retrieve&amp;db=PubMed&amp;list_uids=17589501&amp;dopt=Abstract" data-track=click data-track-source=link data-track-dest="link:Reference62 PubMed">PubMed</a><li class="pin-left pl20"><a href=http://dx.doi.org/10.1038/nature05971 data-track=click data-track-source=link data-track-dest="link:Reference62 Article" itemprop=url>Article</a></ul></ul></ol><p class="hide-print text-right"><a href=/articles/ncomms12700-references.ris class="text14 sans-serif strong" data-track=click data-track-source=download data-track-dest="link:Download references">Download references</a></p></div></div></div></section><section aria-labelledby=acknowledgements><div class="serif article-section js-article-section cleared clear" id=acknowledgements-section><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id=acknowledgements>Acknowledgements</h2><div class="pl20 mq875-pl0 js-collapsible-section" id=acknowledgements-content><p>We thank (i) Drs Albert Lai, Nada Jabado and Philippe P. Roux for sharing reagents; (ii) Drs Elliot Drobetsky, Florence Couteau, Gerardo Ferbeyre and El Bachir Affar for providing reagents, fruitful discussions and critical reading of the manuscript; (iii) Mathieu Neault for artwork; (iv) the organic synthesis service of the Centre de Recherche du Centre Hospitalier Universitaire de Québec (CRCHUQ, Québec, Canada) for synthesis of 1-octyl-D-2-hydroxyglutarate; (v) Raphaëlle Lambert and the Genomics core facility of the Institute for Research in Immunology and Cancer (IRIC, Montréal, Canada); and (vi) Daina Avizonis (Rosalind and Morris Goodman Cancer Research Centre Metabolomics Core Facility; supported by the Canada Foundation of Innovation, The Dr John R. and Clara M. Fraser Memorial Trust, Terry Fox Foundation Team Grant #116128, and McGill University) for metabolite measurements. This study was supported by grants from the Fondation de l’Hôpital Maisonneuve-Rosemont (to F.A.M.), the Cole Foundation (to F.A.M.), the Canadian Institutes of Health Research (CIHR, MOP-133442 to F.A.M.; MOP-286437 to M.-E.H.), Natural Sciences and Engineering Research Council of Canada (NSERC, #402880-2012 to M.-E.H.), the Arthritis Research UK (program grant number 20522), the NIHR Oxford Biomedical Research Unit and the Rosetrees Trust to U.O. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from Abbvie, Bayer Healthcare, Boehringer Ingelheim, CIHR, the Canadian Foundation for Innovation, Eli Lilly and Company, Genome Canada, GlaxoSmithKline, the Ontario Ministry of Economic Development and Innovation, Janssen, the Novartis Research Foundation, Pfizer, Takeda and the Wellcome Trust. A.M. is recipient of Ph.D. studentships from the Cole Foundation and the Fonds de Recherche du Québec - Santé (FRQS)/Fondation des Étoiles. M.-E.L. received a post-doctoral fellowship from the CIHR. M.-E.H. and F.A.M. are Junior 1 Research Scholars of the FRQS. F.A.M. holds a Canada Research Chair in Epigenetics of Aging and Cancer.</p></div></div></section><section aria-labelledby=author-information><div class="serif article-section js-article-section cleared clear" id=author-information-section><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id=author-information>Author information</h2><div class="pl20 mq875-pl0 js-collapsible-section" id=author-information-content><h2 class="h3 strong mb4 visually-hidden" id=author-notes>Author notes</h2><ol class="ml20 clean-list"><li class="suppress-bottom-margin small-space-below" id=n1><ul class="clean-list inline-list h3 strong ma0"><li><span class=js-separator></span><span>Laurence M. Gagné</span><li><span class=js-separator>, </span><span>Marie-Eve Lalonde</span><li><span class=js-separator>&nbsp;&amp; </span><span>Marie-Anne Germain</span></ul> <p>These authors contributed equally to this work</p></ol><h2 class="h3 strong mb4" id=affiliations>Affiliations</h2><ol class="ml20 clean-list"><li id=a1><h3 class=strong>Département de Biochimie et Médecine Moléculaire, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Quebec, Canada H3C 3J7</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Mélissa Carbonneau</span><li><span class=js-separator>, </span><span>Alena Motorina</span><li><span class=js-separator>&nbsp;&amp; </span><span>Frédérick A. Mallette</span></ul><li id=a2><h3 class=strong>Chromatin Structure and Cellular Senescence Research Unit, Maisonneuve-Rosemont Hospital Research Centre, Montréal, Quebec, Canada H1T 2M4</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Mélissa Carbonneau</span><li><span class=js-separator>, </span><span>Marie-Eve Lalonde</span><li><span class=js-separator>, </span><span>Marie-Anne Germain</span><li><span class=js-separator>, </span><span>Alena Motorina</span><li><span class=js-separator>&nbsp;&amp; </span><span>Frédérick A. Mallette</span></ul><li id=a3><h3 class=strong>Centre de Recherche sur le Cancer de l’Université Laval; Départements de Biologie moléculaire, biochimie médicale et pathologie, Université Laval, Québec City, Quebec, Canada G1V 0A6</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Laurence M. Gagné</span><li><span class=js-separator>, </span><span>Jonathan Bergeman</span><li><span class=js-separator>&nbsp;&amp; </span><span>Marc-Étienne Huot</span></ul><li id=a4><h3 class=strong>Brain Tumour Research Centre, Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, 3801 University Street, Montreal, Quebec, Canada H3A 2B4</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Marie-Christine Guiot</span><li><span class=js-separator>&nbsp;&amp; </span><span>Kevin Petrecca</span></ul><li id=a5><h3 class=strong>Division of Neuropathology, Department of Pathology, McGill University, Montreal, Quebec, Canada H3A 2B4</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Marie-Christine Guiot</span></ul><li id=a6><h3 class=strong>Institut universitaire de cardiologie et de pneumologie de Québec, 2725 chemin Sainte-Foy, Québec City, Quebec, Canada G1V 4G5</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Blandine Secco</span><li><span class=js-separator>&nbsp;&amp; </span><span>Mathieu Laplante</span></ul><li id=a7><h3 class=strong>Département de Médecine, Faculté de Médecine, Université Laval, Québec City, Quebec, Canada G1V 0A6</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Blandine Secco</span><li><span class=js-separator>&nbsp;&amp; </span><span>Mathieu Laplante</span></ul><li id=a8><h3 class=strong>Goodman Cancer Research Centre, McGill University, Montréal, Quebec, Canada H3G 1Y6</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Emma E. Vincent</span><li><span class=js-separator>&nbsp;&amp; </span><span>Russell G. Jones</span></ul><li id=a9><h3 class=strong>Department of Physiology, McGill University, Montréal, Quebec, Canada H3G 1Y6</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Emma E. Vincent</span><li><span class=js-separator>&nbsp;&amp; </span><span>Russell G. Jones</span></ul><li id=a10><h3 class=strong>Structural Genomics Consortium, University of Oxford, Old Road Campus, Roosevelt Drive, Headington OX3 7DQ, UK</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Anthony Tumber</span><li><span class=js-separator>&nbsp;&amp; </span><span>Udo Oppermann</span></ul><li id=a11><h3 class=strong>Target Discovery Institute, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7LD, UK</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Anthony Tumber</span></ul><li id=a12><h3 class=strong>Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte-Ste-Catherine Road, Montréal, Quebec, Canada H3T 1E2</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Laura Hulea</span><li><span class=js-separator>&nbsp;&amp; </span><span>Ivan Topisirovic</span></ul><li id=a13><h3 class=strong>Department of Oncology, McGill University, 546 Pine Avenue West, Montréal, Quebec, Canada H2W 1S6</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Laura Hulea</span><li><span class=js-separator>&nbsp;&amp; </span><span>Ivan Topisirovic</span></ul><li id=a14><h3 class=strong>Botnar Research Center, NIHR Oxford Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, Oxford OX3 7LD, UK</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Udo Oppermann</span></ul><li id=a15><h3 class=strong>CHU de Québec–Axe Oncologie (Hôtel-Dieu de Québec), Québec City, Quebec Canada G1R 3S3</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Marc-Étienne Huot</span></ul><li id=a16><h3 class=strong>Département de Médecine, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, Quebec, Canada H3C 3J7</h3><ul class="small-space-below clean-list inline-list"><li><span class=js-separator></span><span>Frédérick A. Mallette</span></ul></ol><div class=js-hide><h2 class="h3 strong">Authors</h2><ol class=clean-list><li id=auth-1><h3 class="sans-serif strong text-gray-light js-search-name">Search for Mélissa Carbonneau in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22M%C3%A9lissa+Carbonneau%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=M%C3%A9lissa+Carbonneau">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22M%C3%A9lissa+Carbonneau%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-2><h3 class="sans-serif strong text-gray-light js-search-name">Search for Laurence M. Gagné in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Laurence+M.%20Gagn%C3%A9%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Laurence+M.%20Gagn%C3%A9">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Laurence+M.%20Gagn%C3%A9%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-3><h3 class="sans-serif strong text-gray-light js-search-name">Search for Marie-Eve Lalonde in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Marie-Eve+Lalonde%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marie-Eve+Lalonde">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marie-Eve+Lalonde%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-4><h3 class="sans-serif strong text-gray-light js-search-name">Search for Marie-Anne Germain in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Marie-Anne+Germain%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marie-Anne+Germain">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marie-Anne+Germain%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-5><h3 class="sans-serif strong text-gray-light js-search-name">Search for Alena Motorina in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Alena+Motorina%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Alena+Motorina">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Alena+Motorina%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-6><h3 class="sans-serif strong text-gray-light js-search-name">Search for Marie-Christine Guiot in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Marie-Christine+Guiot%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marie-Christine+Guiot">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marie-Christine+Guiot%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-7><h3 class="sans-serif strong text-gray-light js-search-name">Search for Blandine Secco in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Blandine+Secco%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Blandine+Secco">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Blandine+Secco%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-8><h3 class="sans-serif strong text-gray-light js-search-name">Search for Emma E. Vincent in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Emma%20E.+Vincent%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Emma%20E.+Vincent">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Emma%20E.+Vincent%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-9><h3 class="sans-serif strong text-gray-light js-search-name">Search for Anthony Tumber in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Anthony+Tumber%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Anthony+Tumber">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Anthony+Tumber%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-10><h3 class="sans-serif strong text-gray-light js-search-name">Search for Laura Hulea in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Laura+Hulea%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Laura+Hulea">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Laura+Hulea%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-11><h3 class="sans-serif strong text-gray-light js-search-name">Search for Jonathan Bergeman in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Jonathan+Bergeman%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Jonathan+Bergeman">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Jonathan+Bergeman%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-12><h3 class="sans-serif strong text-gray-light js-search-name">Search for Udo Oppermann in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Udo+Oppermann%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Udo+Oppermann">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Udo+Oppermann%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-13><h3 class="sans-serif strong text-gray-light js-search-name">Search for Russell G. Jones in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Russell%20G.+Jones%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Russell%20G.+Jones">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Russell%20G.+Jones%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-14><h3 class="sans-serif strong text-gray-light js-search-name">Search for Mathieu Laplante in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Mathieu+Laplante%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Mathieu+Laplante">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Mathieu+Laplante%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-15><h3 class="sans-serif strong text-gray-light js-search-name">Search for Ivan Topisirovic in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Ivan+Topisirovic%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Ivan+Topisirovic">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Ivan+Topisirovic%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-16><h3 class="sans-serif strong text-gray-light js-search-name">Search for Kevin Petrecca in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Kevin+Petrecca%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Kevin+Petrecca">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Kevin+Petrecca%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-17><h3 class="sans-serif strong text-gray-light js-search-name">Search for Marc-Étienne Huot in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Marc-%C3%89tienne+Huot%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marc-%C3%89tienne+Huot">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marc-%C3%89tienne+Huot%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul><li id=auth-18><h3 class="sans-serif strong text-gray-light js-search-name">Search for Frédérick A. Mallette in:</h3><ul class="text13 clean-list inline-list strong small-space-below"><li><a href="/search/executeSearch?sp-q=%22Fr%C3%A9d%C3%A9rick%20A.+Mallette%22&amp;sp-p=all&amp;pag-start=1&amp;sp-c=25&amp;sp-m=1&amp;sp-s=date_descending">Nature Research journals</a> <span class=bullet>&bull;</span> <li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Fr%C3%A9d%C3%A9rick%20A.+Mallette">PubMed</a> <span class=bullet>&bull;</span> <li><a href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Fr%C3%A9d%C3%A9rick%20A.+Mallette%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en">Google Scholar</a></ul></ol></div><h2 class="h3 strong mb4" id=contributions>Contributions</h2><p>M.C., M.-E.H. and F.A.M. designed the study. M.C. performed most of the experiments, M.-A.G. performed the siRNA screen and treatments with 2HG and AGI-5198. L.M.G. performed the experiments with the PI(3)K inhibitor and AGI-5198, as well as determined DEPTOR levels upon KDM4A depletion. M.-E.L. performed endogenous co-immunoprecipitations. B.S. and M.L. carried out cell survival experiments, and provided tools and reagents. A.M., L.H., I.T. performed and analysed cell size by FACS. A.T. and U.O. performed and analysed <i>in vitro</i> demethylation assays. E.E.V. and R.G.J. performed metabolomic analyses. M.-C.G. and K.P. carried out immunohistochemistry on human gliomas and performed the histopathological analysis. M.C., M.-A.G., M.-E.H. and F.A.M. wrote the paper. All the authors discussed the results and commented on the manuscript at all the stages.</p><h2 class="h3 strong mb4" id=competing-interests>Competing interests</h2><p>The authors declare no competing financial interests.</p><h2 class="h3 strong mb4" id=corresponding-author>Corresponding authors</h2><p>Correspondence to <a href=/articles/ncomms12700/email/correspondent/c17/new id=corresp-c17>Marc-Étienne Huot</a> or <a href=/articles/ncomms12700/email/correspondent/c18/new id=corresp-c18>Frédérick A. Mallette</a>.</p></div></div></section><section aria-labelledby=supplementary-information><div class="serif article-section js-article-section cleared clear" id=supplementary-information-section><h2 class="js-section-title section-title position-relative strong tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left small-space-above" id=supplementary-information>Supplementary information</h2><div class="pl20 mq875-pl0 js-collapsible-section" id=supplementary-information-content><div class="cleared standard-space-below" data-container-section=supplementary-information data-component=supplementary-information><h2 class="h3 strong tiny-space-below block icon icon-left pl30 ml20 icon-doctype-pdf-16x16-color">PDF files</h2><ol class="clean-list indented-list ma0"><li class="cleared position-relative standard-space-below" id=s1><span class="indented-counter serif h2 tighten-line-height text-right position-absolute">1.</span><h3 class=text17><a href=https://images.nature.com/original/nature-assets/ncomms/2016/160914/ncomms12700/extref/ncomms12700-s1.pdf data-track=click data-track-source=item-title data-track-dest="link:PDF files, Supplementary Information">Supplementary Information</a></h3><div class=cleared data-component=thumbnail-container><p class="text14 ma0">Supplementary Figures 1-7, Supplementary Table 1-2 and Supplementary References</p></div></ol></div></div></div></section>
                        
                        <section aria-labelledby=comments><div class="serif article-section js-article-section cleared clear" id=comments-section><h2 class="js-section-title section-title strong position-relative tighten-line-height background-gray-light pt20 pb6 pl20 pr20 standard-space-below small-space-above mq640-pt20 mq640-pb10 mq640-mt0 js-extend-left" id=comments>Comments</h2><div class="pl20 mq875-pl0 js-collapsible-section" id=comments-content><p>By submitting a comment you agree to abide by our <a href=/info/tandc.html>Terms</a> and <a href=/info/community-guidelines.html>Community Guidelines</a>. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.</p></div></div></section>
                        <div id="inject-comments">
                        <div class="placeholder" data-replace="true"
                              data-placeholder="/platform/disqus?doi=10.1038/ncomms12700 #article-comments-container">
                        </div>
                        </div>
                        

                        <p class="ma0 text13 tighten-line-height"><a href=http://creativecommons.org/licenses/by/4.0/ itemprop=license rel=license class="pin-left mr10" data-license=by><img alt="Creative Commons BY"src="data:image/png;base64,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"></a>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <a href=http://creativecommons.org/licenses/by/4.0/>http://creativecommons.org/licenses/by/4.0/</a></p>
                    </div>
                </div>

                <div class="hide-print reading-companion js-reading-companion position-relative cleared pin-left"
                     role="complementary">
                    <div data-container-type="reading-companion">
                        
                            <h2 class="h3 sans-serif strong visually-hidden">Article Tools</h2><div class="tighten-line-height cleared text14 position-relative z-index-1 standard-space-below pb20 border-gray-light border-bottom-1" data-article-tools data-container-section=tools><ul class="clean-list ie11-list-hack ma0 flex-box flex-space-between mq875-kill-flex-space-between"><li class="pin-left mr4 position-relative z-index-2"><a href=/articles/ncomms12700.pdf class="inline-block block-link pa10 pl0 js-readcube-pdf" data-article-pdf data-draft-ignore=true data-track=click data-track-source=pdf data-track-dest=link:PDF data-track-dl=51><span class="inline-block icon icon-left icon-tools-pdf-16x16-color pl20">PDF</span></a><div class="popup background-white pa30 pt20 hide readcube-popover" id=readcube-popover data-container-type=article><h2 class="h3 sans-serif strong small-space-below tighten-line-height">The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway</h2><ul class="clean-list ma0 grid grid-12 text-center text13" data-container-type=article data-container-section=readcube-popover><li class="grid grid-6"><a href=/articles/ncomms12700.pdf class="block icon icon-pdf-80x80-color border-gray-light border-all-1 pb10" data-track=click data-track-source=pdf data-track-dest="link:Download as PDF">Download as PDF</a><li class="grid grid-6 last"><a href=http://readcube.com/view/10.1038/ncomms12700 class="block icon icon-readcube-80x80-color border-gray-light border-all-1 pb10" data-track=click data-track-source=readcube data-track-dest="link:View interactive PDF in Readcube">View interactive PDF in ReadCube</a></ul></div><li class="pin-left mr4 mq875-hide position-relative z-index-2"><a href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700&amp;t=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway" class="inline-block block-link pa10 pl0" data-track=click data-track-source=share-on-facebook data-track-dest=link:facebook><span class="inline-block icon icon-left icon-facebook-16x16-color pl20">Share<span class=visually-hidden> on Facebook</span></span></a><li class="pin-left mr4 mq875-hide position-relative z-index-2"><a href="http://twitter.com/home/?status=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway+http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700" class="inline-block block-link pa10 pl0" data-track=click data-track-source=share-on-twitter data-track-dest=link:twitter><span class="inline-block icon icon-left icon-twitter-16x16-color pl20">Share<span class=visually-hidden> on Twitter</span></span></a><li class="pin-left position-relative"><a href=#tools class="inline-block block-link pa10 background-white position-relative z-index-50" data-tools-link data-track=click data-track-source=more-tools data-track-dest=link:more data-track-dl=51><span class="inline-block position-relative icon icon-right pr20 icon-arrow-down-12x7-blue icon-rotate">Tools</span></a></ul></div><div id=tools class="js-hide standard-space-below tools-shadow tools-popup"><div class="cleared border-gray-medium border-all-1 background-white pa20"><h3 class="text13 text-gray-light strong upper sans-serif small-space-below">Tools</h3><ul class="clean-list ie11-list-hack text13 standard-space-below tighten-line-height"><li class="hide mq640-show small-space-below"><a href=/articles/ncomms12700.pdf class="inline-block icon icon-left icon-tools-pdf-16x16-color pl20 js-readcube-pdf" data-draft-ignore=true data-track=click data-track-source=pdf data-track-dest=link:PDF data-track-dl=51>PDF</a><li class=small-space-below><a href="https://s100.copyright.com/AppDispatchServlet?author=M%C3%A9lissa%20Carbonneau%2C%20Laurence%20M.%20Gagn%C3%A9%2C%20Marie-Eve%20Lalonde%2C%20Marie-Anne%20Germain%2C%20Alena%20Motorina%20et%20al.&amp;cc=by&amp;contentID=10.1038%2Fncomms12700&amp;issueNum&amp;publication=Nature%20Communications&amp;publicationDate=2016-09-14&amp;publisherName=NPG&amp;title=The%20oncometabolite%202-hydroxyglutarate%20activates%20the%20mTOR%20signalling%20pathway&amp;volumeNum=7" class="inline-block icon icon-left icon-tools-rights-16x16-blue pl20" data-track=click data-track-source=rights data-track-dest="link:Rights &amp; permissions">Rights &amp; permissions</a><li class="hide js-show small-space-below"><a href=javascript:window.print(); class="inline-block icon icon-left icon-tools-print-16x16-blue pl20" data-track=click data-track-source=print data-track-dest=link:Print data-track-dl=51>Print</a></ul><h3 class="text13 text-gray-light strong upper sans-serif small-space-below clear">Share</h3><ul class="clean-list ie11-list-hack text13 small-space-below tighten-line-height"><li class="pin-left grid-1of2 small-space-below hide mq875-show header-tools-show"><a href="http://twitter.com/home/?status=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway+http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700" data-track=click data-track-source=share-on-twitter data-track-dest=link:twitter class="inline-block icon icon-left icon-twitter-16x16-color pl20">Twitter</a><li class="pin-left grid-1of2 small-space-below hide mq875-show header-tools-show"><a href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700&amp;t=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway" data-track=click data-track-source=share-on-facebook data-track-dest=link:facebook class="inline-block icon icon-left icon-facebook-16x16-color pl20">Facebook</a><li class="pin-left grid-1of2 small-space-below"><a href="http://digg.com/submit?phase=2&amp;url=http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700&amp;title=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway" data-track=click data-track-source=share-on-digg data-track-dest=link:digg class="inline-block icon icon-left icon-digg-16x16-color pl20">Digg</a><li class="pin-left grid-1of2 small-space-below"><a href="https://plus.google.com/share?hl=en&amp;url=http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700&amp;title=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway" data-track=click data-track-source=share-on-googleplus data-track-dest=link:googleplus class="inline-block icon icon-left icon-googleplus-16x16-color pl20">Google+</a><li class="pin-left grid-1of2 small-space-below"><a href="http://www.linkedin.com/cws/share?url=http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700&amp;title=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway" data-track=click data-track-source=share-on-linkedin data-track-dest=link:linkedin class="inline-block icon icon-left icon-linkedin-16x16-color pl20">LinkedIn</a><li class="pin-left grid-1of2 small-space-below"><a href=http://www.reddit.com/s/http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700 data-track=click data-track-source=share-on-reddit data-track-dest=link:reddit class="inline-block icon icon-left icon-reddit-16x16-color pl20">Reddit</a><li class="pin-left grid-1of2 small-space-below"><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700&amp;title=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway" data-track=click data-track-source=share-on-stumbleupon data-track-dest=link:stumbleupon class="inline-block icon icon-left icon-stumbleupon-16x16-color pl20">StumbleUpon</a><li class="pin-left grid-1of2 small-space-below"><a href="http://www.citeulike.org/posturl2?username=&amp;url=http%3A%2F%2Fwww.nature.com%2Farticles%2Fncomms12700&amp;title=The+oncometabolite+2-hydroxyglutarate+activates+the+mTOR+signalling+pathway&amp;rewrite=yes" data-track=click data-track-source=share-on-citeulike data-track-dest=link:citeulike class="inline-block icon icon-left icon-citeulike-16x16-color pl20">CiteULike</a></ul></div></div>
                        

                        
                        
                        
                        
                        <div class="clear cleared" data-component="reading-companion-placeholder">
                            <div class="animate-width" data-component="reading-companion-sticky">
                                
                            </div>
                        </div>
                    </div>
                </div>

                <div class="grid grid-4 mq875-grid-12 pb30 last">
                    
    <div id="div-gpt-ad-right-2"
         class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide hide-overflow"
         data-gpt-unitpath="/285/nature_communications/article"
         data-gpt-sizes="300x250"
         data-gpt-targeting="template=mosaic;pos=right;abr=!webtv;tile=2;artid=ncomms12700">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/nature_communications/article&amp;sz=300x250&amp;tile=2&amp;c=1118562975&amp;t=template%3Dmosaic%26pos%3Dright%26abr%3D%21webtv%26tile%3D2%26artid%3Dncomms12700">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/nature_communications/article&amp;sz=300x250&amp;tile=2&amp;c=1118562975&amp;t=template%3Dmosaic%26pos%3Dright%26abr%3D%21webtv%26tile%3D2%26artid%3Dncomms12700"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                </div>
            </article>
        </div>
    </div>
</div>

<div class="js-header-menu menu mb20 z-index-50 composite-layer background-gray-light animate-opacity-top tighten-line-height" id="menu">
    <div class="menu-inner js-hide">
        <nav>
            <h3 class="visually-hidden">Menu</h3>
            <div class="nav-border">
                <div class="background-gradient-brand-secondary-tertiary">
                    <div class="content table grid-12 box-sizing pl20 menu-row">
                        <div class="table-row" data-test="menu-row-branded">
                            <div class="background-brand-secondary grid-1of5 table-cell v-middle menu-cell mq875-hide">
                                <h2 class="h3 pt20 pb20 pr20 mt6 mb6">
                                    <a href="/ncomms" data-track="click" data-track-source="menu-group" data-track-dest="link:Nature Communications">Nature Communications</a>
                                </h2>
                            </div>
                            
    
        <div class="background-brand-tertiary grid-4of5 table-cell v-middle menu-cell mq875-grid-12 mq875-block">
            <ul class="cleared clean-list horizontal-list text13 ma20">
                
                    <li class="pr30">
                        <a href="/ncomms/articles" data-track="click" data-track-source="menu-item"
                           data-track-dest="link:Browse Articles">Browse Articles</a>
                    </li>
                
                    <li class="pr30">
                        <a href="/ncomms/browse-subjects" data-track="click" data-track-source="menu-item"
                           data-track-dest="link:Browse Subjects">Browse Subjects</a>
                    </li>
                
                    <li class="pr30">
                        <a href="/ncomms/about" data-track="click" data-track-source="menu-item"
                           data-track-dest="link:About the journal">About the journal</a>
                    </li>
                
                    <li class="pr30">
                        <a href="/ncomms/submit" data-track="click" data-track-source="menu-item"
                           data-track-dest="link:Submit">Submit</a>
                    </li>
                
                    <li class="pr30">
                        <a href="/ncomms/journal-policies" data-track="click" data-track-source="menu-item"
                           data-track-dest="link:Journal policies">Journal policies</a>
                    </li>
                
                    <li class="pr30">
                        <a href="/ncomms/contact" data-track="click" data-track-source="menu-item"
                           data-track-dest="link:Contact">Contact</a>
                    </li>
                
            </ul>
        </div>
    

                        </div>
                    </div>
                </div>
            </div>

            <div>
                <div class="background-gradient-brand-gray">
                    <div class="content table grid-12 box-sizing pl20 menu-row">
                        <div class="table-row" data-test="menu-row">
                            <div class="background-gray-medium grid-1of5 table-cell v-middle menu-cell mq875-grid-12 mq875-block">
                                <h2 class="h3 pt20 pb20 pr20 mt6 mb6">
                                    <a href="/siteindex" class="js-mq875-hide" data-track="click" data-track-source="menu-group" data-track-dest="link:Journals A-Z">Journals A-Z</a>
                                        <a class="js-accordion-toggle hide js-mq875-show-inline">Journals A-Z<span class="position-relative icon icon-right icon-arrow-down-12x7-gray icon-rotate pr20"></span></a>
                                </h2>
                            </div>
                            <div class="background-gray-light grid-4of5 table-cell v-middle menu-cell js-mq875-hide mq875-grid-12 mq875-block">
                                <ul class="cleared clean-list horizontal-list text13 ma20">
                                    <li class="pr30">
                                        <a href="/nature" data-track="click" data-track-source="menu-item" data-track-dest="link:Nature">Nature</a>
                                    </li>
                                    <li class="pr30">
                                        <a href="/ncomms" data-track="click" data-track-source="menu-item" data-track-dest="link:Nature Communications">Nature Communications</a>
                                    </li>
                                    <li class="pr30">
                                        <a href="/nprot" data-track="click" data-track-source="menu-item" data-track-dest="link:Nature Protocols">Nature Protocols</a>
                                    </li>
                                    <li class="pr30">
                                        <a href="/reviews" data-track="click" data-track-source="menu-item" data-track-dest="link:Review journals">Review journals</a>
                                    </li>
                                    <li class="pr30">
                                        <a href="/srep" data-track="click" data-track-source="menu-item" data-track-dest="link:Scientific Reports">Scientific Reports</a>
                                    </li>
                                    <li class="pr30">
                                        <a href="/siteindex" class="right-arrow strong" data-track="click" data-track-source="view-all" data-track-dest="link:Journals A-Z">View all</a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div>
                <div class="background-gradient-brand-gray">
                    <div class="content table grid-12 box-sizing pl20 menu-row">
                        <div class="table-row" data-test="menu-row">
                            <div class="background-gray-medium grid-1of5 table-cell v-middle menu-cell mq875-grid-12 mq875-block">
                                <h2 class="h3 pt20 pb20 pr20 mt6 mb6">
                                    <a href="/siteindex" class="js-mq875-hide" data-track="click" data-track-source="menu-group" data-track-dest="link:All Subjects">All Subjects</a>
                                    <a class="js-accordion-toggle hide js-mq875-show-inline">All Subjects<span class="position-relative icon icon-right icon-arrow-down-12x7-gray icon-rotate pr20"></span></a>
                                </h2>
                            </div>
                            <div class="background-gray-light grid-4of5 table-cell v-middle menu-cell js-mq875-hide mq875-grid-12 mq875-block">
                                <ul class="cleared clean-list horizontal-list text13 ma20">
                                    <li class="pr30">
                                        <a href="/subjects/biological-sciences" data-track="click" data-track-source="menu-item" data-track-dest="link:Biological Sciences">Biological Sciences</a>
                                    </li>
                                    <li class="pr30">
                                            <a href="/subjects/earth-and-environmental-sciences" data-track="click" data-track-source="menu-item" data-track-dest="link:Earth &amp; Environmental Sciences">Earth &amp; Environmental Sciences</a>
                                    </li>
                                    <li class="pr30">
                                        <a href="/subjects/health-sciences" data-track="click" data-track-source="menu-item" data-track-dest="link:Health Sciences">Health Sciences</a>
                                    </li>
                                    <li class="pr30">
                                        <a href="/subjects/physical-sciences" data-track="click" data-track-source="menu-item" data-track-dest="link:Physical Sciences">Physical Sciences</a>
                                    </li>
                                    <li class="pr30">
                                            <a href="/subjects/scientific-community-and-society" data-track="click" data-track-source="menu-item" data-track-dest="link:Scientific Community &amp; Society">Scientific Community &amp; Society</a>
                                    </li>
                                    <li class="pr30">
                                        <a href="/subjects" class="right-arrow strong" data-track="click" data-track-source="view-all" data-track-dest="link:All Subjects">View all</a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div>
                <div class="background-gradient-brand-gray">
                    <div class="content table grid-12 box-sizing pl20 menu-row">
                        <div class="table-row" data-test="menu-row">
                            <div class="background-gray-medium grid-1of5 table-cell v-middle menu-cell mq875-grid-12 mq875-block">
                                <h2 class="h3 pt20 pb20 pr20 mt6 mb6">
                                    <a href="/" class="js-mq875-hide" data-track="click" data-track-source="menu-group" data-track-dest="link:nature.com">nature.com</a>
                                    <a class="js-accordion-toggle hide js-mq875-show-inline">nature.com<span class="position-relative icon icon-right icon-arrow-down-12x7-gray icon-rotate pr20"></span></a>
                                </h2>
                            </div>
                            <div class="background-gray-light grid-4of5 table-cell v-middle menu-cell js-mq875-hide mq875-grid-12 mq875-block">
                                <ul class="cleared clean-list horizontal-list text13 ma20">
                                    <li class="pr30">
                                            <a href="/subscriptions/index.html" data-track="click" data-track-source="menu-item" data-track-dest="link:Subscriptions">Subscriptions</a>
                                    </li>
                                    <li class="pr30">
                                           <a href="/authors/index.html" data-track="click" data-track-source="menu-item" data-track-dest="link:Authors &amp; Referees">Authors &amp; Referees</a>
                                    </li>
                                    <li class="pr30">
                                            <a href="/libraries/index.html" data-track="click" data-track-source="menu-item" data-track-dest="link:Librarians">Librarians</a>
                                    </li>
                                    <li class="pr30">
                                            <a href="/advertising/index.html" data-track="click" data-track-source="menu-item" data-track-dest="link:Advertisers">Advertisers</a>
                                    </li>
                                    <li class="pr30">
                                            <a href="/npg_/press_room/index.html" data-track="click" data-track-source="menu-item" data-track-dest="link:Press">Press</a>
                                    </li>
                                    <li class="pr30">
                                            <a href="/npg_/index_npg.html" data-track="click" data-track-source="menu-item" data-track-dest="link:About">About</a>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </nav>
    </div>
</div>

<div id="search-menu" class="menu pt20 mb20 z-index-50 composite-layer background-white animate-opacity-top" data-component="tray">
    <div class="menu-inner js-hide">
        <section>
            <h2 class="visually-hidden">Search</h2>
            <div class="hide-print content mb40 mq1200-padded position-relative" data-test="inline-search">
                <div class="pb30 pt30 cleared background-white">
                    <div class="grid grid-8 grid-left-2 mq875-grid-12 mq875-ml0 mq640-pb30">
                        <form action="/search" method="get" role="search" autocomplete="off" class="mq875-pr20 mq875-pl20" data-track="submit" data-track-source="search-submit" data-track-dest-fields="q">
                            <div class="position-relative">
                                <div class="background-gray-medium cleared">
                                    <div class="search-input-box background-white cleared">
                                        <div class="search-input-layout pin-left grid-12">
                                            <div class="search-input-field pr4 serif">
                                                <label for="keywords" class="visually-hidden">Search Nature.com</label>
                                                <input type="search" id="keywords" class="serif" name="q" value="" placeholder="Search Nature.com" data-test="search-keywords" />
                                            </div>
                                        </div>
                                        <span class="search-input-suffix inline-block text13 equalize-line-height text-right">
                                            <span class="search-input-suffix-inner block">
                                                <a href="/search/advanced" data-test="search-suffix-link" class="color-blue" data-track="click" data-track-source="search-menu" data-track-dest="link:/search/advanced" data-track-dl="1">advanced</a>
                                            </span>
                                        </span>
                                    </div>
                                </div>
                                <div class="position-absolute search-input-btn">
                                    <button type="submit" class="icon icon-center search-btn" data-test="search-submit">
                                        Search
                                    </button>
                                </div>
                            </div>
                        </form>
                    </div>
                </div>
            </div>
        </section>
    </div>
</div>


<footer>
    <div class="content mq1200-padded mt70 mb30 cleared" itemscope itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        <div class="grid grid-12 last clear-float cleared mb15 text-gray-light text13 flex-box flex-wrap-reverse">
            <h2 aria-level="2" class="text13 strong emphasis ma0 sans-serif" itemprop="name">Nature Communications</h2>
            <p class="pt0 pr10 pb0 pl10 ma0"><abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">2041-1723</span> (online)</p>
            
        </div>

        <hr class="separator mb30">

        <div class="grid grid-12 last">
    <h2 aria-level="2" class="hide">nature.com sitemap</h2>

    <div class="cleared z-index-1 text13 hide-print">
        <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb20">
            <h3 class="h4">For authors and referees</h3>
            <ul class="clean-list ma0 mt10 mb6">
                <li class="pb4"><a href="https://www.nature.com/authors/index.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Guide to Authors">Guide to Authors</a></li>
                <li class="pb4"><a href="https://www.nature.com/authors/peer_review/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Guide to Referees">Guide to Referees</a></li>
                <li class="pb4"><a href="https://www.nature.com/authors/editorial_policies/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Editorial policies">Editorial policies</a></li>
                <li class="pb4"><a href="https://authorservices.springernature.com/language-editing/?utm_source=natureAuthors&amp;utm_medium=referral&amp;utm_campaign=natureAuthors"
                       data-track="click" data-track-source="sitemap-item" data-track-dest="link:Language editing">Language editing</a></li>
                <li class="pb4"><a href="https://authorservices.springernature.com/scientific-editing/?utm_source=natureAuthors&amp;utm_medium=referral&amp;utm_campaign=natureAuthors"
                       data-track="click" data-track-source="sitemap-item" data-track-dest="link:Scientific editing">Scientific editing</a></li>
                <li class="pb4" ><a href="https://www.nature.com/reprints/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Reprints &amp; permissions">Reprints &amp;
                    permissions</a></li>
            </ul>
        </div>
        <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb20 just-mq640-last">
            <h3 class="h4">For readers</h3>
            <ul class="clean-list ma0 mt10 mb6">
                <li class="pb4"><a href="https://www.nature.com/siteindex/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Journals A-Z">Journals A-Z</a></li>
                <li class="pb4"><a href="https://www.nature.com/browse/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Subject Pages">Subject Pages</a></li>
                <li class="pb4"><a href="https://www.nature.com/protocolexchange/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Protocol Exchange">Protocol Exchange</a></li>
                <li class="pb4"><a href="https://blogs.nature.com" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Blogs">Blogs</a></li>
                <li class="pb4"><a href="https://www.nature.com/nature/podcast/index.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Podcasts">Podcasts</a></li>
                <li class="pb4"><a href="https://www.nature.com/webcasts/index.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Webcasts">Webcasts</a></li>
                <li class="pb4"><a href="https://secure.nature.com/subscribe/nature" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Subscriptions">Subscriptions</a></li>
                <li class="pb4"><a href="https://www.nature.com/mobile" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Mobile apps">Mobile apps</a></li>
                <li class="pb4"><a href="https://www.nature.com/webfeeds/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:RSS">RSS</a></li>
            </ul>
        </div>
        <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb20 just-mq875-last">
            <h3 class="h4">For librarians</h3>
            <ul class="clean-list ma0 mt10 mb6">
                <li class="pb4"><a href="https://www.springernature.com/gp/librarians/manage-your-account" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Account administration">Account administration</a></li>
                <li class="pb4"><a href="https://www.springernature.com/gp/librarians/licensing" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Site licenses">Site licenses</a></li>
                <li class="pb4"><a href="https://www.nature.com/libraries/catalog/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Catalogs">Catalogs</a></li>
                <li class="pb4"><a href="https://www.nature.com/libraries/print_subscription/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Print subscriptions">Print subscriptions</a></li>
                <li class="pb4"><a href="https://www.springernature.com/gp/librarians/licensing" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Pay per view">Pay per view</a></li>
                <li class="pb4"><a href="https://www.nature.com/libraries/open_access/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Open access">Open access</a></li>
                <li class="pb4"><a href="https://www.springernature.com/gp/librarians/tools-services/promote-your-content" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Promotion tools">Promotion tools</a></li>
                <li class="pb4"><a href="https://www.nature.com/libraries/public_interfaces/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Public interfaces">Public interfaces</a></li>
                <li class="pb4"><a href="https://www.springernature.com/gp/librarians/tools-services/promote-your-content/user-guides" data-track="click" data-track-source="sitemap-item" data-track-dest="link:User guides">User guides</a> </li>
                <li class="pb4"><a href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Library relations">Library relations</a></li>
                <li class="pb4"><a href="https://www.springernature.com/gp/librarians/manage-your-account/discovery" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Publisher collaborations">Publisher collaborations</a></li>
            </ul>
        </div>
        <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb20 just-mq640-last full-size-last just-mq1200-last just-mq480-last">
            <h3 class="h4">Careers and events</h3>
            <ul class="clean-list ma0 mt10 mb6">
              <li class="pb4"><a href="https://www.nature.com/natureconferences/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Natureconferences">Natureconferences</a></li>
              <li class="pb4"><a href="https://www.nature.com/natureevents/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Natureevents">Natureevents</a></li>
              <li class="pb4"><a href="https://www.nature.com/naturejobs/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Naturejobs.com">Naturejobs.com</a></li>
            </ul>
        </div>
        <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb20">
            <h3 class="h4">Regional websites</h3>
            <ul class="clean-list ma0 mt10 mb6">
                <li class="pb4"><a href="https://www.natureasia.com/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Natureasia">Natureasia</a></li>
                <li class="pb4"><a href="https://www.nature.com/nchina/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Nature China (International site)">Nature China (International site)</a></li>
                <li class="pb4"><a href="https://www.nature.com/nindia" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Nature India">Nature India</a></li>
                <li class="pb4"><a href="https://www.natureasia.com/ja-jp/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Nature Japan">Nature Japan</a></li>
                <li class="pb4"><a href="https://www.natureasia.com/ko-kr/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Nature Korea">Nature Korea</a></li>
                <li class="pb4"><a href="https://www.nature.com/nmiddleeast/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Nature Middle East">Nature Middle
                    East</a></li>
            </ul>
        </div>
        <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb20 just-mq640-last just-mq875-last">
            <h3 class="h4">Nature Research</h3>
            <ul class="clean-list ma0 mt10 mb6">
              <li class="pb4"><a href="https://www.nature.com/npg_/index_npg.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:About us">About us</a></li>
              <li class="pb4"><a href="https://www.nature.com/npg_/work" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Work for us">Work for us</a></li>
              <li class="pb4"><a href="https://www.nature.com/help/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Help">Help</a></li>
              <li class="pb4"><a href="https://www.nature.com/npg_/contact/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Contact us">Contact us</a></li>
              <li class="pb4"><a href="https://www.nature.com/info/privacy.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Privacy Policy">Privacy Policy</a></li>
              <li class="pb4"><a href="https://www.nature.com/info/cookies.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Use of cookies">Use of cookies</a></li>
              <li class="pb4"><a href="https://www.nature.com/info/legal_notice.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Legal notice">Legal notice</a></li>
              <li class="pb4"><a href="https://www.nature.com/info/accessibility_statement.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Accessibility statement">Accessibility statement</a></li>
              <li class="pb4"><a href="https://www.nature.com/info/tandc.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Terms &amp; Conditions">Terms &amp; Conditions</a></li>
              <li class="pb4"><a href="https://www.nature.com/info/partners.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Partners">Partners</a></li>
            </ul>
        </div>
        <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb20">
            <h3 class="h4">For advertisers</h3>
            <ul class="clean-list ma0 mt10 mb6">
                <li class="pb4"><a href="https://www.nature.com/advertising" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Advertising options">Advertising
                    options</a></li>
                <li class="pb4"><a href="https://www.nature.com/advertising/audience" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Journal audience">Journal
                    audience</a></li>
                <li class="pb4"><a href="https://www.nature.com/natureevents/science/organizers" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Event advertising">Event advertising</a></li>
                <li class="pb4"><a href="https://www.nature.com/naturejobs/science/orders/new" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Job posts">Job posts</a></li>
                <li class="pb4"><a href="https://www.nature.com/advertising/contact" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Contact representative">Contact
                    representative</a></li>
            </ul>
        </div>
        <div class="grid grid-3 mq875-grid-4 mq640-grid-6 mq480-grid-12 mb20 just-mq640-last full-size-last just-mq1200-last just-mq480-last">
            <h3 class="h4">For press</h3>
            <ul class="clean-list ma0 mt10 mb6">
                <li class="pb4"><a href="http://press.nature.com/" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Press site">Press site</a></li>
                <li class="pb4"><a href="https://www.nature.com/npg_/press_room/index.html" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Press room">Press room</a></li>
                <li class="pb4"><a href="http://press.nature.com/contact-us" data-track="click" data-track-source="sitemap-item" data-track-dest="link:Contact press office">Contact press office</a></li>
            </ul>
        </div>
    </div>
    <div class="grid grid-12 last mb30">
        <img src="/static/images/sn-logo.4368f3b1.svg" alt="Springer Nature"/>
        <small class="block pt15 pb6 ma0 text-gray-light text11">© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.</small>
    </div>
</div>


    </div>
</footer>

<script>var readingCompanionData = {"sections":[{"id":"abstract","title":"Abstract"},{"id":"introduction","title":"Introduction"},{"id":"results","title":"Results"},{"id":"discussion","title":"Discussion"},{"id":"methods","title":"Methods"},{"id":"additional-information","title":"Additional information"},{"id":"references","title":"References"},{"id":"acknowledgements","title":"Acknowledgements"},{"id":"author-information","title":"Author information"},{"id":"supplementary-information","title":"Supplementary information"},{"id":"comments","title":"Comments","extraClass":"hide"}],"figures":[{"num":1,"imagePaths":["//images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f1.jpg"],"title":"Activation of mTOR signalling by 2HG-producing IDH1/2 gain-of-function mutations.","link":"/articles/ncomms12700/figures/1"},{"num":2,"imagePaths":["//images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f2.jpg"],"title":"Targeted-siRNA screen reveals KDM4A as an α-KG-dependent enzyme modulating mTOR activity.","link":"/articles/ncomms12700/figures/2"},{"num":3,"imagePaths":["//images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f3.jpg"],"title":"KDM4A interacts with the mTORC1/2 complex.","link":"/articles/ncomms12700/figures/3"},{"num":4,"imagePaths":["//images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f4.jpg"],"title":"Functional implication of IDH1/2 mutations in central neuron system-derived cells.","link":"/articles/ncomms12700/figures/4"},{"num":5,"imagePaths":["//images.nature.com/m685/nature-assets/ncomms/2016/160914/ncomms12700/images/ncomms12700-f5.jpg"],"title":"Non-canonical regulation of mTOR activity by 2HG-mediated inhibition of KDM4A.","link":"/articles/ncomms12700/figures/5"}],"references":[{"id":"1","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Hanahan, D.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Weinberg, R. A.</span></span> <cite>Hallmarks of cancer: the next generation</cite>. <i>Cell</i> <b>144</b>, <span>646</span>–<span>674</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"2","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Yan, H.</span></span> <i>et al.</i> <cite>IDH1 and IDH2 mutations in gliomas</cite>. <i>N. Engl. J. Med.</i> <b>360</b>, <span>765</span>–<span>773</span> (<span>2009</span>).</span>","schemaType":"Article"},{"id":"3","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Mardis, E. R.</span></span> <i>et al.</i> <cite>Recurring mutations found by sequencing an acute myeloid leukemia genome</cite>. <i>N. Engl. J. Med.</i> <b>361</b>, <span>1058</span>–<span>1066</span> (<span>2009</span>).</span>","schemaType":"Article"},{"id":"4","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Dang, L.</span></span> <i>et al.</i> <cite>Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</cite>. <i>Nature</i> <b>462</b>, <span>739</span>–<span>744</span> (<span>2009</span>).</span>","schemaType":"Article"},{"id":"5","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Ward, P. S.</span></span> <i>et al.</i> <cite>The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate</cite>. <i>Cancer Cell</i> <b>17</b>, <span>225</span>–<span>234</span> (<span>2010</span>).</span>","schemaType":"Article"},{"id":"6","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Xu, W.</span></span> <i>et al.</i> <cite>Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases</cite>. <i>Cancer Cell</i> <b>19</b>, <span>17</span>–<span>30</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"7","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Chowdhury, R.</span></span> <i>et al.</i> <cite>The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases</cite>. <i>EMBO Rep.</i> <b>12</b>, <span>463</span>–<span>469</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"8","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Tsukada, Y.</span></span> <i>et al.</i> <cite>Histone demethylation by a family of JmjC domain-containing proteins</cite>. <i>Nature</i> <b>439</b>, <span>811</span>–<span>816</span> (<span>2006</span>).</span>","schemaType":"Article"},{"id":"9","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Whetstine, J. R.</span></span> <i>et al.</i> <cite>Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases</cite>. <i>Cell</i> <b>125</b>, <span>467</span>–<span>481</span> (<span>2006</span>).</span>","schemaType":"Article"},{"id":"10","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Katoh, M.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Katoh, M.</span></span> <cite>Identification and characterization of JMJD2 family genes in silico</cite>. <i>Int. J. Oncol.</i> <b>24</b>, <span>1623</span>–<span>1628</span> (<span>2004</span>).</span>","schemaType":"Article"},{"id":"11","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Kim, J.</span></span> <i>et al.</i> <cite>Tudor, MBT and chromo domains gauge the degree of lysine methylation</cite>. <i>EMBO Rep.</i> <b>7</b>, <span>397</span>–<span>403</span> (<span>2006</span>).</span>","schemaType":"Article"},{"id":"12","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Black, J. C.</span></span> <i>et al.</i> <cite>Conserved antagonism between JMJD2A/KDM4A and HP1gamma during cell cycle progression</cite>. <i>Mol. Cell</i> <b>40</b>, <span>736</span>–<span>748</span> (<span>2010</span>).</span>","schemaType":"Article"},{"id":"13","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Mallette, F. A.</span></span> <i>et al.</i> <cite>RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites</cite>. <i>EMBO J.</i> <b>31</b>, <span>1865</span>–<span>1878</span> (<span>2012</span>).</span>","schemaType":"Article"},{"id":"14","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Mallette, F. A.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Richard, S.</span></span> <cite>JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5</cite>. <i>Cell Rep.</i> <b>2</b>, <span>1233</span>–<span>1243</span> (<span>2012</span>).</span>","schemaType":"Article"},{"id":"15","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Hara, K.</span></span> <i>et al.</i> <cite>Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action</cite>. <i>Cell</i> <b>110</b>, <span>177</span>–<span>189</span> (<span>2002</span>).</span>","schemaType":"Article"},{"id":"16","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Kim, D. H.</span></span> <i>et al.</i> <cite>mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery</cite>. <i>Cell</i> <b>110</b>, <span>163</span>–<span>175</span> (<span>2002</span>).</span>","schemaType":"Article"},{"id":"17","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Jacinto, E.</span></span> <i>et al.</i> <cite>Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</cite>. <i>Nat. Cell Biol.</i> <b>6</b>, <span>1122</span>–<span>1128</span> (<span>2004</span>).</span>","schemaType":"Article"},{"id":"18","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Sarbassov, D. D.</span></span> <i>et al.</i> <cite>Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton</cite>. <i>Curr. Biol.</i> <b>14</b>, <span>1296</span>–<span>1302</span> (<span>2004</span>).</span>","schemaType":"Article"},{"id":"19","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Sancak, Y.</span></span> <i>et al.</i> <cite>PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase</cite>. <i>Mol. Cell</i> <b>25</b>, <span>903</span>–<span>915</span> (<span>2007</span>).</span>","schemaType":"Article"},{"id":"20","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Vander Haar, E.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Lee, S. I.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Bandhakavi, S.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Griffin, T. J.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Kim, D. H.</span></span> <cite>Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40</cite>. <i>Nat. Cell Biol.</i> <b>9</b>, <span>316</span>–<span>323</span> (<span>2007</span>).</span>","schemaType":"Article"},{"id":"21","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Frias, M. A.</span></span> <i>et al.</i> <cite>mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s</cite>. <i>Curr. Biol.</i> <b>16</b>, <span>1865</span>–<span>1870</span> (<span>2006</span>).</span>","schemaType":"Article"},{"id":"22","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Pearce, L. R.</span></span> <i>et al.</i> <cite>Identification of Protor as a novel Rictor-binding component of mTOR complex-2</cite>. <i>Biochem. J.</i> <b>405</b>, <span>513</span>–<span>522</span> (<span>2007</span>).</span>","schemaType":"Article"},{"id":"23","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Kim, D. H.</span></span> <i>et al.</i> <cite>GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR</cite>. <i>Mol. Cell</i> <b>11</b>, <span>895</span>–<span>904</span> (<span>2003</span>).</span>","schemaType":"Article"},{"id":"24","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Peterson, T. R.</span></span> <i>et al.</i> <cite>DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival</cite>. <i>Cell</i> <b>137</b>, <span>873</span>–<span>886</span> (<span>2009</span>).</span>","schemaType":"Article"},{"id":"25","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Laplante, M.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Sabatini, D. M.</span></span> <cite>mTOR signaling in growth control and disease</cite>. <i>Cell</i> <b>149</b>, <span>274</span>–<span>293</span> (<span>2012</span>).</span>","schemaType":"Article"},{"id":"26","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Gao, D.</span></span> <i>et al.</i> <cite>mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR</cite>. <i>Mol. Cell</i> <b>44</b>, <span>290</span>–<span>303</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"27","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Duan, S.</span></span> <i>et al.</i> <cite>mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR</cite>. <i>Mol. Cell</i> <b>44</b>, <span>317</span>–<span>324</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"28","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Zhao, Y.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Xiong, X.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Sun, Y.</span></span> <cite>DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy</cite>. <i>Mol. Cell</i> <b>44</b>, <span>304</span>–<span>316</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"29","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Ohgaki, H.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Kleihues, P.</span></span> <cite>Genetic profile of astrocytic and oligodendroglial gliomas</cite>. <i>Brain Tumor Pathol.</i> <b>28</b>, <span>177</span>–<span>183</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"30","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Liu, X. Y.</span></span> <i>et al.</i> <cite>Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations</cite>. <i>Acta Neuropathol.</i> <b>124</b>, <span>615</span>–<span>625</span> (<span>2012</span>).</span>","schemaType":"Article"},{"id":"31","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Pollack, I. F.</span></span> <i>et al.</i> <cite>IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group</cite>. <i>Childs Nerv. Syst.</i> <b>27</b>, <span>87</span>–<span>94</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"32","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Chin, R. M.</span></span> <i>et al.</i> <cite>The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR</cite>. <i>Nature</i> <b>510</b>, <span>397</span>–<span>401</span> (<span>2014</span>).</span>","schemaType":"Article"},{"id":"33","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Duran, R. V.</span></span> <i>et al.</i> <cite>Glutaminolysis activates Rag-mTORC1 signaling</cite>. <i>Mol. Cell</i> <b>47</b>, <span>349</span>–<span>358</span> (<span>2012</span>).</span>","schemaType":"Article"},{"id":"34","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Lorin, S.</span></span> <i>et al.</i> <cite>Glutamate dehydrogenase contributes to leucine sensing in the regulation of autophagy</cite>. <i>Autophagy</i> <b>9</b>, <span>850</span>–<span>860</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"35","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Marino, G.</span></span> <i>et al.</i> <cite>Regulation of autophagy by cytosolic acetyl-coenzyme A</cite>. <i>Mol. Cell</i> <b>53</b>, <span>710</span>–<span>725</span> (<span>2014</span>).</span>","schemaType":"Article"},{"id":"36","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Fingar, D. C.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Salama, S.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Tsou, C.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Harlow, E.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Blenis, J.</span></span> <cite>Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E</cite>. <i>Genes Dev.</i> <b>16</b>, <span>1472</span>–<span>1487</span> (<span>2002</span>).</span>","schemaType":"Article"},{"id":"37","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Rohle, D.</span></span> <i>et al.</i> <cite>An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells</cite>. <i>Science</i> <b>340</b>, <span>626</span>–<span>630</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"38","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Lu, C.</span></span> <i>et al.</i> <cite>IDH mutation impairs histone demethylation and results in a block to cell differentiation</cite>. <i>Nature</i> <b>483</b>, <span>474</span>–<span>478</span> (<span>2012</span>).</span>","schemaType":"Article"},{"id":"39","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Cloos, P. A.</span></span> <i>et al.</i> <cite>The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3</cite>. <i>Nature</i> <b>442</b>, <span>307</span>–<span>311</span> (<span>2006</span>).</span>","schemaType":"Article"},{"id":"40","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Klose, R. J.</span></span> <i>et al.</i> <cite>The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36</cite>. <i>Nature</i> <b>442</b>, <span>312</span>–<span>316</span> (<span>2006</span>).</span>","schemaType":"Article"},{"id":"41","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Shin, S.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Janknecht, R.</span></span> <cite>Diversity within the JMJD2 histone demethylase family</cite>. <i>Biochem. Biophys. Res. Commun.</i> <b>353</b>, <span>973</span>–<span>977</span> (<span>2007</span>).</span>","schemaType":"Article"},{"id":"42","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Johmura, Y.</span></span> <i>et al.</i> <cite>SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence</cite>. <i>Nat. Commun.</i> <b>7</b>, <span>10574</span> (<span>2016</span>).</span>","schemaType":"Article"},{"id":"43","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Neault, M.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Mallette, F. A.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Richard, S.</span></span> <cite>miR-137 modulates a tumor suppressor network-inducing senescence in pancreatic cancer cells</cite>. <i>Cell Rep.</i> <b>14</b>, <span>1966</span>–<span>1978</span> (<span>2016</span>).</span>","schemaType":"Article"},{"id":"44","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Zhang, D.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Yoon, H. G.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Wong, J.</span></span> <cite>JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2)</cite>. <i>Mol. Cell. Biol.</i> <b>25</b>, <span>6404</span>–<span>6414</span> (<span>2005</span>).</span>","schemaType":"Article"},{"id":"45","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Black, J. C.</span></span> <i>et al.</i> <cite>KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors</cite>. <i>Cell</i> <b>154</b>, <span>541</span>–<span>555</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"46","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Jin, J.</span></span> <i>et al.</i> <cite>Noncanonical NF-kappaB pathway controls the production of type I interferons in antiviral innate immunity</cite>. <i>Immunity</i> <b>40</b>, <span>342</span>–<span>354</span> (<span>2014</span>).</span>","schemaType":"Article"},{"id":"47","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Garami, A.</span></span> <i>et al.</i> <cite>Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2</cite>. <i>Mol. Cell</i> <b>11</b>, <span>1457</span>–<span>1466</span> (<span>2003</span>).</span>","schemaType":"Article"},{"id":"48","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Inoki, K.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Li, Y.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Xu, T.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Guan, K. L.</span></span> <cite>Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling</cite>. <i>Genes Dev.</i> <b>17</b>, <span>1829</span>–<span>1834</span> (<span>2003</span>).</span>","schemaType":"Article"},{"id":"49","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Tee, A. R.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Manning, B. D.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Roux, P. P.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Cantley, L. C.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Blenis, J.</span></span> <cite>Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb</cite>. <i>Curr. Biol.</i> <b>13</b>, <span>1259</span>–<span>1268</span> (<span>2003</span>).</span>","schemaType":"Article"},{"id":"50","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Figueroa, M. E.</span></span> <i>et al.</i> <cite>Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</cite>. <i>Cancer Cell</i> <b>18</b>, <span>553</span>–<span>567</span> (<span>2010</span>).</span>","schemaType":"Article"},{"id":"51","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Losman, J. A.</span></span> <i>et al.</i> <cite>(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible</cite>. <i>Science</i> <b>339</b>, <span>1621</span>–<span>1625</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"52","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Choo, A. Y.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Yoon, S. O.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Kim, S. G.</span></span>, <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Roux, P. P.</span></span> &amp; <span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Blenis, J.</span></span> <cite>Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation</cite>. <i>Proc. Natl Acad. Sci. USA</i> <b>105</b>, <span>17414</span>–<span>17419</span> (<span>2008</span>).</span>","schemaType":"Article"},{"id":"53","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Kauffman, E. C.</span></span> <i>et al.</i> <cite>Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer</cite>. <i>Mol. Carcinog.</i> <b>50</b>, <span>931</span>–<span>944</span> (<span>2011</span>).</span>","schemaType":"Article"},{"id":"54","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Morita, M.</span></span> <i>et al.</i> <cite>mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation</cite>. <i>Cell Metab.</i> <b>18</b>, <span>698</span>–<span>711</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"55","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Csibi, A.</span></span> <i>et al.</i> <cite>The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4</cite>. <i>Cell</i> <b>153</b>, <span>840</span>–<span>854</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"56","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Fu, X.</span></span> <i>et al.</i> <cite>2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling</cite>. <i>Cell Metab.</i> <b>22</b>, <span>508</span>–<span>515</span> (<span>2015</span>).</span>","schemaType":"Article"},{"id":"57","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Mallette, F. A.</span></span> <i>et al.</i> <cite>Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence</cite>. <i>Ann. N. Y. Acad. Sci.</i> <b>1197</b>, <span>142</span>–<span>151</span> (<span>2010</span>).</span>","schemaType":"Article"},{"id":"58","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Li, S.</span></span> <i>et al.</i> <cite>Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation</cite>. <i>Neuro Oncol.</i> <b>15</b>, <span>57</span>–<span>68</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"59","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Mamer, O.</span></span> <i>et al.</i> <cite>The complete targeted profile of the organic acid intermediates of the citric acid cycle using a single stable isotope dilution analysis, sodium borodeuteride reduction and selected ion monitoring GC/MS</cite>. <i>Metabolomics</i> <b>9</b>, <span>1019</span>–<span>1030</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"60","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">McGuirk, S.</span></span> <i>et al.</i> <cite>PGC-1alpha supports glutamine metabolism in breast cancer</cite>. <i>Cancer Metab.</i> <b>1</b>, <span>22</span> (<span>2013</span>).</span>","schemaType":"Article"},{"id":"61","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Hutchinson, S. E.</span></span> <i>et al.</i> <cite>Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry</cite>. <i>J. Biomol. Screen.</i> <b>17</b>, <span>39</span>–<span>48</span> (<span>2012</span>).</span>","schemaType":"Article"},{"id":"62","title":"<span><span itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"http://schema.org/Person\"><span itemprop=\"name\">Ng, S. S.</span></span> <i>et al.</i> <cite>Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity</cite>. <i>Nature</i> <b>448</b>, <span>87</span>–<span>91</span> (<span>2007</span>).</span>","schemaType":"Article"}],"hasAccess":true};</script>


<script>
    if ('localStorage' in window) {
        window.SN = window.SN || {};
        window.SN.fontLoader = window.SN.fontLoader || {};
        window.SN.fontLoader.staticFontLocation = "/static/fonts/lora-source-sans-bundle.woff.json";
    }

</script>
<script src="/static/js/mosaic.129e5c52.js"></script>
<script>

    var idp = {
        onProofChanged: function () {
            location.reload()
        },
        hasNatureUserProof: function (hasProof) {
            if (!hasProof) {
                document.getElementById("my-account").setAttribute("style", "display: none;");
                document.getElementById("login-button").setAttribute("style", "");
            }
        }
    }
</script>
<script src="https://verify.nature.com/verify/nature.min.js"></script>
<noscript>
    <img src="https://verify.nature.com/verify/nature.png" alt="" width="0" height="0"/>
    <img alt="" id="DCSIMG" width="1" height="1" src="//statse.webtrendslive.com/dcs0zztfg00000s969s37qoal_2f6z/njs.gif?dcsuri=/nojavascript&amp;WT.js=No&amp;WT.tv=10.2.55">
</noscript>
<script>
    var appendExtraFlagsToLinks = function(params) {
        $('a').filter(function(_, x) {
            var href = $(x).attr('href');
            return href && href.startsWith('/');
        }).each(function(_, x) {
            var $x = $(x);
            var url = new URL('http://temp.com' + $x.attr('href'));
            params.forEach(function(param) {
                url.searchParams.set(param[0], param[1]);
            });
            $x.attr('href', url.pathname + url.search + url.hash);
        });
    };

    var transformNatureAssetSourcesToDraft = function() {
        var regex = /\/nature-assets\//;

        var targets = [['img', 'src'], ['a', 'href']];

        targets.forEach(function(target) {
            $(target[0]).filter(function(_, x) {
                return regex.test($(x).attr(target[1]));
            }).each(function(_, x) {
                var $x = $(x);
                $x.attr(target[1], $x.attr(target[1]).replace('nature-assets', 'nature-assets-draft'));
            });
        });
    };

    if (window.URLSearchParams) {
        var params = new URLSearchParams(location.search.slice(1));
        var proof = params.get('proof');
        var platform = params.get('platform');
        var draft = params.get('draft');
        if (proof || platform || draft) {
            appendExtraFlagsToLinks(
                [['proof', proof], ['platform', platform], ['draft', draft]].filter(function(pair) {
                    return pair[1];
                }));
        }
        if (proof || draft) {
            transformNatureAssetSourcesToDraft();
        }
    }
</script>

<script src="//content.readcube.com/ping?doi=10.1038/ncomms12700&amp;format=js&amp;last_modified=2016-09-14" async></script>
<img src="/platform/track/article/ncomms12700" width="1" height="1" alt="" class="visually-hidden"/>
</body>
</html>
